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Abstract 
The importance of clean water and adequate sanitation is a widely 
recognized characteristic of healthy communities. Across the developing 
world, many communities are without this vital infrastructure, thereby 
vulnerable to enteric infections from pathogens that travel through the 
environment and may cause diarrhea. Looking beyond diarrhea, a more 
serious, long-lasting subclinical condition called environmental enteropathy 
(EE) may develop in the intestinal tract from enteropathogen exposure, 
which permanently alters the ability of the intestine to take up nutrients and 
the host to fight off infections. 
 
The first manuscript of this dissertation relates water and sanitation 
conditions in households to child EE biomarkers in stool, urine and serum. 
This study found that the water and sanitation conditions were associated 
with fecal markers for EE in a peri-urban community of Iquitos, Peru. The 
results provide preliminary evidence for the hypothesis that children under 
24 months of age living in unsanitary conditions will have elevated levels of 
fecal EE markers for gut inflammation and gut permeability that lead to 
stunting.  
 
 
iii 
The second manuscript characterizes fecal contamination on household 
floors, an important transmission route for fecal pathogens that may greatly 
affect children under 24 months of age who spend a lot of time playing and 
eating off the floor. This study found that households with improved 
sanitation and cement floors in the kitchen area had reduced fecal 
contamination compared to those with unimproved sanitation and dirt floors. 
These findings suggest that the sanitation facilities of a home may impact 
the microbial load found on floors, contributing to the potential for 
household floors to serve as an indirect route of fecal pathogen transmission 
to children. 
 
The third and fourth manuscripts present saliva as a novel and minimally 
invasive specimen for use in community based studies to assess microbial 
pressure and pathogen-specific infections. The outcome measure of salivary 
secretory immunoglobulin A was found to be associated with the sanitation 
and household characteristics of children living in peri-urban Iquitos, Peru 
and demonstrated an important proof of concept for future water and 
sanitation interventions that this marker can differentiate between 
households within a community.   
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Chapter 1 
Introduction 
 
Background 
Diarrheal diseases are a leading cause of morbidity and mortality in children 
under five years old, accounting for 10 percent, approximately 760,000, of 
all annual childhood deaths.1 Children living in low-income countries 
disproportionately suffer from malnutrition, which has been shown to affect 
cognitive development, increase infection risk, limit physical capacity and 
future childbearing, reduce adult economic productivity, and increase 
mortality risk.2 Interestingly, a pooled analysis of nine studies conducted 
between 1978 and 1998 in Africa, Asia, and the Americas showed that 
although interventions to improve hand washing, sanitation, and hygiene 
reduced diarrheal incidence by 30 percent, there was only a 2.4 percent 
reduction in prevalence of stunting.3 Dietary interventions have also been 
unsuccessful in helping children achieve normal growth, with the growth 
effect achieved in the most successful studies only eliminating a third of the 
average deficit.4  
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Environmental enteropathy (EE) is a subclinical disorder of the small 
intestine characterized by an abnormal intestinal architecture and increased 
permeability.5 As seen in Figure 1, enteropathy is mainly characterized by 
villous atrophy and intestinal inflammation. These two conditions lead to 
reduced intestinal barrier function and allow for increased translocation of 
antigenic macromolecules. The inflamed mucosal membrane with 
compromised tight junctions enable the passage of fecal pathogens from the 
intestinal lumen into the body, eliciting a subsequent systematic immune 
reaction (Figure 2).6 This chronic inflammation may mediate stunting by 
diversion of energy and nutrients needed for growth to prioritize a host’s 
survival and maintenance due to infection.7 In addition, the deterioration in 
the absorptive surface area of the small intestine due to fusion of villi may 
mediate undernutrition by reduced uptake of nutrients.5  
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Figure 1. Proposed causal pathway linking enteropathy with adverse 
health outcomes in developing countries (Prendergast & Kelly, 2012) 
 
 
 
4 
Figure 2. Proposed pathogenesis associated with environmental 
enteropathy (Korpe and Petri, 2012) 
 
  
Data from many regions of the developing world suggests that diarrheal 
disease is not responsible for the long-term pattern of growth faltering.3, 8 
For example, Gambian infants that exhibited severe mucosal damage and 
inflammation had up to 43% of their observed growth faltering attributable 
to this intestinal permeability, which was chronic and far exceeded the 7.3% 
of days in their first two years of life that they spent with diarrhea.9 Though 
these infants suffered from diarrhea and lost weight from these acute 
episodes, they tended to catch up afterward so that diarrhea prevalence was 
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not related to their overall growth.10 In addition, a recent meta-analysis of 
data from cluster-randomized controlled trials with an intervention period of 
9-12 months, found that only a small benefit on linear growth in children 
under five years of age came from water, sanitation and hygiene 
interventions1.11 These data indicate that EE rather than diarrhea, is the 
mediator between exposure to fecal pathogens and stunting (Figure 3).  
 
                                                 
1 These specific interventions include solar disinfection of water, provision of soap, and improvement of 
water quality. 
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Figure 3. Proposed causal pathway between poor sanitation conditions 
and growth faltering (bottom square) versus the conventional 
conceptual model that poor sanitation conditions are mediated by 
diarrhea to cause growth faltering in children. 
 
 
These findings suggest that the lack of improved growth following water, 
sanitation and hygiene interventions is due to unalterable gut dysfunction 
that has been established in children under five. This is further supported by 
the growing body of literature that shows the association between 
environmental factors related to poor water, sanitation and hygiene 
conditions and stunting.12-16 Therefore, for those children living in poor 
sanitation conditions, intestinal permeability is hypothesized to be “set” at an 
early age and persist throughout life.10 Exposure to pathogens at an early age 
is of greatest concern because this is the age when children are growing and 
developing rapidly and are therefore most sensitive to developmental insults. 
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Given the growing evidence that unhygienic environmental conditions in 
which children live contribute to, or perhaps causes EE, no specific 
organism or mechanism has been definitively identified as the major cause. 
It has been reported that Helicobacter pylori may allow other pathogens 
easier access to the small intestine and Giardia intestinalis causes an acute 
elevation of Giardia-specific IgM antibodies and is associated with a 
increased intestinal permeability, increased acute phase proteins and reduced 
weight gain.10 Though both these organisms are transmitted via the fecal-
oral routes of exposure, it may be that the observed associations with growth 
was a reflection of the levels of the overall fecal pathogen ingestion, rather 
than a specific effect of either H. pylori or Giardia. It is highly possible that 
EE comes from the frequent exposure to a combination of fecal pathogens 
rather than a single pathogen.  
 
There are many fecal-oral transmission pathways, which account for 
important routes of exposure for the pathogens that cause diarrheal diseases. 
These pathways can broadly be categorized into the ‘five F’s’ – fluids 
(water), fingers (hands), flies, food, and floors (Figure 4).17 A lack of access 
to clean water is often implicated as the primary fecal-oral transmission 
route, however, a number of randomized, controlled trials investigating the 
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effect of drinking water on gastrointestinal health have shown no additional 
benefit from point-of-use interventions.18-20 This lack of benefit is 
hypothesized to be because the environmental conditions from poor 
sanitation and hygiene allow for other sources of exposure through fecal-oral 
transmission pathways other than water. These other sources of exposure 
may nullify any potential benefit observed from improved water quality 
alone in a low-income setting. In addition, from an updated review of 
epidemiological studies on the effect of water and sanitation interventions on 
self-reported diarrhea episodes, no difference was found in point-of-use 
water interventions when blinding was taken into account.21 These studies 
point to the importance of focusing in on sanitation interventions as the 
primary mechanism to interrupt the transmission of pathogens via the fecal-
oral routes of transmission, rather than water supply interventions which 
may play a lesser role than once thought in reducing pathogen exposure. 
Figure 4 illustrates the role for each water, sanitation and hygiene 
intervention to interrupt the fecal-oral transmission pathways.  
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Figure 4. Fecal-Oral Transmission Pathways visualized through the “F” 
diagram and the interventions designed to interrupt these pathways 
(modified from Pruss et al, 2002). 
 
 
 
To accurately assess EE it is important to have an objective measure that 
does not depend on a self-reported outcome, as it often occurs with diarrhea. 
EE has most commonly been measured indirectly with a non-invasive dual 
sugar permeability assay.22, 23 The more direct measure of an intestinal 
biopsy would be invasive and infeasible and so investigators use an indirect 
measure of gut function to determine the ratio of lactulose to mannitol (L:M) 
excreted in urine.16 Lactulose and mannitol characterize different conditions 
in the gut. The increased absorption of the lactulose disaccharide passing 
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through tight junctions indicates a loss of mucosal integrity while the 
increased passage of the mannitol monosaccharide through the transcellular 
routes of aqueous pores, reflect a loss of absorptive area of the hydrophilic 
portion of the cell.24 Therefore, a higher ratio of the excretion percentage of 
lactulose to mannitol in urine is an indicator of intestinal permeability and 
used as a marker of EE.  
 
Other markers of EE increasingly in use include immunoglobulin G 
endotoxin core antibody (IgG EndoCAb) titers, and the fecal markers of 
neopterin (NEO), alpha-anti-trypsin (AAT), and myeloperoxidase (MPO). 
The marker of IgG EndoCAb titers is measured because increased levels 
may indicate an infection or chronic immune stimulation.  Elevated levels of 
IgG EndoCAb titers in the plasma reflect exposure to an endotoxin, a cell 
wall component of many gram-negative bacteria that could potentially cross 
a leaky mucosal membrane in the gut.16 Lastly, the fecal markers of NEO, 
AAT and MPO represent great potential for measuring exposure to 
unhygienic environments and unlike the L:M ratio, their measurement 
reflects an alterable state of intestinal function that precedes the final “end 
state” of EE.25 Each one of these three stool markers has different functions. 
NEO is a marker of gut inflammation, in which a TH1 response is produced 
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by activated T lymphocytes. A previous study found that elevated levels of 
NEO in stool resulted in growth failure in Gambian children.26 In the case of 
intestinal inflammation or damage to the mucosa, AAT leaves the gut and 
thus is a classic marker of a protein losing enteropathy, which otherwise is 
highly resistant to permeating the mucosa and is excreted intact in the stool. 
MPO is a specific marker for neutrophil activity that is not elevated in the 
stools of breastfed children and has been associated with disease states in 
inflammatory bowel disease.25 The NEO, AAT, and MPO fecal biomarkers 
are all affordable, commercially available, standardized assays that can be 
performed on normal stool to predict linear growth deficits in children.25 
Unlike the L:M test, the results can easily be carried out across laboratories 
with a minimal amount of equipment and technical expertise required.  
 
Recent studies are showing that lack of cleanliness within the household are 
associated with EE and point to the need to go beyond diarrhea in study 
outcomes.16, 27, 28 The absence of overt symptoms associated with EE 
explains why this under studied condition has not been previously identified 
as a major concern in environments with high fecal contamination.  
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A less explored route of exposure to fecal pathogens is the floors pathway, 
which may be a significant contributor to environmental contamination with 
fecal pathogens. A recent study of household floors in Tanzania showed that 
it was the dirt floors within the household rather than the latrine floors that 
had the highest burden of enterococci and E. coli.29 Children less than 24 
months of age, who are most vulnerable to enteric infection and developing 
EE, have been observed to have frequent behaviors of playing and eating off 
of the ground in high-density, low-income neighborhoods in Accra, Ghana.30 
The combination of high bacterial loads that have been found on floors in 
the home environment31-33 along with the high frequency young children 
play on floors and engage in soil to hand to mouth activities,34 there is a 
need to understand the risk that this fecal-oral pathway poses to developing 
enteric infections. 
 
A challenge with using diarrheal disease as the metric to represent exposures 
to fecal pathogens is the use self-reporting to characterize the disease state. 
Self-reporting has the potential to introduce a large amount of bias, such as 
recall bias, courtesy bias and researcher bias. The problems with the internal 
validity of water, sanitation and hygiene impact evaluations using diarrhea 
as the study outcome have been well established in the literature.35-37 Stool 
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samples are a more objective measure to classify diarrhea, however, this is 
challenging due to low rates of compliance and pathogen detection.38 Blood 
sampling is also a preferred outcome variable to self-reported diarrhea 
however it is invasive, requires trained personnel, is time-consuming, and 
carries a risk of needlestick injuries.39 Alternative outcome measures for 
water, sanitation and hygiene intervention impact evaluations that are 
objective and specific to the fecal pathogen contamination are therefore a 
necessary area of research.40, 41  
 
Saliva collection is increasingly being shown to accurately diagnose 
infections from viral, bacterial and parasitic infections.42 The use of 
antibodies in saliva is objective, simple, rapid, requires little training, 
eliminates the risk of needle-stick injuries, is appropriate for both children 
and adults, and is suitable for nonclinical settings.43 Oral fluid is emerging as 
a novel method to measure exposure to fecal pathogens by the presence of 
antibodies in saliva, particularly in crevicular fluid. An increase in specific 
antibodies in saliva as a result of infection has been described in the 
literature as a potent measure of disease exposure and its use could enhance 
epidemiological studies of waterborne diseases.44 Saliva is a mixture of 
secretions from salivary glands and the crevicular fluid from between the 
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gum margins and the teeth.  Immunoglobulin concentrations in crevicular 
fluid are much higher than in salivary gland secretions and hence, a saliva 
sample that has a high proportion of crevicular fluid is most suitable for 
antibody detection.45 Griffin et. al documented the first stage of a pilot, 
proof-of-concept project to develop a non-invasive salivary antibody 
technique for surveillance of waterborne infections.38 This study collected 
saliva with an Oracol sampler sponge, an absorbent foam swab, (Malvern 
Medical Developments, Worcester, UK) as shown in Figure 5. 
 
Figure 5. Oracol oral fluid collection device (Malvern Medical 
Developments, Worcester, UK)45 
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Oracol was designed to specifically target the gum area where crevicular 
fluid is found and the sponge is rubbed firmly along the base of the gums of 
the upper and lower jaw for 1 minute, using an action similar to tooth 
brushing.38, 45 The sampler sponge is then tubed and returned to the 
laboratory at 4 degrees C, where the fluid is squeezed out and clarified by 
centrifugation.  
 
Typically, the salivary IgA response to a fecal pathogen challenge occurs 
before the IgG response and the IgA response tends to peak earlier than the 
IgG response, which will continue to increase even after the IgA response 
has peaked.38 The primary function of salivary lgA is the opsonization of 
foreign invaders at the oral port of entrance to the body and the blockade of 
pathogen infectivity.46 Total IgA and total IgG are used as an overall 
indication of immune response while pathogen specific IgA and IgG assays 
are currently under development for pathogens such as Helicobacter pylori, 
Toxoplasma gondii, Cryptosporidium, and four noroviruses.38 It is important 
when carrying out the analysis to control for the different factors that affect 
salivary flow such as time since waking and food ingestion. The basis of the 
assay is that a specific antibody, if present in the specimen, cross-links 
antigenic sites on separate particles, agglutinating them and allowing for 
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visual reading.47 Thus, the use of salivary immunoassays offers an efficient, 
non-invasive and economical means of determining the exposure of 
individuals to fecal pathogens present their environment. 
 
Study Site 
Iquitos, Peru is an excellent location for the research described in this 
dissertation given the Satellite Laboratory IQTLAB located in the 
community. The IQTLAB is equipped to carry out microbiologic, 
immunologic, and PCR based diagnostics. This laboratory was founded in 
2002 by Dr. Margaret Kosek, Pablo Peñataro Yori, RN, MPH, and Dr. 
Robert Gilman of Johns Hopkins University Bloomberg School of Public 
Health and brings in experts from Asociación Benéfica Prisma, a non-
governmental organization that has been working in Peru for over 25 years 
to strengthen the capacity of the poor and vulnerable to achieve social and 
economic development.  The capabilities of the IQTLAB present great 
opportunity to carry out environmental microbiologic research in addition to 
many other relevant areas of research. 
 
Iquitos is part of the multisite Etiology, Risk Factors and Interactions of 
Enteric Infections and Malnutrition and the Consequences for Child Health 
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and Development (MAL-ED) cohort study, which is investigating enteric 
infections and nutritional status on child growth and cognitive development 
through the use of standard protocols of surveillance and assays 
implemented. The MAL-ED study includes eight sites from diverse 
epidemiologic settings – Fortaleza (Brazil), Dhaka (Bangladesh), Vellore 
(India), Bhaktapur (Nepal), Loreto (Peru), Naushahro Feroze (Pakistan), 
Haydom (Tanzania), and Venda (South Africa) – which span rural and urban 
environments and are representative of the conditions of children living in 
poverty across the developing world.48 The Peru site is of particular interest 
for the investigation of the impacts from poor water, sanitation and hygiene 
conditions on environmental enteropathy given that it is also the site for a 
grant from the Bill & Melinda Gates Foundation on biomarkers of gut 
function within the grand challenges in global health initiative. The goal of 
the grant program is to identify and validate biomarkers that can assess gut 
function and guide new ways to improve the health and development of 
children in the developing world. The grant is pioneering the use of the fecal 
markers of NEO, AAT and MPO to use as a more effective way to measure 
the risk a child faces in developing environmental enteropathy and therefore 
presents an opportunity for intervention for that child. Given the cohort of 
children with well-characterized monthly stool samples under the MAL-ED 
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study, along with the work on advancing gut biomarkers, Iquitos is ideally 
suited to simultaneously explore the environmental exposures to fecal 
pathogens that may be causing these enteric infections. 
 
Going beyond diarrhea to examine the impacts of fecal-oral diseases is 
ideally suited to the conditions in Iquitos, Peru. The burden of diarrheal 
illness is high in this peri-urban population with one study on shigella-
associated diarrhea reporting a diarrheal disease incidence of 4.38 episodes 
per child-year.49 These incidence rates for a stable population of children 
under five are relatively high when compared to the literature in the last 
decade.50 In addition, the childhood stunting rates in this region are elevated 
to almost 50 percent while the rest of Peru is approximately 20 percent.51 
The possible attribution of stunting to fecal pathogen exposure and 
environmental enteropathy is further supported by the length for age z-
scores (LAZ) from a birth cohort in Iquitos of children 0 to 24 months of age 
in Figure 6. Here the LAZ scores were one standard deviation below normal 
during birth but declined more severely over the next 24 months, pointing to 
possible environmental risk factors in this community.52  
 
Figure 6. Anthropometric z scores from 0 to 24 months of age in cohort 
from Iquitos, Peru.52 
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The Iquitos, Peru research site is also well suited to study environmental 
contamination from water, sanitation and hygiene conditions. The 
development statistics of the study site community Santa Clara, located 
15km outside of the city center of Iquitos, show high rates of diarrheal 
disease and stunting compared to the rest of the country as a whole. In 
addition the percent of the population in Santa Clara with access to clean 
water and improved sanitation lags behind the rest of the country with only 
half having access to clean water and a fifth with access to an improved 
toilet (Table 1). 
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Table 1. Development Statistics in from Santa Clara community in 
Iquitos Peru and the overall country statistics from Peru in 2012. 
(Source: Instituto Nacional de Estadística e Informática, 2012) 
 
 
 
The maternal education levels for mothers in the region are relatively high 
with one study showing less than one percent were illiterate, and 48 percent 
had advanced past primary school level.49 This points to the environment as 
a potential source of contamination rather than other socio-economic factors 
common in low-income settings. All combined, the development 
characteristics of Iquitos, Peru present a unique opportunity to study the 
connection between poor sanitation and the condition of environmental 
enteropathy.  
 
Hypothesis and Specific Aims 
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The overarching hypothesis underlying the work in this dissertation is that 
fecal contamination in the household environment due to a lack of adequate 
water, sanitation and hygiene contributes to the development of 
environmental enteropathy in peri-urban, flood-prone communities in 
Iquitos, Peru. This hypothesis will be investigated with three specific aims as 
laid out in Figure 7. 
 
Figure 7. Schematic diagram of sampling framework for specific aims 
within MAL-ED study. 
 
 
Specific Aim 1 
The first aim of this dissertation was to estimate the association between 
household water and sanitation conditions and hygiene practices and 
environmental enteropathy in children under five in the Santa Clara 
community in Iquitos, Peru. This aim included secondary data analysis of 
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data collected at the Peru site of the MAL-ED study to estimate the relative 
importance of household environmental contamination on gut inflammation. 
The MAL-ED longitudinal follow-up study prospectively collected diarrhea 
surveillance, stool samples, and growth measures on a monthly basis from 0 
to 24 months of age to characterize the hypothesized pathways between 
enteric disease and growth. The stool samples were analyzed for three fecal 
gut markers (NEO, AAT, and MPO) and the L:M test. This site in the 
Peruvian Amazon is of particular interest for this research question for its 
focus on gut function where approximately 200 children were enrolled at 
birth.  
 
A robust set of data was collected on the environmental household 
conditions from community surveys of the population that include a Follow-
up Socio-Economic (FSE) status form (bi-annual) and a community census 
administered in 2010 and 2012. The FSE form was similarly administered to 
the other seven sites in the MAL-ED study and contains water, sanitation 
and hygiene variables along with wealth, education and other household 
characteristics. The census survey was only administered in Iquitos, Peru 
and included every household with a child enrolled in the MAL-ED study in 
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2010 and 2012. Most importantly, the census collected site-specific 
information on water storage practices throughout the community.  
 
The outcome variables used were the gut biomarkers of intestinal 
inflammation, which included MPO, NEO and AAT. The sugar permeability 
tests were carried out to measure the lactulose to mannitol ratio which has 
been used in previous studies to assess the permeability of the gut to 
macromolecules and intestinal absorptive capacity, to characterize altered 
gut physiology, a key pathway leading to growth failure in children. 
Surveillance visits were made to households on a bi-weekly basis and stool 
samples were collected on a monthly basis. Additional stool samples were 
collected if the child was reported to be symptomatic for diarrhea at the time 
of a surveillance visit. Multivariate regression models evaluated the 
associations between the household environmental contamination variables 
and the various markers for EE. Mixed models were used to account for 
within-subject correlation over time. 
 
Specific Aim 2 
The second specific aim measured the concentration of fecal contamination 
on household floors and surfaces and estimated its association with 
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environmental enteropathy in children under five within the household. This 
aim characterized the level of fecal microorganisms on the floors and 
surfaces in the household environment in Iquitos, Peru and related this 
contamination to the different water, sanitation and hygiene characteristics 
of the home. There is a need to better understand the source, distribution, 
and fate of fecal contamination in households and this study examined the 
potential role for floors in the transmission of fecal pathogens. Two 
household floor sampling sites were chosen - one in the highly trafficked 
entrance area and another in the area of food preparation where there were 
more frequent water activities. Replicate samples were taken from each 
entrance floor sampling site within the household to quantify the within-
sample variability. This provided a better characterization of fecal 
contamination in the household. 
 
Specific Aim 3 
The third aim of this dissertation investigated the utility of salivary 
immunoassays as a novel and non-invasive approach to improve assessment 
of recent exposure to fecal pathogens in a community-based longitudinal 
study. The objective of this study was to verify the application of salivary 
antibody tests in a pilot community study for surveillance of gastrointestinal 
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infections. This longitudinal antibody monitoring was then associated with 
the household cleanliness factors related to water, sanitation and hygiene 
conditions. In low-income settings the use of saliva as a non-invasive and 
low-cost specimen with a rapid sampling technique may vastly improve the 
quality of impact evaluations associated with water, sanitation and hygiene 
interventions.  
 
This study was nested within the MAL-ED cohort of children in Iquitos, 
Peru and the saliva specimen sampling was carried out alongside the 
ongoing stool collection under the MAL-ED protocol. The saliva specimens 
were collected with the Oracol sampler sponge and analyzed for total protein 
and secretory IgA (SIgA) using off-the-shelf commercial kits from 
Salimetrics, LLC. The strengths of this study were the frequent weekly 
longitudinal sampling of each child, as opposed to the yearly sampling that 
has been done under other studies.53-55 During saliva collection, data was 
collected on the other factors that can affect antibody concentration such as 
human patterns of diurnal Ig variability (e.g., time since last sleeping), 
volume of the saliva sample collected, oral health of the child, and if the 
child had eaten anything in the last hour and protein in the last twenty 
minutes before saliva sampling. The measurement for microbial exposure 
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was estimated using proxies for fecal contamination in the household 
including the types of water and sanitation infrastructure, as well as hand 
washing behaviors. The levels of microbial contamination found on 
household floors and surfaces from Specific Aim 2 were also used to 
estimate the microbial exposures and were related to the SIgA measures in 
saliva. 
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Abstract 
Poor child gut health and a lack of access to an improved toilet or clean 
water is an area of interest to understand the biological mechanisms 
underlying stunting. A birth cohort of 270 children from peri-urban Iquitos 
Peru were characterized for their household sanitation, water use, hygiene 
and household characteristics. These children were had monthly stool 
samples, quarterly urine samples and annual serum samples analyzed to 
derive estimates of their progression toward environmental enteropathy. This 
study found that sanitation conditions were associated with fecal markers for 
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EE (no sanitation facility compared to those with a toilet had -0.43 log 
myelperoxidase (MPO), 95% CI: -0.74, -0.13) as well as water conditions 
when comparing those with an intermittent connection versus those that had 
a continuous supply (MPO increased 0.36 log, 95% CI: 0.08, 0.63). These 
results provide preliminary evidence for the hypothesis that children under 
24 months of age living in unsanitary conditions will have elevated levels of 
fecal EE markers for gut inflammation and permeability that lead to 
stunting.  
 
Introduction 
Stunting is a widespread condition for children in low and middle income 
countries1 and if not reversed by 2 years old, stunting can have long-term 
effects on health and development. In 2011, a global estimate for stunted 
children under 5 years old was 165 million based on a height-for-age Z score 
(HAZ) –2 or lower.2 An even larger number of children that are above the -2 
HAZ threshold still experience inadequate growth, damaging the 
development potential and human capital of entire societies.3 Stunting is 
now recognized as a major global health priority4 and the Sustainable 
Development Goals recently adopted at the 2015 UN Summit state “by 2030 
end all forms of malnutrition, including achieving by 2025 the 
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internationally agreed targets on stunting and wasting in children under 5 
years of age” (Target 2.2, https://sustainabledevelopment.un.org/topics). To 
achieve these ambitious targets, an in-depth understanding is needed of the 
complex interactions between enteric infections and undernutrition that 
contribute to linear growth faltering.5 
 
Childhood enteric infections brought on by chronic exposures to fecal 
pathogens, are predicted to account for 25-43% of the worldwide stunting 
burden.6 Fecally contaminated environments put children at risk for chronic 
exposure to enteric pathogens and with 2.5 billion people who do not have 
access to an sanitation facility7, a large portion of children in the developing 
world are at risk. Sustained episodes of acute gastroenteritis (symptomatic or 
not) may lead to perpetual inflammation and structural changes in the small 
bowel8, a condition known as environmental enteropathy (EE), and is a key 
mediator in the relationship between enteric infections and linear growth. It 
is a subclinical condition defined by structural and functional changes to the 
small bowel (blunting of the finger-like villi and crypt hyperplasia)9 and 
accompanied by increased intestinal inflammation, permeability, and 
bacterial translocation, which may lead to systemic immune activation and 
decreased nutrient absorptive capacity of the intestine.8, 10-12 A murine model 
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has demonstrated that the etiology of EE originates from both a 
malnourished diet and repeated oral exposures to commensal bacteria.13 
Therefore, food security alone cannot fully explain our understanding of 
growth faltering and new efforts are needed to understand how fecal-oral 
contamination of the environment impacts the development of EE. 
  
The evidence linking water, sanitation and hygiene conditions (WASH) with 
childhood stunting has increased substantially in recent years.14, 15 Most 
notable is a cluster-randomized controlled trial (RCT) in Mali that 
demonstrated increased child growth for children with increased access to 
toilets 16. The inverse relationship between fecal-oral contamination and 
childhood stunting has also been reported in non-randomized studies 17-21. 
The increasing evidence that improved hygienic environments might 
contribute to improved growth outcomes for children justifies research into 
the WASH-EE mechanism through which these improvements in linear 
growth may occur. 
 
There is scant evidence, however, linking environmental conditions to the 
physiologic, anatomic, and functional changes in the gut as a result of a 
prolonged and persistent exposure to multiple enteropathogens.5 EE was 
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identified in a study of Zambian adults and found that small intestinal 
artcitecture (crypt depth but not villous atrophy) was associated with a 
hygiene score.9 In Bangladesh, children from clean households versus 
contaminated homes had less intestinal permeability, though only marginally 
significant.20 Also in Bangladesh, children that engaged in soil eating 
behaviors or had an animal corral in their sleeping quarters were found to 
have a higher EE score.22, 23. An additional challenge for EE studies is that 
biomarkers that can be used in environments with poor WASH conditions to 
obtain population based measurements of EE is an open area of 
investigation.24 
 
The aim of this study was to explore the associations between household 
WASH factors and fecal, urine and serum biomarkers for EE in a 
longitudinal cohort. We hypothesized that reasonable improvements in water 
and sanitary infrastructure and hygienic practices could improve the small 
intestine structure and function in children younger than 24 months of age. A 
comprehensive set of WASH variables were examined with an in-depth 
characterization of water storage practices. These variables were then related 
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to various fecal, urine and serum biomarkers for EED at the Iquitos Peru site 
of the MAL-ED2 study.  
 
Methods and Materials 
 
Study site and population 
The study site is located along the Nanay River, a tributary of the Amazon, 
in three peri-urban communities - Santa Clara de Nanay, Santo Tomas, and 
La Union (3°47’S, 73°20’W). These communities are located about 15 
kilometers outside of the city center of Iquitos in the Department of Loreto 
with a population of approximately 5,000 people and a population density of 
4.6 people per square meter.25 Despite Peru’s success in meeting its 
Millennium Development goals for both access to improved water and 
sanitation,26 these peri-urban communities still lag behind the country and 
only 50 percent of the population uses improved water sources and 20 
percent has access to an improved toilet facility.25 There is no centralized 
sewerage in the community and therefore, even those that have an improved 
toilet option such as a pour flush toilet, face a hazard from frequent 
overflows and lack of services to hygienically empty, transport and treat 
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fecal matter. Water storage risks recontamination of improved drinking 
supplies27 and is utilized widely throughout the community due to the 
intermittent supply for those connected to the piped system and frequent 
breakdowns of hand pumps. The municipal water system delivers water to 
households for hour-long intervals and hand pumps are connected to artesian 
wells that are often shared between households. Bleach is readily available 
in the community and used for water treatment. The community is 
vulnerable to frequent floods that inundate latrines causing overflow and 
putting those with onsite sanitation at greatest risk for contamination.  
 
Childhood stunting is remarkably high in this study community when 
compared to the rest of Peru and beyond. For children under 5 years old in 
peri-urban Iquitos Peru, 46.3 percent are stunted (HAZ < -2)25 compared to 
Africa and Asia where 35.6 percent and 26.8 percent of children under 5 
years old are stunted, respectively.2 A cohort study in Santa Clara found the 
incidence of diarrheal illness in children 12-23 months of age is 4.38 
episodes per child-year,28 which is relatively high when compared to the 
literature in the last decade.29 When comparing the number of pathogens 
detected in the stool of children under two years old across MAL-ED sites, 
the Peru site was in the low range for children at three months old compared 
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to other sites with about 0.5 pathogens detected per stool. The Peruvian 
children then progressively acquired more pathogens detected per stool and 
by 24 months old they had about 2.0 pathogens detected per stool.30 This 
frequent detection of pathogens in stool is potentially caused by widespread 
fecal contamination and may lead to chronic insults to the infant 
gastrointestinal tract. 
 
Selection Criteria 
The MAL-ED birth cohort used a prospective longitudinal design among 
eight country sites with historically high incidence of diarrheal disease and 
undernutrition to investigate the hypothesis that enteropathogen infection 
contributes to undernutrition by causing EE.31 The study was designed to 
enroll approximately 200 healthy infants born to mothers greater than 16 
years old within 17 days of birth. Enrollment was limited to one child per 
household and children were excluded from the cohort if they were enrolled 
for less than six months, had a caregiver with plans to move out of the 
catchment area during the first 6-months of follow-up, exhibited serious 
indications of disease or were of low birth weight (<1500g). Enrollment 
occurred over a two year period from January 2010 to February 2012 and 
children were followed through 24 months of age. 
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Household water, sanitation and hygiene risk factors 
Each household with a child enrolled in the MAL-ED study was 
administered a socio-economic survey with questions related to water 
(source type, continuity of supply, point-of-use treatment and collection), 
sanitation access (type of facility, sharing behavior with other households), 
hygiene behaviors (hand washing activities, use of toilet paper), and 
household characteristics (floor type, roofing and wall materials, number of 
rooms, years of tenancy, electricity, etc). A hygiene index variable score was 
calculated as a cumulative score from the following four questions: i) Do 
you wash your hands after helping your child defecate? ii) Do you wash 
your hands before preparing food? iii) Do you wash your hands after going 
to the bathroom? and iv) Do you use toilet paper?. The hygiene index score 
had three levels with good indicating the interviewee answered all questions 
as always practicing the hygienic behaviors; average indicated that for one 
of the four questions the interviewee only sometimes practiced the hygienic 
behavior; and poor indicated that for two or more questions the interviewee 
only sometimes practiced the hygienic behavior. The wealth index was a 
sum of different possessions owned in each household giving equal weight 
to all possessions. The survey was adapted from questions used by the 
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Demographic and Health Surveys.31 It was administered at 6, 12, 18 and 24 
months of age for the children enrolled. Other variables of interest recorded 
were head-of-household and maternal education, monthly income level (in 
soles) and crowding. Breastfeeding status was recorded alongside these 
variables by a separate survey to characterize exclusive, mixed and fully 
weaned breastmilk intake. 
 
An in-depth characterization of water storage practices was done by a 
community census that was administered in 2010 and 2012. The questions 
administered in the survey had been previously validated in a 2005 census 
and were shown to relate to the risk of diarrheal disease in the study 
community.28 The variables of interest include the total volume of water 
stored in the household, types of containers used for storage and lid type 
(with or without lids). These questions were recorded by observation from 
trained field workers well acquainted with the local practices of water 
storage.  
 
Stool collection and fecal marker assays 
Longitudinal stool samples were collected more frequently and were less 
logistically burdensome than both serum and urine collection. Fecal markers 
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of EE - myeloperoxidase (MPO), neopterin (NEO), alpha-1-antitrypsin 
(AAT) - that have been found to be associated with declines in length-for-
age scores across all eight sites of the MAL-ED cohort study24 were utilized 
in this study for stool analysis. Stool samples were collected by field 
workers (without fixatives) on a monthly basis from birth to 24 months of 
age. Children were followed twice weekly for active surveillance for 
diarrheal disease and illness. Prior to stool testing all samples were stored at 
−70°C. Analysis for fecal markers was done on a monthly basis until 12 
months of age and then at 15, 18, 21 and 24 months. Stool samples were 
analyzed in parallel for MPO (Alpco, Salem, New Hampshire), NEO 
(GenWay Biotech, San Diego, California), and AAT (Biovendor, Chandler, 
North Carolina) as previously described.5 In summary, MPO and NEO were 
chosen as markers of gut inflammation to represent immune activation and 
AAT was chosen as a marker of intestinal permeability and mucosal protein 
wasting secondary to EE. All fecal markers are considered stable in stool 
specimens and resistant to degradation in the intestinal lumen.  
 
Urine collection and dual sugar test 
There is no gold standard to characterize the EE condition, however, the 
urinary lactulose to mannitol (L:M) dual sugar test has been used most 
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widely to asses intestinal barrier function and identify altered permeability 
(lactulose) and malabsorption (mannitol). Despite its wide use, few 
standards exist across studies and laboratories for administration of sugar 
dosages, urine collection times, assessment of analyte concentrations, or the 
interpretation of results.32 In addition, administration of the five-hour 
“bagged” urine collections are burdensome for both families and field 
workers.33 Despite these logistical and technical challenges, the dual sugar 
permeability test was administered under the MAL-ED protocol to each 
infant at 3, 6, 9, and 15 months of age.5, 32 Urine aliquots were stored at 
−70°C prior to measurement of lactulose and mannitol concentrations by 
LC-MS/MS. The disaccharide solution was administered after stool 
sampling was complete to avoid inaccurate protein measurements in stool 
due to dilution from the watery stool caused by the L:M test. 
 
Serum collection and plasma markers 
Both known and potential biomarkers of EE are also found in serum such as 
alpha-1-acid glycoprotein (AGP)34 and citrulline6, however, collection of 
serum in field-based studies can be logistically challenging and limits the 
frequency of longitudinal samples that can be collected per child. Therefore, 
serum was collected and analyzed for the AGP, and citrulline markers at 7, 
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15, and 24 months of age. The AGP marker was included because it is often 
used in population based studies34 to monitor inflammation during an 
infection35 and was expected to be higher with more EE.36 Plasma levels of 
AGP were determined by radial immunodiffusion.5 Serum citrulline 
concentrations are potential biomarkers for overall mucosal function37 and it 
is reduced in villus atrophy syndrome which has decreased epithelial cell 
surface area.38 
 
Data Analysis 
Longitudinal analyses were conducted on the entire sample enrolled up to 24 
months of age. The primary outcomes of fecal, urine and plasma markers 
were each log-transformed for normality. Fecal markers were averaged over 
three month time periods (6, 12, 18 and 24 months of age) to reduce the 
variability from individual measurements. The means of each fecal marker 
were age-matched to the socio-economic survey data with water, sanitation, 
hygiene and household independent variables. For example, if fecal markers 
were averaged over months 6, 7 and 8 they were then matched to the 
independent variables collected from the survey administered at 6 months of 
age for that child. The urine and serum markers were similarly age matched 
to the independent variables. The relationships between WASH variables 
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and the EE markers was explored using mixed-effects linear regression, with 
a random effect specified at the child level to account for within-child 
correlations. The final multivariate mixed-effects models were adjusted for 
age, season, breastfeeding, maternal education, and wealth index. An 
available-data analysis was used and missing data were considered missing 
at random. Therefore the likelihood based modeling approach with correct 
specification of mean and covariance model was deemed appropriate. To 
assess model fit the intraclass correlation (ICC) was used to determine if 
there was greater variability within than between individuals. In the case of a 
low ICC (less than 0.10) a multivariate regression model was run to 
determine the R-squared and adjusted R-squared values of each model to 
assess the model fit. Data analyses were performed in Stata version 12.1 
(College Station, TX). 
 
Ethics Statement 
All data presented in this analysis was collected as part of the Peru site 
MAL-ED cohort, and was approved by institutional review boards from 
Johns Hopkins Bloomberg School of Public Health (Baltimore, MD) and 
Asociación Benéfica Proyectos de Informática, Salud, Medicina, y 
Agricultura (A.B. PRISMA), Lima, Peru.  
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Results 
 
Community profile 
A total of 303 children were enrolled from the catchment area and 270 
children remained in the study remained in the study to be surveyed for the 
6-month baseline survey with WASH household characteristics. Between 
each six-month sampling period less than ten percent of the sample were lost 
to follow up until the children were 24 months of age. Either the 2010 or 
2012 community census that was administered closest to the child’s birth 
date was used to represent the water storage variables for a total of 258 
children in the cohort. The median number of household members was 6.6 
(95% CI: 6.0, 6.6) with 28.5 percent of the population had lived in their 
current house for less than one year (Table 1). The time-varying WASH 
variables that reported at least one change over the 24 months study were: i) 
type of sanitation facility used by the household (63.9 percent of 
population), ii) shared sanitation facility (46.4 percent of population), 
drinking water source option (55.5 percent of the population), household use 
of chlorine to treat their water (37.7 percent of the population), the 
continuity of the piped water supply (39.8 percent of the population), the 
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main floor type of the household (34. 2 percent of the population), 
household hygiene score (60.5 percent of the population); and the household 
location of the cooking activities (51.9 percent of the population).  
 
The fecal marker analyte results from asymptomatic stool samples collected 
at the 6, 12, 18 and 24 month time points and averaged with the subsequent 
two months resulted in 889 observations for MPO, 892 observations for 
NEO and 877 observations for AAT. The median concentration for MPO, 
NEO and AAT all decreased across the 6, 12, 18 and 24 month time points 
as shown in Table S1. 
 
Associations between sanitation variables and EE markers 
The community had three main categories for the primary sanitation 
variable: a pour flush toilet in or near the house that flushes to a septic tank 
onsite (14.8 percent, n=40), no access to a sanitation facility and instead 
utilized the bush, field or bucket toilet (15.2 percent, n=41) and pit latrines 
located outside the home (58.2 percent, n=157) (Table 1). The pour flush 
toilet was considered to be the most hygienic option by definition of the 
Joint Monitoring Program that classifies a flush or pour flush toilet to a 
septic tank as improved.39 The households that had either unimproved option 
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of no facility or a pit latrine when compared to the flush toilet both had 
lower markers for EE as indicated by MPO (-0.34 log, 95% CI: -0.61, -0.08) 
and NEO (-0.21 log, 95% CI : -0.42, 0.00) (Table 2). Meanwhile for the 
serum EE markers there was higher EE for households that had no facility 
versus those with a flush toilet to a septic  (0.26 log, 95% CI : 0.09, 0.43) 
(Table 2). Sharing toilet facilities where a household reported two or more 
families using the same toilet or latrine was reported in 26.3 percent of the 
population (n=71) at the 6-month baseline survey. If families shared their 
sanitation facilities, there was an average of 2.1 families using the same 
toilet or latrine. For households that shared sanitation facilities compared to 
those that did not share, the only EE marker for which a significant 
association was reported was for MPO which had 0.16 higher log MPO 
(95% CI: 0.00, 0.33) (Table 2). In the fully adjusted multivariate regression 
models the relationship remained significant was for households with no 
sanitation facility compared to those with a pour flush toilet for MPO and 
the effect size increased to (-0.43 log, 95% CI: -0.74, -0.13) (Table 3). 
 
Associations between water variables and EE markers 
The main drinking water source for households in the study community was 
a tube well or borehole and in the 6-month survey this represented 41.5 
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percent (n=112) of the population (Table 1). The second most prominent 
type of drinking water source was a piped water connection to the household 
for 25.2 percent (n=68) (Table 1). A household water connection was also 
considered the most hygienic option in this study as these households were 
less likely to store water and therefore there was a lower recontamination 
risk. For households with a piped connection into their yard or plot, there 
was 0.29 log (95% CI: 0.07, 0.52) and 0.28 log (95% CI: 0.09, 0.46) higher 
MPO and NEO respectively, when compared to homes with household piped 
connections (Table 2). Similarly, for households with tube wells or 
boreholes as their drinking water source there was was 0.21 log (95% CI: 
0.01, 0.40) and 0.16 log (95% CI: 0.005, 0.31)) higher MPO and NEO 
respectively, when compared to homes with household piped connections 
(Table 2). And lastly, for households that used a public tap or stand pipe, 
they had higher L:M test ratios when compared to homes with household 
connections (0.38 log, 95% CI: -0.002, 0.77). These relationships remained 
significant in the fully adjusted  multivariate regression models, and their 
effect sizes increased, except for homes with tubewells or boreholes and 
MPO that was no longer significant (Table 3). An intermittent water 
connection was common in the community with 87.0 percent of the 
population reporting interruptions at the 6-month survey (Table 1). Those 
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that had intermittent connections had higher EE fecal markers with 0.37 log 
(95% CI:0.16, 0.57) higher MPO and 0.23 log (95% CI: 0.03, 0.43) higher 
AAT (Table 2). In the fully adjusted multivariate regression models the 
relationship remained significant for MPO with 0.36 log (95% CI: 0.08, 
0.63) higher for those with an intermittent connection versus those that had a 
continuous supply (Table 3). The mean total volume of water stored per 
capita by household was reported to be 16.5 liters (standard deviation = 15.1 
liters) (Table 1b). In the fully adjusted models, there was statistical 
significance for fecal EE markers where for those that stored greater 
volumes of water there was lower MPO (-0.33 log (95% CI: -0.58, -0.08) for 
the third quartile and -0.26 log (95% CI: -0.52, -0.005) for the fourth 
quartile) and lower NEO (-0.21 log (95% CI: -0.41, -0.01) for the second 
quartile and -0.26 (95% CI: -0.46, -0.07) for the third quartile) when 
compared to the quartile with the lowest amount of water stored (Table 3). 
Household treatment of water with chlorine was reported in 14.1 percent of 
the population (Table 1), however, there was no statistical significance with 
the EE markers in either the unadjusted or adjusted models (Tables 2 and 3).  
 
Associations between hygiene variables and EE markers 
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The majority of the population (66.7 percent) reported a hygiene score that 
indicated they always practiced all hygienic behaviors at the 6-month 
baseline survey (Table 1). When comparing to those in the population that 
always practiced hygienic behaviors, higher EE serum markers were 
reported for those that practiced for most of the time (0.15 log (95% CI: 
0.01, 0.28) for AGP and 0.11 log (95% CI: 0.001, 0.21) for citrulline (Table 
2). These relationships were no longer significant in the fully adjusted 
models (Table 3).  
 
Associations between household variables and EE markers 
Households in the study community had two main floor types with dirt (73.0 
percent) or cement (21.5 percent) and a small percentage of households with 
wood floors (5.6 percent) at the baseline 6 month survey (Table 1). In the 
unadjusted analyses, dirt floors had lower fecal and urine EE markers when 
compared to households with cement floors however, none were statistically 
significant (Table 2). In the fully adjusted model, those with dirt floors had a 
lower L:M test ratio (-0.35 log (95% CI: -0.61, -0.09) when compared to 
cement floors (Table 3). The location of cooking activities in the households 
varied by 72.5 percent inside the house and 25.3 percent outside the house at 
the 6-month baseline survey (Table 1). For households with cooking 
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activities performed outside the house there was lower fecal EE markers for 
both MPO and AAT (-0.20 log (95% CI: -0.37, -0.02) and -0.30 log (95% 
CI: (-0.46, -0.13) respectively) (Table 2). The relationship for cooking 
activities outside with AAT remained statistically significant and increased 
effect size in the fully adjusted model (-0.40 log, 95% CI: -0.60, -0.21) 
(Table 3). 
 
Discussion 
To our knowledge this is the first prospective longitudinal study to show 
significant associations with household WASH conditions and development 
of EE in a birth cohort for the first 24 months of life. After adjusting for 
potentially confounding covariates, the hypothesized water pathway showed 
higher EE for less protected drinking water sources (+0.32 log MPO and 
+0.28 log NEO for water piped to a yard or plot, and +0.20 log NEO for 
water from a tube well compared to a household piped water connection), 
lower EE as the water quantity stored per capita increased (-0.33 log MPO 
for third quartile, -0.26 log MPO for fourth quartile, -0.21 log NEO for 
second quartile, and -0.26 log NEO compared to the first quartile of amount 
of water stored), and higher EE for households that had a water supply that 
experienced interruptions (+0.36 log MPO). The hypothesized sanitation 
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pathway also showed lower EE for households that did not have access to a 
toilet facility and therefore defecated in places thought to be a greater 
distance from their household living environments (-0.43 log MPO).  
 
Even among a relatively contained community with many shared 
infrastructure characteristics we were able to find a difference in the gut 
health of children from homes that used different types of toilet facilities and 
drinking water infrastructure. The longitudinal study design was able to 
capture the changes in the facilities used by households and account for 
these changes over time in relation to the development of EE over the first 
24 months of life. Interestingly, the overall environmental contamination 
caused by open defecation did not nullify the differences between 
households even though households in the study community were in relative 
proximity to one another at the village level. This observation supports prior 
conclusions20 that the household level is the appropriate unit of intervention 
for water and sanitation infrastructure.  
 
The finding that the pour flush toilet sanitation option, which meets the 
definition for improved sanitation by the JMP was associated with higher 
fecal markers for EE compared to the unimproved option of no facility, is 
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important for this study setting. We hypothesize this finding is attributable to 
the common occurrence of fecal matter overflowing from the toilet storage 
pit and contaminating the surrounding household environment.40 The pour 
flush toilets were typically located in close proximity to the households and 
may have created a greater risk for children to be exposed to fecal pathogens 
when the facilities overflowed as compared to homes where people 
defecated further away out in the open.41  
 
This study found evidence for increased EE fecal marker of MPO for 
households that sometimes had interruptions in their water supply. 
Interruptions in water supply may force a household to use a less protected 
water sources or may contaminate the piped water supply from a loss of 
pressure and allow environmental waters to enter the pipes, which are often 
contaminated where sanitary improvements are lacking42. This finding 
supports the assertion that improved drinking water sources will not make 
meaningful contributions to public health if these systems are subject to poor 
reliability.43 A low availability of water stored in liters per capita was 
recorded in the households of the study community with an average of 16.5 
liters per capita. This is far below the recommended quantity of 50 liters per 
person per day to meet basic health needs for drinking, cooking and 
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hygiene.44 This study found an inverse relationship with amount of water 
stored and fecal EE markers of MPO and NEO suggesting that a greater 
quantity of water available in the home improves the gut health risks 
associated with poor hygiene.  
 
Households that performed their cooking activities outside had lower 
occurrence of EE as indicated by AAT, the marker for nutrient wasting. This 
highly significant finding showed the potential protective effect that solar 
inactivation may have for open air kitchens on child gut health. This may be 
explained by the greater risk of exposure to fecal pathogens in the household 
when cooking and water activities are performed in an enclosed, dark and 
humid environment where the majority of the floors are dirt and difficult to 
disinfect. In contrast, homes that cook outside may harbor fewer pathogens 
given solar inactivation45 or wash out of fecal contamination following rain 
events. 
 
This study was the first to compare associations between the WASH 
characteristics across five markers for intestinal inflammation, permeability, 
and nutrient absorptive capacity as stand alone determinants for the 
progression toward EE. The fecal markers of MPO and NEO showed the 
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greatest potential as biomarkers for the condition and had the strongest 
associations for both the water and sanitation variables with 18-27% of the 
variability in the fecal markers explained by the WASH determinants. The 
L:M urine marker would be considered a secondary candidate for 
determining EE under this analysis. There is a need to assess the utility of 
potential biomarkers for EE within communities of varying levels of WASH 
characteristics since a clear gold standard is not yet defined. This analysis 
provides more support to continue using MPO and NEO in exploratory 
WASH studies.  
 
This study has several important limitations. First, the characterization 
WASH variables that were tailored to the local context only occurred at the 
baseline of the study from the community census. Given the importance of 
water storage in the community, it would have been preferred to align the 
community census variables for water storage with the longitudinal data 
collection of the MAL-ED socio-economic survey variables and the 
collection of the EE markers. Second, information on fecal matter storage 
and treatment was not available. The main sanitation variable used in this 
analysis was type of toilet facility and often this does not guarantee safe and 
sanitary removal of fecal matter from the household environment. Lastly, the 
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heterogeneity of the floor type variable was not captured by the socio-
economic survey. The homes in this community that have cement floors 
mostly have cement in the entrance area while at the back of the house, 
where the cooking and washing activities take place, is often dirt. This is a 
potential source of information bias in the analysis for the relationship of 
floor type to the fecal markers for EE. 
 
The strengths of the study are the longitudinal design with monthly 
measurements for the EE fecal markers from birth to closely track the 
trajectory of these markers. The questionnaire that was administered every 
six months also provided a close monitoring of the WASH characteristics of 
the home to capture any changes that the families may have had in these 
dynamically changing low-income households. The community census also 
provided detailed information on water storage which was widely practiced 
throughout the community. These strengths combined reduced potential 
biases from measurement error to understand the relationships between the 
WASH characteristics of the household and the development of EE in this 
cohort.  
 
Conclusion 
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Water and sanitation conditions were associated with fecal markers for EE in 
this peri-urban community of Iquitos, Peru. The results provide preliminary 
evidence for the hypothesis that children under 24 months of age living in 
unsanitary conditions will have elevated levels of fecal markers for gut 
inflammation and permeability. Future studies are needed to examine the 
usefulness of these fecal markers in diverse settings where there is in-depth 
understanding of the water, sanitation, hygiene and household characteristics 
leading to increased contamination and exposure to fecal pathogens. 
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Table 1a. Water, sanitation, hygiene and household socio-economic characteristics of children enrolled 
in MAL-ED Peru site at 6, 12, 18 and 24 months of age. 
 
WASH Household Characteristic  6 months (n) 
N=270 
12 months (n) 
N= 241 
18 months (n) 
N=213 
24 months (n) 
N=198 
Type of toilet facility that households 
usually use (%): 
   
 
Pour flush to septic tank
No facility/bush/field or bucket toilet
Pit latrine without flush  
Flush to piped sewer system
Flush to pit latrine
Flush to somewhere else
14.8 (40) 
15.2 (41) 
58.2 (157) 
1.8 (5) 
1.1 (3) 
6.3 (17) 
12.0 (29) 
16.6 (40) 
58.9 (142) 
3.7 (9) 
2.1 (5) 
4.2 (10) 
12.7 (27) 
18.3 (39) 
56.8 (121) 
5.2 (11) 
1.4 (3) 
3.3 (7) 
22.7 (45) 
12.6 (25) 
51.5 (102) 
8.1 (16) 
2.5 (5) 
1.5 (3) 
Type of flooring material (%): 
Cement
Dirt
Wood
Tile
 
21.5 (58) 
73.0 (197) 
5.6 (15) 
-- 
 
22.8 (55) 
69.7 (168) 
7.1 (17) 
0.4 (1) 
 
23.6 (50) 
68.9 (146) 
7.6 (16) 
-- 
 
27.3 (54) 
67.7 (134) 
5.1 (10) 
-- 
Drinking water source (%): 
Piped into dwelling
Piped into yard/plot
Public tap/stand pipe
Tube well or borehole
Protected well
Unprotected well
Surface water
25.2 (68) 
19.3 (52) 
4.8 (13) 
41.5 (112) 
1.1 (3) 
3.0 (8) 
1.1 (3) 
21.6 (52) 
17.8 (43) 
8.3 (20) 
41.1 (99) 
0.8 (2) 
4.6 (11) 
2.1 (5) 
 
22.1 (47) 
17.8 (38) 
3.3 (7) 
42.7 (91) 
1.9 (4) 
4.7 (10) 
0.5 (1) 
23.2 (46) 
16.7 (33) 
1.5 (3) 
43.4 (86) 
3.5 (7) 
6.6 (13) 
0.5 (1) 
Total volume of stored water in the HH 
per capita in liters (reported) 
(Mean, 95% CI) 
16.9 (14.9, 18.9) 
(n=237) 
17.3 (15.1, 19.4) 
(n=215) 
17.4 (15.2, 19.5) 
(n=188) 
17.2 (14.9, 19.5) 
(n=175) 
HH uses chlorine to treat their water (%): 
No
Yes
 
85.9 (232) 
14.1 (38) 
 
89.2 (215) 
10.8 (26) 
 
88.3 (188) 
11.7 (25) 
 
82.3 (163) 
17.7 (35) 
Continuity of piped water supply (%):     
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Continuous
Sometimes interrupted
13.0 (35) 
87.0 (235) 
17.4 (42) 
82.6 (199) 
12.2 (26) 
87.8 (187) 
12.6 (25) 
87.4 (173) 
Toilet facility is shared: 
No
Yes
 
73.7 (199) 
26.3 (71) 
 
74.7 (180) 
25.3 (61) 
 
79.8 (170) 
20.2 (43) 
 
76.3 (151) 
23.7 (47) 
Number of members per household 
(Mean, 95% CI) 
6.3 (6.0, 6.6) 
(n=270) 
 
5.9 (5.7, 6.2) 
(n=236) 
 
5.8 (5.5, 6.1) 
(n=213) 
 
5.7 (5.4, 6.0) 
(n=198) 
Household location of cooking activities: 
Inside the house
Outside the house
Both inside and outside the house
 
72.5 (195) 
25.3 (68) 
2.2 (6) 
73.0 (176) 
25.3 (61) 
1.7 (4) 
80.6 (170) 
18.5 (39) 
1.0 (2) 
73.7 (146) 
20.7 (41) 
5.6 (11) 
Hygiene Score: 
4
3
0-2
 
66.7 (180) 
14.8 (40) 
18.5 (50) 
 
68.9 (166) 
14.1 (34) 
17.0 (41) 
 
62.3 (132) 
14.2 (30) 
23.6 (50) 
 
63.6 (126) 
17.7 (35) 
18.7 (37) 
Wealth Index [3-18]  (Mean, 95% CI): 9.5 (9.2, 9.8) 9.4 (9.1, 9.8) 9.3 (9.0, 9.7) 9.9 (9.5, 10.3) 
Duration of time family has lived in 
home (%): 
Less than one year
Between one year and five years 
Between five years and ten years 
Between ten years and twenty years
More than twenty years
 
 
28.5 (77) 
33.0 (89) 
16.7 (45) 
12.2 (33) 
9.6 (26) 
 
 
20.8 (50) 
41.9 (101) 
19.5 (47) 
8.3 (20) 
9.5 (23) 
 
 
20.7 (44) 
36.2 (77) 
24.9 (53) 
8.9 (19) 
9.4 (20) 
 
 
20.3 (40) 
42.1 (83) 
18.8 (37) 
13.7 (27) 
5.1 (10) 
Maternal education in years 
(Mean, 95% CI): 
7.8 (7.5, 8.2) 
(n=268) 
7.8 (7.5, 8.2) 
(n=237) 
7.9 (7.5, 8.3) 
(n=211) 
7.6 (7.3 8.0) 
(n=197) 
Breastfeeding: 
Mixed
Weaned
 
98.6 (216) 
0.9 (2) 
 
96.8 (209) 
3.2 (7) 
 
58.7 (122) 
41.4 (86) 
 
19.0 (37) 
81.0 (158) 
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Table 1b. Water storage variables from community census with children enrolled in MAL-ED Peru 
site. 
 
Water Storage Variable N Mean SD 
Total volume of stored water in the HH (L) 
Option 1 (reported) 
258 
 
99.7 92.9 
 
Total volume of stored water in the HH (L) 
Option 2 (summation by lid type) 
257 
 
94.6 90.7 
 
No lid: Total volume of stored water in the HH (L) 
 
257 
 
50.3 72.3 
 
Provisional lid: Total volume of stored water in the 
HH (L) 
 
257 
 
7.6 47.1 
 
Secured lid: Total volume of stored water in the HH 
(L) 
 
257 
 
36.7 29.5 
 
Total volume of stored water in the HH per capita 
Option 1 (reported) 
258 
 
16.5 15.1 
 
Total volume of stored water in the HH per capita 
Option 2 (summation by lid type) 
257 
 
15.7 14.6 
 
No lid: Total volume of stored water in the HH per 
capita 
 
257 
 
8.3 12.1 
 
Provisional lid: Total volume of stored water in the 
HH per capita 
 
257 
 
1.1 6.7 
 
Secured lid: Total volume of stored water in the HH 
per capita 
 
257 
 
6.1 4.8 
 
Percent of water stored with no lid 256 37.2 35.2 
Percent of water stored with provisional lid 256 5.6 25.2 
 
64 
Percent of water stored with secured lid 256 54.9 36.4 
Minimum volume of container used for water 
storage (L) 
Option 1 (reported directly) 
204 12.2 8.0 
Minimum volume of container used for water 
storage (L) 
Option 2 (extracted from data) 
257 12.4 7.4 
Minimum volume of container used for water 
storage per capita (L) 
Option 1 (reported directly) 
204 2.3 1.9 
Minimum volume of container used for water 
storage per capita (L) 
Option 2 (extracted from data) 
257 2.2 1.8 
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Table 2. Unadjusted mixed models for WASH household characteristics with EE biomarkers (Part 1) 
WASH Household Characteristic 
MPO 
β 95% CI)
N=269, n=884 
NEO 
β 95% CI)
N= 269, n=887 
AAT 
β 95% CI)
N=268 n=871 
SANITATION    
Type of toilet facility that households 
usually use: 
   
Pour flush toilet to septic tank
No facility/bush/field or bucket toilet
Pit latrine without flush  
Flush toilet to piped sewer system
Flush toilet to pit latrine
Flush toilet to somewhere else
REF 
-0.34 (-0.61, -0.08)**
-0.21 (-0.42, 0.00)* 
-0.33 (-0.72, 0.06) 
-0.09 (-0.65, 0.47) 
-0.29 (-0.68, 0.11) 
REF 
-0.07 (-0.28, 0.14) 
-0.06 (-0.23, 0.11) 
0.05 (-0.26, 0.36) 
0.05 (-0.39, 0.50) 
-0.03 (-0.35, 0.28) 
REF 
-0.07 (-0.32, 0.19) 
0.09 (-0.12, 0.29) 
-0.17 (-0.56, 0.21) 
0.19 (-0.39, 0.76) 
0.28 (-0.11, 0.68) 
Toilet facility is shared: 
No
Yes
 
REF 
0.16 (0.00, 0.33)* 
 
REF 
0.05 (-0.09, 0.18) 
 
REF 
0.13 (-0.03, 0.30) 
WATER    
Drinking water source: 
Piped into dwelling
Piped into yard/plot
Public tap/stand pipe
Tube well or borehole
Protected well
Unprotected well
Surface water
REF 
0.29 (0.07, 0.52)* 
0.16 (-0.19, 0.51) 
0.21 (0.01, 0.40)* 
0.04 (-0.54, 0.62) 
0.64 (0.27, 1.02)† 
-0.05 (-0.78, 0.67) 
REF 
0.28 (0.09, 0.46)** 
0.01 (-0.27, 0.29) 
0.16 (0.005, 0.31)* 
-0.18 (-0.65, 0.28) 
0.32 (0.03, 0.62)* 
-0.08 (-0.65, 0.50) 
 
REF 
0.01 (-0.22, 0.24) 
0.07 (-0.28, 0.42) 
0.06 (-0.13, 0.25) 
-0.26 (-0.83, 0.31) 
0.05 (-0.31, 0.41) 
-0.20 (-0.89, 0.49) 
Total volume of stored water in the HH 
per capita (reported) 
Q1
Q2
Q3
Q4
REF 
-0.006 (-0.23, 0.22) 
-0.21 (-0.44, 0.02) 
-0.08 (-0.30, 0.15) 
 
REF 
-0.08 (-0.26, 0.10) 
-0.14 (-0.33, 0.04) 
0.05 (-0.13, 0.23) 
REF 
-0.04 (-0.26, 0.19) 
-0.02 (-0.24, 0.21) 
0.11 (-0.11, 0.34) 
HH uses chlorine to treat their water: 
No
 
REF 
 
REF 
 
REF 
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Yes -0.10 (-0.31, 0.11) 0.02 (-0.15, 0.19) -0.04 (-0.25, 0.17) 
Continuity of piped water supply: 
Continuous
Sometimes interrupted
 
REF 
0.37 (0.16, 0.57)† 
 
REF 
0.12 (-0.04, 0.28) 
 
REF 
0.23 (0.03, 0.43)* 
HYGIENE    
Hygiene Score: 
Always 
Most of the time 
Sometimes
 
REF 
-0.04 (-0.24, 0.17) 
0.08 (-0.11, 0.27) 
 
REF 
-0.10 (-0.26, 0.06) 
-0.06 (-0.21, 0.09) 
 
REF 
0.08 (-0.12, 0.28) 
-0.04 (-0.23, 0.14) 
HOUSEHOLD    
Type of flooring material: 
Cement
Dirt
Wood
 
REF 
-0.07 (-0.25, 0.11) 
-0.07 (-0.41, 0.27) 
 
REF 
-0.09 (-0.24, 0.05) 
-0.28 (-0.55, -0.01)* 
 
REF 
-0.15 (-0.32, 0.03) 
-0.38 (-0.71, -0.06)* 
Number of household members in 
quartiles  -0.02 (-0.06, 0.008) -0.01 (-0.04, 0.01) -0.02 (-0.05, 0.01) 
Household location of cooking 
activities: 
Inside the house
Outside the house
Both inside and outside the house
REF 
-0.20 (-0.37, -0.02)* 
-0.25 (-0.73, 0.23) 
REF 
-0.09 (-0.23, 0.05) 
0.25 (-0.13, 0.63) 
REF 
-0.30 (-0.46, -0.13)† 
0.44 (-0.001, 0.88)* 
Wealth Index: 
Q1
Q2
Q3
Q4
 
REF 
-0.10 (-0.32, 0.13) 
-0.12 (-0.31, 0.06) 
-0.06 (-0.25, 0.13) 
 
REF 
0.01 (-0.16, 0.19) 
0.02 (-0.12, 0.17) 
-- 
 
REF 
-0.12 (-0.35, 0.10) 
0.07 (-0.12, 0.25) 
-0.01 (-0.20, 0.18) 
Duration of time family has lived in 
home: 
Less than one year
Between one year and five years 
Between five years and ten years 
Between ten years and twenty years
More than twenty years
 
REF 
0.07 (-0.11, 0.26) 
0.02 (-0.20, 0.25) 
0.21 (-0.06, 0.48) 
-0.20 (-0.49, 0.09) 
 
REF 
-0.005 (-0.16, 0.15) 
0.03 (-0.15, 0.20) 
0.02 (-0.19, 0.24) 
-0.17 (-0.40, 0.06) 
 
REF 
0.04 (-0.14, 0.23) 
0.08 (-0.14, 0.30) 
0.15 (-0.11, 0.41) 
-0.11 (-0.39, 0.17) 
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Maternal education (y) 
Low
High
REF 
0.15 (0.00, 0.31)*
REF 
0.15 (0.02, 0.27)*
REF 
0.13 (-0.02, 0.28) 
CHILD    
Child age (months) -0.06 (-0.07, -0.05)† -0.07 (-0.08, -0.07)† -0.07 (-0.08, -0.06)† 
Breastfeeding: 
Mixed
Weaned
 
REF 
-0.27 (-0.49, -0.04)* 
 
REF 
-0.43 (-0.61, -0.26)† 
 
REF 
-0.55 (-0.77, -0.33)† 
* Significance at the p<0.05 level 
** Significance at the p<0.01 level 
† Significant difference at the p<0.001 level 
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Table 2. Unadjusted mixed models for WASH household characteristics with EE biomarkers (Part 2) 
WASH Household Characteristic 
LM 
β 95% CI)
N=270, n=732 
AGP 
β 95% CI)
N=236, n=439 
CIT 
β 95% CI)
N=253, n=550 
SANITATION    
Type of toilet facility that households 
usually use:  
  
Pour flush toilet to septic tank
No facility/bush/field or bucket toilet
Pit latrine without flush  
Flush toilet to piped sewer system
Flush toilet to pit latrine
Flush toilet to somewhere else
REF 
-0.17 (-0.48, 0.15) 
0.01 (-0.24, 0.26) 
-0.08 (-0.64, 0.48) 
-0.62 (-1.36, 0.11) 
-0.24 (-0.66, 0.18) 
REF 
0.26 (0.09, 0.43)** 
0.02 (-0.12, 0.16) 
-- 
-0.07 (-0.53, 0.39) 
0.20 (-0.05, 0.45) 
REF 
-0.03 (-0.17, 0.10) 
0.03 (-0.08, 0.14) 
-0.06 (-0.25, 0.13) 
-0.25 (-0.52, 0.02) 
-0.007 (-0.23, 0.21) 
Toilet facility is shared: 
No
Yes
 
REF 
0.02 (-0.18, 0.21) 
REF 
-0.07 (-0.18, 0.05) 
REF 
-0.03 (-0.12, 0.06) 
WATER    
Drinking water source: 
Piped into dwelling
Piped into yard/plot
Public tap/stand pipe
Tube well or borehole
Protected well
Unprotected well
Surface water
 
REF 
-0.07 (-0.33, 0.19) 
0.38 (-0.002, 0.77)* 
0.03 (-0.19, 0.25) 
-0.25 (-1.18, 0.68) 
0.26 (-0.25, 0.76) 
-0.31 (-1.05, 0.43) 
REF 
-0.04 (-0.19, 0.11) 
0.03 (-0.20, 0.26) 
-0.01 (-0.13, 0.110 
0.09 (-0.31, 0.48) 
0.02 (-0.26, 0.29) 
0.38 (-0.09, 0.85) 
REF 
0.11 (-0.008, 0.23) 
0.06 (-0.12, 0.24) 
0.10 (-0.005, 0.20) 
0.08 (-0.20, 0.35) 
0.11 (-0.08, 0.310 
-0.26 (-0.69, 0.16) 
Total volume of stored water in the 
HH per capita (reported) 
Q1
Q2
Q3
Q4
 
REF 
-0.03 (-0.30, 0.24) 
-0.15 (-0.41, 0.11) 
-0.09 (-0.35, 0.17) 
 
REF 
-0.04 (-0.19, 0.11) 
-0.13 (-0.27, 0.02) 
-0.12 (-0.26, 0.02) 
REF 
-0.07 (-0.20, 0.05) 
-0.07 (-0.19, 0.05) 
-0.02 (-0.14, 0.10) 
HH uses chlorine to treat their water: 
No
 
REF 
 
REF 
 
REF 
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Yes -0.14 (-0.40, 0.11) 0.0003 (-0.15, 0.15) 0.0009 (-0.11, 0.11) 
Continuity of piped water supply: 
Continuous
Sometimes interrupted
 
REF 
-0.16 (-0.40, 0.08) 
REF 
0.03 (-0.10, 0.17) 
REF 
0.03 (-0.08, 0.13) 
HYGIENE    
Hygiene Score: 
Always 
Most of the time 
Sometimes
 
REF 
-0.01 (-0.25, 0.23) 
0.21 (-0.02, 0.43) 
 
REF 
0.15 (0.01, 0.28)* 
-0.05 (-0.18, 0.09) 
 
REF 
0.11 (0.001, 0.21)* 
0.09 (-0.01, 0.20) 
HOUSEHOLD    
Type of flooring material: 
Cement
Dirt
Wood
 
REF 
-0.04 (-0.25, 0.17) 
-0.04 (-0.45, 0.37) 
 
REF 
0.02 (-0.09, 0.14) 
0.18 (-0.03, 0.40) 
 
REF 
0.006 (-0.09, 0.10) 
0.06 (-0.12, 0.24) 
Number of household members in 
quartiles  0.02 (-0.01, 0.06) -0.0008 (-0.02, 0.02) -0.005 (-0.02, 0.01) 
Household location of cooking 
activities: 
Inside the house
Outside the house
Both inside and outside the house
REF 
0.04 (-0.16, 0.23) 
0.60 (0.01, 1.19)* 
REF 
0.05 (-0.07, 0.16) 
0.05 (-0.23, 0.34) 
REF 
0.04 (-0.05, 0.13) 
0.05 (-0.17, 0.28) 
Wealth Index: 
Q1
Q2
Q3
Q4
 
REF 
-0.12 (-0.35, 0.11) 
-0.20 (-0.44, 0.04) 
-0.37 (-0.61, -0.12)** 
REF 
-0.11 (-0.27, 0.05) 
-0.06 (-0.19, 0.06) 
-0.11 (-0.24, 0.02) 
REF 
0.09 (-0.03, 0.21) 
0.03 (-0.06, 0.13) 
0.07 (-0.04, 0.17) 
Duration of time family has lived in 
home: 
Less than one year
Between one year and five years 
Between five years and ten years 
Between ten years and twenty years
More than twenty years
 
REF 
-0.004 (-0.22, 0.21) 
-0.05 (-0.31, 0.22) 
-0.16 (-0.47, 0.14) 
-0.05 (-0.37, 0.27) 
 
REF 
-0.05 (-0.17, 0.08) 
-0.07 (-0.22, 0.07) 
-0.04 (-0.21, 0.13) 
-- 
 
REF 
-0.10 (-0.20, 0.00)* 
0.03 (-0.09, 0.15) 
-0.02 (-0.16, 0.12) 
-0.09 (-0.25, 0.06) 
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Maternal education (y) 
Low
High
REF 
0.02 (-0.16, 0.19) 
REF 
-0.09 (-0.19, 0.02) 
REF 
-0.04 (-0.12, 0.04) 
CHILD    
Child age (months) 0.04 (0.02, 0.06)† -0.007 (-0.02, 0.0008) 0.06 (0.05, 0.06)† 
Breastfeeding: 
Mixed
Weaned
 
REF 
0.36 (-0.39, 1.12) 
REF 
-0.02 (-0.21, 0.18) 
REF 
0.08 (-0.05, 0.21) 
* Significance at the p<0.05 level 
** Significance at the p<0.01 level 
† Significant difference at the p<0.001 level 
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Table 3. Multivariate mixed-effects models for WASH household characteristics and EE biomarkers. 
All models adjusted for age, season, breastfeeding, maternal education, and wealth index (Part 1). 
 
N 
n 
MPO 
(ng/mL) 
703 
194 
NEO 
(nmol/L) 
705 
194 
AAT 
(mg/g) 
691 
194 
 β (95% CI) n β (95% CI) n β (95% CI) n 
Type of toilet facility households use: 
Pour flush toilet to septic tank
No facility/bush/field or bucket toilet
Pit latrine without flush  
Flush toilet to piped sewer system
Flush toilet to pit latrine
Flush toilet to somewhere else
 
REF 
-0.43 (-0.74, -0.13)**
-0.18 (-0.42, 0.06) 
-0.22 (-0.65, 0.22) 
-0.07 (-0.73, 0.59) 
-0.39 (-0.83, 0.05) 
 
109
106
410
29
11
27
 
REF 
-0.06 (-0.30, 0.19) 
-0.01 (-0.21, 0.18) 
0.29 (-0.06, 0.65) 
0.14 (-0.39, 0.68) 
0.04 (-0.32, 0.40) 
 
109
106
412
29
11
27
 
REF 
-0.07 (-0.37, 0.23) 
0.07 (-0.17, 0.31) 
-0.28 (-0.74, 0.17) 
0.03 (-0.66, 0.72) 
0.19 (-0.27, 0.64) 
 
113
105
401
26
10
26
Drinking water source: 
Piped into dwelling
Piped into yard/plot
Public tap/stand pipe
Tube well or borehole
Protected well
Unprotected well
Surface water
REF 
0.32 (0.06, 0.57)* 
0.40 (-0.02, 0.83) 
0.10 (-0.14, 0.33) 
0.19 (-0.43, 0.81) 
0.47 (0.05, 0.88)* 
0.72 (-0.30, 1.74) 
 
159
144
36
296
12
34
4 
REF 
0.28 (0.07, 0.49)** 
-0.03 (-0.37, 0.32) 
0.20 (0.006, 0.39)* 
-0.18 (-0.68, 0.33) 
0.36 (0.03, 0.70)* 
0.60 (-0.24, 1.44) 
 
159
144
36
298
12
34
4 
 
REF 
-0.11 (-0.37, 0.15) 
0.12 (-0.31, 0.56) 
-0.08 (-0.31, 0.16) 
-0.31 (-0.97, 0.35) 
-0.16 (-0.58, 0.25) 
-0.30 (-1.35, 0.74) 
 
156
140
35
292
11
36
4 
Total volume of stored water in the 
HH3  
Q1
Q2
Q3
Q4
REF 
-0.18 (-0.43, 0.08) 
-0.33 (-0.58, -0.08)**
-0.26 (-0.52, -0.005)* 
 
182
168
169
184
REF 
-0.21 (-0.41, -0.01)* 
-0.26 (-0.46, -0.07)**
-0.13 (-0.33, 0.08) 
 
182
169
170
184
REF 
-0.14 (-0.39, 0.10) 
-0.13 (-0.37, 0.12) 
-0.11 (-0.36, 0.15) 
 
174
170
165
182
HH uses chlorine to treat their water: 
No 
REF 
-0.18 (-0.43, 0.08) 
 
618
REF 
0.06 (-0.14, 0.26) 
 
620
REF 
0.03 (-0.22, 0.28) 
 
606
                                                 
3 Liters of water stored per capita reported directly by the interviewee 
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Yes 85 85 85
Continuity of piped water supply: 
Continuous
Sometimes interrupted
REF 
0.36 (0.08, 0.63)** 
 
97
606
REF 
-0.006 (-0.23, 0.22) 
 
97
608
REF 
0.20 (-0.08, 0.48) 
 
94
597
Practices good hygiene composite 
score 
Always 
Most of the time 
Sometimes 
 
 
REF 
-0.04 (-0.27, 0.19) 
0.11 (-0.11, 0.33) 
 
 
460
104
139
 
 
REF 
-0.08 (-0.26, 0.11) 
0.01 (-0.17, 0.20) 
 
 
461
104
140
 
 
REF 
0.20 (-0.03, 0.44) 
-0.05 (-0.28, 0.18) 
 
 
453
100
138
Type of flooring material: 
Cement
Dirt
Wood
 
REF 
-0.10 (-0.31, 0.12) 
-0.03 (-0.47, 0.42) 
 
166
510
27
 
REF 
-0.08 (-0.26, 0.09) 
-0.23 (-0.59, 0.13) 
 
167
511
27
 
REF 
-0.20 (-0.42, 0.02) 
-0.30 (-0.73,0.13) 
 
166
495
30
Household location of cooking 
activities: 
Inside the house
Outside the house
Both inside and outside the house
REF 
-0.16 (-0.35, 0.03) 
-0.42 (-0.96, 0.12) 
 
 
529
159
15
 
REF 
-0.09 (-0.24, 0.07) 
-0.09 (-0.53, 0.35) 
 
 
531
159
15
 
REF 
-0.40 (-0.60, -0.21)†
0.30 (-0.21, 0.82) 
 
 
518
156
17
Wealth Index 
Q1
Q2
Q3
Q4
 
REF 
-0.24 (-0.49, 0.01) 
-0.26 (-0.47, -0.04)* 
-0.13 (-0.37, 0.12) 
 
274
88
174
167
 
REF 
0.02 (-0.19, 0.22) 
-0.04 (-0.22, 0.13) 
0.001 (-0.19, 0.20) 
 
275
88
174
168
 
REF 
-0.17 (-0.43, 0.09) 
-0.07 (-0.29, 0.15) 
-0.17 (-0.41, 0.08) 
 
265
85
172
169
Maternal education (y) 
Low
High
REF 
0.20 (0.02, 0.39)* 
 
395
308
REF 
0.13 (-0.02, 0.28) 
 
396
309
REF 
0.11 (-0.07, 0.29) 
 
386
305
Child age (months) 
 
-0.06 (-0.08, -0.05)† 
 
703 -0.06 (-0.07, -0.05)† 
 
705 -0.04 (-0.06, -0.03)†
 
691
Breastfeeding  
Mixed
Weaned
 
REF 
-0.09 (-0.33, 0.14) 
 
501
201
 
REF 
-0.42 (-0.61, -0.23)† 
 
502
202
 
REF 
-0.50 (-0.74, -0.26)†
 
486
204
Seasonal effect 
Sine
 
-0.24 (-0.35, -0.14)† 
 
703
 
0.06 (-0.03, 0.14) 
 
705
 
0.02 (-0.08, 0.13) 
 
691
 
73 
Cosine 0.11 (0.004, 0.21)* 703 0.02 (-0.07, 0.10) 705 -0.01 (-0.12, 0.09) 691
 
* Significance at the p<0.05 level 
** Significance at the p<0.01 level 
† Significant difference at the p<0.001 level 
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Table 3. Multivariate mixed-effects models for WASH household characteristics and EE biomarkers. 
All models adjusted for age, season, breastfeeding, maternal education, and wealth index (Part 2). 
 
N 
n 
LM 
 
565 
194 
AGP 
 
344 
175 
CIT 
(umol/pL) 
440 
192 
 β (95% CI) n β (95% CI) n β (95% CI) n 
Type of toilet facility households use: 
Pour flush toilet to septic tank
No facility/bush/field or bucket toilet
Pit latrine without flush  
Flush toilet to piped sewer system
Flush toilet to pit latrine
Flush toilet to somewhere else
 
REF 
-0.28 (-0.65, 0.09) 
-0.03 (-0.32, 0.27) 
-0.19 (-0.85, 0.47) 
-0.39 (-1.27, 0.48) 
-0.39 (-0.86, 0.07) 
 
82
85
340
12
7 
29
 
REF 
0.18 (-0.04, 0.37) 
0.03 (-0.13, 0.19) 
0.26 (-0.27, 0.78) 
-0.11 (-0.66, 0.44) 
0.30 (0.02, 0.59)* 
 
57
53
203
4 
4 
17
 
REF 
-0.05 (-0.21, 0.11) 
0.009 (-0.11, 0.14) 
0.03 (-0.19, 0.25) 
-0.42 (-0.74, -0.10)** 
-0.003 (-0.24, 0.24) 
 
71
62
254
21
9 
17
Drinking water source: 
Piped into dwelling
Piped into yard/plot
Public tap/stand pipe
Tube well or borehole
Protected well
Unprotected well
Surface water
 
REF 
-0.07 (-0.36, 0.22) 
0.64 (0.14, 1.14)** 
-0.09 (-0.36, 0.18) 
-0.75 (-1.77, 0.26) 
-0.11 (-0.65, 0.44) 
-0.51 (-1.43, 0.40) 
 
134
128
35
227
5 
19
6 
REF 
-0.04 (-0.21, 0.13) 
0.11 (-0.18, 0.40) 
-0.07 (-0.23, 0.09) 
0.06 (-0.42, 0.54) 
-0.04 (-0.37, 0.28) 
-0.41 (-1.51, 0.68) 
 
92
76
3 
133
5 
12
1 
REF 
0.12 (-0.008, 0.23) 
0.008 (-0.12, 0.24) 
0.10 (-0.005, 0.20) 
0.03 (-0.20, 0.35) 
0.10 (-0.08, 0.310 
-0.73 (-1.36, - 0.11)* 
 
103
94
24
177
9 
21
2 
Total volume of stored water in the 
HH4  
Q1
Q2
Q3
Q4
 
REF 
-0.12 (-0.40, 0.17) 
-0.26 (-0.54, 0.01) 
-0.26 (-0.55, 0.04) 
 
142
122
154
147
 
REF 
-0.06 (-0.22, 0.11) 
-0.10 (-0.26, 0.06) 
-0.15 (-0.32, 0.02) 
 
87
73
93
91
 
REF 
-0.07 (-0.21, 0.06) 
-0.05 (-0.18, 0.07) 
-0.006 (-0.14, 0.12) 
 
118
98
108
116
HH uses chlorine to treat their water: 
No 
 
REF 
 
501
 
REF 
 
311
 
REF 
 
386
                                                 
4 Liters of water stored per capita reported directly by the interviewee 
 
75 
Yes -0.12 (-0.43, 0.19) 64 0.05 (-0.15, 0.25) 33 0.02 (-0.12, 0.15) 54
Continuity of piped water supply: 
Continuous
Sometimes interrupted
 
REF 
0.05 (-0.29, 0.39) 
 
82
483
 
REF 
0.09 (-0.11, 0.28) 
 
52
292
 
REF 
-0.04 (-0.18, 0.10) 
 
65
375
Practices good hygiene composite 
score 
Always 
Most of the time 
Sometimes 
 
 
REF 
0.11 (-0.17, 0.39) 
0.19 (-0.08, 0.46) 
 
 
387
78
100
 
 
REF 
0.14 (-0.02, 0.30) 
-0.05 (-0.22, 0.11) 
 
 
232
54
58
 
 
REF 
0.13 (0.01, 0.25)* 
0.07 (-0.06, 0.20) 
 
 
292
75
73
Type of flooring material: 
Cement
Dirt
Wood
 
REF 
-0.35 (-0.61, -0.09)** 
-0.06 (-0.60, 0.48) 
 
125
419
21
 
REF 
-0.001 (-0.17, 0.13) 
0.06 (-0.21, 0.33) 
 
83
243
18
 
REF 
0.02 (-0.10, 0.13) 
0.12 (-0.13, 0.37) 
 
102
322
16
Household location of cooking 
activities: 
Inside the house
Outside the house
Both inside and outside the house
 
 
REF 
0.08 (-0.14, 0.31) 
0.72 (0.13, 1.31)* 
 
 
417
134
14
 
 
REF 
0.02 (-0.12, 0.16) 
-0.02 (-0.35, 0.31) 
 
 
249
84
11
 
 
REF 
0.04 (-0.06, 0.14) 
0.09 (-0.16, 0.34) 
 
 
318
109
13
Wealth Index 
Q1
Q2
Q3
Q4
 
REF 
-0.09 (-0.35, 0.18) 
-0.28 (-0.56, 0.00)* 
-0.47 (-0.78, -0.16)** 
 
137
151
150
112
 
REF 
-0.04 (-0.23, 0.15) 
-0.03 (-0.18, 0.12) 
-0.02 (-0.19, 0.15) 
 
127
40
91
86
 
REF 
0.06 (-0.07, 0.20) 
0.04 (-0.07, 0.15) 
0.08 (-0.04, 0.21) 
 
167
56
112
105
Maternal education (y) 
Low
High
 
REF 
0.20 (-0.009, 0.40) 
 
315
250
 
REF 
-0.04 (-0.16, 0.08) 
 
197
147
 
REF 
-0.02 (-0.12, 0.07) 
 
258
182
Child age (months) 0.04 (0.01, 0.06)† 
 
565 -0.01 (-0.02, 0.003) 
 
344 0.05 (0.04, 0.06)† 
 
440
Breastfeeding  
Mixed
Weaned
 
REF 
-0.14 (-1.11, 0.82) 
 
558
5 
 
REF 
0.002 (-0.23, 0.23) 
 
296
47
 
REF 
0.09 (-0.05, 0.23) 
 
310
129
Seasonal effect 
Sine
 
-0.03 (-0.15, 0.09) 
 
565
 
0.002 (-0.08, 0.08) 
 
344
 
-0.02 (-0.07, 0.04) 
 
440
 
76 
Cosine -0.09 (-0.21, 0.04) 565 -0.02 (-0.10, 0.05) 344 -0.02 (-0.07, 0.04) 440
 
* Significance at the p<0.05 level 
** Significance at the p<0.01 level 
† Significant difference at the p<0.001 level 
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Table S1. Median concentrations of fecal markers of EE - 
myeloperoxidase (MPO), neopterin (NEO), alpha-1-antitrypsin (AAT) 
 
 MPO (ng/mL) NEO (nmol/L) AAT (mg/g) 
6 months 14,363 3,782 0.53 
12 months 9,047 2,758 0.44 
18 months 6,215 1,623 0.35 
24 months 4,002 1,037 0.19 
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Table S2. Unadjusted analysis for water storage variables in each household with log-transformed EE 
using mixed-effects models (Part 1). 
 
Risk Factor 
MPO 
β 95% CI)
(N=727, n=232) 
NEO 
β 95% CI)
(N=727, n=232) 
AAT 
β 95% CI)
(N=727, n=232) 
Total volume (L) 
Option 1 (reported) 
Q1
Q2
Q3
Q4
REF 
0.07 (-0.24, 0.38) 
-0.10 (-0.40, 0.20) 
-0.02 (-0.32, 0.28) 
 
REF 
-0.04 (-0.32, 0.24) 
-0.15 (-0.42, 0.11) 
0.22 (-0.04, 0.49) 
REF 
0.37 (0.04, 0.69) 
0.005 (-0.30, 0.31) 
0.37 (0.07, 0.68) 
Total volume (L) 
Option 2 (summation by lid type) 
Q1
Q2
Q3
Q4
REF 
0.06 (-0.26, 0.38) 
-0.17 (-0.46, 0.13) 
-0.15 (-0.44, 0.15) 
 
REF 
-0.06 (-0.35, 0.23) 
-0.16 (-0.42, 0.11) 
0.20 (-0.07, 0.46) 
REF 
0.29 (-0.04, 0.63) 
0.07 (-0.23, 0.37) 
0.27 (-0.04, 0.57) 
No lid: Total volume (L) 
Q1
Q2
Q3
Q4
REF 
-0.23 (-0.56, 0.10) 
-0.09 (-0.39, 0.21) 
-0.16 (-0.45, 0.12) 
 
REF 
0.03 (-0.27, 0.32) 
-0.15 (-0.42, 0.12) 
-0.002 (-0.26, 0.26) 
REF 
0.19 (-0.15, 0.53) 
-0.01 (-0.32, 0.29) 
0.30 (0.004, 0.59) 
Secured lid: Total volume (L) 
Q1
Q2
Q3
Q4
 
REF 
0.04 (-0.25, 0.34) 
0.10 (-0.21, 0.41) 
0.36 (0.05, 0.66) 
 
REF 
0.07 (-0.20, 0.33) 
0.10 (-0.18, 0.38) 
0.29 (0.01, 0.57) 
REF 
0.27 (-0.03, 0.58) 
0.35 (0.03, 0.67) 
0.30 (-0.02, 0.62) 
Total volume per capita 
Option 1 (reported) 
Q1
Q2
Q3
 
 
REF 
0.10 (-0.22, 0.41) 
0.06 (-0.24, 0.36) 
 
 
REF 
-0.05 (-0.33, 0.23) 
-0.05 (-0.32, 0.22) 
 
 
REF 
0.10 (-0.22, 0.43) 
0.07 (-0.24, 0.38) 
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Q4 -0.05 (-0.35, 0.25) 0.18 (-0.09, 0.45) 0.35 (0.04, 0.65) 
Total volume per capita 
Option 2 (summation by lid type) 
Q1
Q2
Q3
Q4
REF 
0.003 (-0.31, 0.31) 
-0.08 (-0.39, 0.23) 
-0.15 (-0.46, 0.17) 
 
REF 
-0.09 (-0.37, 0.19) 
-0.10 (-0.38, 0.18) 
0.14 (-0.14, 0.42) 
REF 
0.31 (-0.008, 0.63) 
0.13 (-0.19, 0.44) 
0.43 (0.10, 0.75) 
No lid: Total volume per capita 
Q1
Q2
Q3
Q4
 
REF 
-0.10 (-0.42, 0.21) 
-0.11 (-0.40, 0.19) 
-0.24 (-0.52, 0.05) 
 
REF 
0.03 (-0.26, 0.31) 
-0.26 (-0.52, 0.01) 
0.10 (-0.16, 0.36) 
 
REF 
0.26 (-0.07, 0.59) 
-0.05 (-0.36, 0.25) 
0.29 (-0.005, 0.59) 
Secured lid: Total volume per capita  
Q1
Q2
Q3
Q4
 
REF 
-0.06 (-0.49, 0.37) 
0.12 (-0.16, 0.40) 
0.29 (0.02, 0.56) 
 
REF 
0.12 (-0.27, 0.51) 
0.06 (-0.19, 0.32) 
0.28 (0.03, 0.52) 
 
REF 
0.02 (-0.43, 0.47) 
-0.05 (-0.34, 0.25) 
0.13 (-0.15, 0.42) 
Percent of water stored with no lid 
Q1
Q2
Q3
Q4
 
REF 
-0.22 (-0.54, 0.10)  
0.01 (-0.28, 0.31) 
-0.25 (-0.54, 0.03) 
  
REF 
-0.06 (-0.35, 0.23) 
-0.05 (-0.32, 0.22) 
-0.03 (-0.29, 0.23) 
 
REF 
0.25 (-0.08, 0.58) 
0.04 (-0.28, 0.35) 
0.21 (-0.08, 0.51) 
Percent of water stored with secured lid 
Q1
Q2
Q3
Q4
 
REF 
0.28 (-0.01, 0.58) 
0.26 (-0.004, 0.53) 
-- 
  
REF 
-0.06 (-0.32, 0.21) 
-0.03 (-0.28, 0.21) 
-- 
 
REF 
-0.10 (-0.41, 0.21) 
-0.20 (-0.48, 0.08) 
-- 
Minimum volume of container (L) 
Option 1 (reported directly) 
Q1
Q2
Q3
Q4
 
 
REF 
0.27 (-0.03, 0.58) 
0.35 (0.03, 0.67) 
0.30 (-0.02, 0.62) 
 
 
REF 
-0.07 (-0.62, 0.49) 
0.004 (-0.21, 0.22) 
0.62 (-0.73, 1.97) 
 
 
REF 
0.31 (-0.31, 0.93) 
0.08 (-0.17, 0.33) 
-0.68 (-2.21, 0.85) 
 
80 
Minimum volume of container (L) 
Option 2 (extracted from data) 
Q1
Q2
Q3
Q4
 
 
REF 
-0.07 (-0.49, 0.34) 
0.14 (-0.08, 0.37) 
0.34 (-1.34, 2.03) 
 
 
REF 
0.009 (-0.37, 0.39) 
0.02 (-0.18, 0.23) 
0.06 (-1.46, 1.58) 
 
 
REF 
-0.28 (-0.71, 0.16) 
0.04 (-0.19, 0.28) 
-0.16 (-1.93, 1.62) 
Minimum volume of container per capita (L) 
Option 1 (reported directly) 
Q1
Q2
Q3
Q4
 
 
REF 
-0.05 (-0.36, 0.27) 
0.27 (-0.06, 0.60) 
0.16 (-0.18, 0.50) 
 
 
REF 
0.08 (-0.20, 0.37) 
0.01 (-0.29, 0.31) 
0.06 (-0.25, 0.37) 
 
 
REF 
0.10 (-0.22, 0.43) 
0.10 (-0.23, 0.45) 
0.19 (-0.16, 0.54) 
Minimum volume of container per capita (L) 
Option 2 (extracted from data) 
Q1
Q2
Q3
Q4
 
 
REF 
0.23 (-0.06, 0.52) 
0.32 (0.02, 0.61) 
0.10 (-0.22, 0.42) 
 
 
REF 
-0.04 (-0.30, 0.22) 
0.001 (-0.27, 0.27) 
0.06 (-0.23, 0.35) 
 
 
REF 
-0.20 (-0.49, 0.10) 
-0.14 (-0.44, 0.16) 
0.38 (0.06, 0.71) 
*Significance at the p<0.05 level 
** Significance at the p<0.01 level 
† Significant difference at the p<0.001 level 
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Table S2. Unadjusted analysis for water storage variables in each household with log-transformed EE 
using mixed-effects models (Part 2). 
 
Risk Factor 
LM 
β 95% CI)
(N=652, n=237) 
AGP 
β 95% CI)
(N=393, n=211) 
CIT 
β 95% CI)
(N=485, n=223) 
Total volume (L) 
Option 1 (reported) 
Q1
Q2
Q3
Q4
 
REF 
-0.10 (-0.37, 0.17) 
0.004 (-0.26, 0.26) 
0.004 (-0.26, 0.26) 
 
REF 
-0.14 (-0.29, 0.005) 
-0.15 (-0.30, -0.01)* 
-0.11 (-0.25, 0.03) 
 
REF 
-0.03 (-0.16, 0.10) 
-0.04 (-0.16, 0.08) 
-0.04 (-0.16, 0.08) 
Total volume (L) 
Option 2 (summation by lid type) 
Q1
Q2
Q3
Q4
 
REF 
-0.11 (-0.38, 0.17) 
-0.02 (-0.28, 0.23) 
-0.009 (-0.27, 0.25) 
 
REF 
-0.18 (-0.33, -0.03)* 
-0.14 (-0.28, 0.004) 
-0.09 (-0.23, 0.05) 
 
REF 
-0.04 (-0.17, 0.09) 
0.006 (-0.11, 0.13) 
-0.05 (-0.17, 0.07) 
No lid: Total volume (L) 
Q1
Q2
Q3
Q4
 
REF 
0.14 (-0.14, 0.42) 
0.13 (-0.12, 0.39) 
0.12 (-0.13, 0.37) 
 
REF 
0.03 (-0.12, 0.18) 
-0.04 (-0.19, 0.11) 
-0.06 (-0.19, 0.08) 
 
REF 
-0.16 (-0.28, -0.03)* 
-0.04 (-0.16, 0.08) 
-0.03 (-0.15, 0.09) 
Secured lid: Total volume (L) 
Q1
Q2
Q3
Q4
 
REF 
-0.29 (-0.66, 0.08) 
-0.05 (-0.29, 0.20) 
-0.02 (-0.25, 0.22) 
 
REF 
0.12 (-0.08, 0.33) 
-0.08 (-0.20, 0.05) 
-0.03 (-0.17, 0.10) 
 
REF 
-0.15 (-0.33, 0.03) 
0.01 (-0.10, 0.12) 
-0.07 (-0.18, 0.04) 
Total volume per capita 
Option 1 (reported) 
Q1
Q2
Q3
 
REF 
-0.03 (-0.30, 0.24) 
-0.15 (-0.41, 0.11) 
-0.09 (-0.35, 0.17) 
 
REF 
-0.04 (-0.19, 0.11) 
-0.13 (-0.27, 0.02) 
-0.12 (-0.26, 0.02) 
REF 
-0.07 (-0.20, 0.05) 
-0.07 (-0.19, 0.05) 
-0.02 (-0.14, 0.10) 
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Q4
Total volume per capita 
Option 2 (summation by lid type) 
Q1
Q2
Q3
Q4
 
REF 
-0.15 (-0.42, 0.12) 
-0.15 (-0.41, 0.12) 
-0.14 (-0.41, 0.14) 
REF 
-0.04 (-0.19, 0.11) 
-0.10 (-0.26, 0.04) 
-0.10 (-0.24, 0.05) 
REF 
-0.03 (-0.15, 0.09) 
-0.02 (-0.14, 0.11) 
0.03 (-0.10, 0.15) 
No lid: Total volume per capita 
Q1
Q2
Q3
Q4
 
REF 
0.25 (-0.04, 0.53) 
0.15 (-0.10, 0.40) 
0.05 (-0.20, 0.30) 
 
REF 
0.03 (-0.12, 0.18) 
-0.05 (-0.19, 0.10) 
-0.05 (-0.19, 0.09) 
 
REF 
-0.17 (-0.29, -0.04)**
-0.06 (-0.17, 0.06) 
-0.006 (-0.12, 0.11) 
Secured lid: Total volume per capita  
Q1
Q2
Q3
Q4
 
REF 
-0.08 (-0.34, 0.18) 
-0.005 (-0.28, 0.27) 
-0.15 (-0.41, 0.12) 
 
REF 
0.03 (-0.11, 0.17) 
-0.06 (-0.22, 0.09) 
-0.004 (-0.16, 0.15) 
 
REF 
-0.11 (-0.23, 0.006) 
-0.02 (-0.14, 0.11) 
-0.12 (-0.24, 0.006) 
Percent of water stored with no lid 
Q1
Q2
Q3
Q4
 
REF 
0.26 (-0.01, 0.54) 
0.05 (-0.20, 0.31) 
0.11 (-0.14, 0.36) 
 
REF 
-0.01 (-0.16, 0.14) 
-0.02 (-0.16, 0.13) 
-0.04 (-0.18, 0.10) 
 
REF 
-0.19 (-0.32, -0.06)**
-0.02 (-0.13, 0.10) 
-0.04 (-0.16, 0.08) 
Percent of water stored with secured lid 
Q1
Q2
Q3
Q4
 
REF 
-0.02 (-0.28, 0.24) 
-0.04 (-0.28, 0.19) 
-- 
 
REF 
0.02 (-0.12, 0.17) 
0.05 (-0.07, 0.18) 
-- 
 
REF 
0.05 (-0.07, 0.17) 
-0.03 (-0.14, 0.08) 
-- 
Minimum volume of container (L) 
Option 1 (reported directly) 
Q1
Q2
Q3
Q4
 
 
REF 
-0.18 (-0.74, 0.37) 
-0.001 (-0.22, 0.22) 
-0.66 (-2.12, 0.80) 
 
 
REF 
0.17 (-0.11, 0.45) 
0.004 (-0.11, 0.12) 
-0.56 (-1.28, 0.16) 
 
 
REF 
-0.21 (-0.46, 0.04) 
-0.007 (-0.11, 0.09) 
-0.48 (-1.15, 0.18) 
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Minimum volume of container (L) 
Option 2 (extracted from data) 
Q1
Q2
Q3
Q4
 
 
REF 
-0.07 (-0.43, 0.29) 
-0.04 (-0.23, 0.16) 
-0.04 (-1.44, 1.37) 
 
 
REF 
-0.04 (-0.24, 0.15) 
0.05 (-0.06, 0.16) 
0.43 (-0.58, 1.45) 
 
 
REF 
-0.05 (-0.21, 0.12) 
0.10 (0.007, 0.19)* 
-0.48 (-2.62, 1.66) 
Minimum volume of container per capita (L) 
Option 1 (reported directly) 
Q1
Q2
Q3
Q4
 
 
REF 
-0.33 (-0.62, -0.04) 
-0.17 (-0.47, 0.13) 
-0.17 (-0.48, 0.14) 
 
 
REF 
-0.05 (-0.20, 0.10) 
-0.14 (-0.30, 0.02) 
0.03 (-0.14, 0.19) 
 
 
REF 
0.002 (-0.13, 0.13) 
-0.02 (-0.15, 0.12) 
-0.04 (-0.18, 0.10) 
Minimum volume of container per capita (L) 
Option 2 (extracted from data) 
Q1
Q2
Q3
Q4
 
 
REF 
-0.17 (-0.42, 0.08) 
-0.19 (-0.44, 0.06) 
-0.03 (-0.31, 0.25) 
 
 
REF 
-0.09 (-0.23, 0.04) 
-0.11 (-0.27, 0.05) 
0.009 (-0.13, 0.15) 
 
 
REF 
0.01 (-0.10, 0.13) 
0.11 (-0.02, 0.24) 
0.09 (-0.03, 0.21) 
*Significance at the p<0.05 level 
** Significance at the p<0.01 level 
† Significant difference at the p<0.001 level 
 
 
 
 
84 
References 
1. Grantham-McGregor, S.; Cheung, Y. B.; Cueto, S.; Glewwe, P.; 
Richter, L.; Strupp, B.; International Child Development Steering, G., 
Developmental potential in the first 5 years for children in developing 
countries. Lancet 2007, 369, (9555), 60-70. 
2. Black, R. E.; Victora, C. G.; Walker, S. P.; Bhutta, Z. A.; Christian, 
P.; de Onis, M.; Ezzati, M.; Grantham-McGregor, S.; Katz, J.; Martorell, R.; 
Uauy, R.; Maternal; Child Nutrition Study, G., Maternal and child 
undernutrition and overweight in low-income and middle-income countries. 
Lancet 2013, 382, (9890), 427-51. 
3. Prendergast, A. J.; Humphrey, J. H., The stunting syndrome in 
developing countries. Paediatr Int Child Health 2014, 34, (4), 250-65. 
4. UNICEF, W., World Bank Levels and trends in child malnutrition; 
New York, NY: United Nations International Children’s Fund; Geneva: 
WHO; Washington, DC: World Bank, 2015. 
5. Kosek, M.; Guerrant, R. L.; Kang, G.; Bhutta, Z.; Yori, P. P.; Gratz, 
J.; Gottlieb, M.; Lang, D.; Lee, G.; Haque, R.; Mason, C. J.; Ahmed, T.; 
Lima, A.; Petri, W. A.; Houpt, E.; Olortegui, M. P.; Seidman, J. C.; Mduma, 
E.; Samie, A.; Babji, S.; Investigators, M.-E. N., Assessment of 
environmental enteropathy in the MAL-ED cohort study: theoretical and 
analytic framework. Clin Infect Dis 2014, 59 Suppl 4, S239-47. 
6. Guerrant, R. L.; DeBoer, M. D.; Moore, S. R.; Scharf, R. J.; Lima, A. 
A., The impoverished gut--a triple burden of diarrhoea, stunting and chronic 
disease. Nat Rev Gastroenterol Hepatol 2013, 10, (4), 220-9. 
7. Organization, W. H. Progress on drinking water and sanitation: joint 
monitoring programme update 2014; Geneva: World Health Organization, 
UNICEF, 2014. 
8. Korpe, P. S.; Petri, W. A., Jr., Environmental enteropathy: critical 
implications of a poorly understood condition. Trends in molecular medicine 
2012, 18, (6), 328-36. 
9. Kelly, P.; Menzies, I.; Crane, R.; Zulu, I.; Nickols, C.; Feakins, R.; 
Mwansa, J.; Mudenda, V.; Katubulushi, M.; Greenwald, S.; Farthing, M., 
Responses of small intestinal architecture and function over time to 
 
85 
environmental factors in a tropical population. The American journal of 
tropical medicine and hygiene 2004, 70, (4), 412-9. 
10. Dewey, K. G.; Adu-Afarwuah, S., Systematic review of the efficacy 
and effectiveness of complementary feeding interventions in developing 
countries. Matern Child Nutr 2008, 4 Suppl 1, 24-85. 
11. Prentice, A., Nutrient requirements for growth, pregnancy and 
lactation: the Keneba experience. S Afr J Clin Nutr 1993, 6, 33-38. 
12. Bhutta, Z. A.; Ahmed, T.; Black, R. E.; Cousens, S.; Dewey, K.; 
Giugliani, E.; Haider, B. A.; Kirkwood, B.; Morris, S. S.; Sachdev, H. P.; 
Shekar, M.; Maternal; Child Undernutrition Study, G., What works? 
Interventions for maternal and child undernutrition and survival. Lancet 
2008, 371, (9610), 417-40. 
13. Brown, E. M.; Wlodarska, M.; Willing, B. P.; Vonaesch, P.; Han, J.; 
Reynolds, L. A.; Arrieta, M. C.; Uhrig, M.; Scholz, R.; Partida, O.; 
Borchers, C. H.; Sansonetti, P. J.; Finlay, B. B., Diet and specific microbial 
exposure trigger features of environmental enteropathy in a novel murine 
model. Nat Commun 2015, 6, 7806. 
14. Clasen, T.; Boisson, S.; Routray, P.; Torondel, B.; Bell, M.; 
Cumming, O.; Ensink, J.; Freeman, M.; Jenkins, M.; Odagiri, M.; Ray, S.; 
Sinha, A.; Suar, M.; Schmidt, W. P., Effectiveness of a rural sanitation 
programme on diarrhoea, soil-transmitted helminth infection, and child 
malnutrition in Odisha, India: a cluster-randomised trial. Lancet Glob Health 
2014, 2, (11), e645-53. 
15. Patil, S. R.; Arnold, B. F.; Salvatore, A. L.; Briceno, B.; Ganguly, S.; 
Colford, J. M., Jr.; Gertler, P. J., The effect of India's total sanitation 
campaign on defecation behaviors and child health in rural Madhya Pradesh: 
a cluster randomized controlled trial. PLoS medicine 2014, 11, (8), 
e1001709. 
16. Pickering, A. J.; Djebbari, H.; Lopez, C.; Coulibaly, M.; Alzua, M. L., 
Effect of a community-led sanitation intervention on child diarrhoea and 
child growth in rural Mali: a cluster-randomised controlled trial. Lancet 
Glob Health 2015, 3, (11), e701-11. 
17. Esrey, S. A., Water, waste, and well-being: a multicountry study. Am 
J Epidemiol 1996, 143, (6), 608-623. 
 
86 
18. Checkley, W.; Gilman, R. H.; Black, R. E.; Epstein, L. D.; Cabrera, 
L.; Sterling, C. R.; Moulton, L. H., Effect of water and sanitation on 
childhood health in a poor Peruvian peri-urban community. Lancet 2004, 
363, (9403), 112-118. 
19. Fink, G.; Gunther, I.; Hill, K., The effect of water and sanitation on 
child health: evidence from the demographic and health surveys 1986-2007. 
Int J Epidemiol 2011, 40, (5), 1196-204. 
20. Lin, A.; Arnold, B. F.; Afreen, S.; Goto, R.; Huda, T. M.; Haque, R.; 
Raqib, R.; Unicomb, L.; Ahmed, T.; Colford, J. M., Jr.; Luby, S. P., 
Household environmental conditions are associated with enteropathy and 
impaired growth in rural Bangladesh. The American journal of tropical 
medicine and hygiene 2013, 89, (1), 130-7. 
21. Rah, J. H.; Cronin, A. A.; Badgaiyan, B.; Aguayo, V. M.; Coates, S.; 
Ahmed, S., Household sanitation and personal hygiene practices are 
associated with child stunting in rural India: a cross-sectional analysis of 
surveys. BMJ open 2015, 5, (2), e005180. 
22. George, C. M.; Oldja, L.; Biswas, S.; Perin, J.; Lee, G. O.; Kosek, M.; 
Sack, R. B.; Ahmed, S.; Haque, R.; Parvin, T.; Azmi, I. J.; Bhuyian, S. I.; 
Talukder, K. A.; Mohammad, S.; Faruque, A. G., Geophagy is associated 
with environmental enteropathy and stunting in children in rural Bangladesh. 
The American journal of tropical medicine and hygiene 2015, 92, (6), 1117-
24. 
23. George, C. M.; Oldja, L.; Biswas, S. K.; Perin, J.; Lee, G. O.; Ahmed, 
S.; Haque, R.; Sack, R. B.; Parvin, T.; Azmi, I. J.; Bhuyian, S. I.; Talukder, 
K. A.; Faruque, A. G., Fecal Markers of Environmental Enteropathy are 
Associated with Animal Exposure and Caregiver Hygiene in Bangladesh. 
The American journal of tropical medicine and hygiene 2015. 
24. Kosek, M.; Haque, R.; Lima, A.; Babji, S.; Shrestha, S.; Qureshi, S.; 
Amidou, S.; Mduma, E.; Lee, G.; Yori, P. P.; Guerrant, R. L.; Bhutta, Z.; 
Mason, C.; Kang, G.; Kabir, M.; Amour, C.; Bessong, P.; Turab, A.; 
Seidman, J.; Olortegui, M. P.; Quetz, J.; Lang, D.; Gratz, J.; Miller, M.; 
Gottlieb, M.; network, M.-E., Fecal markers of intestinal inflammation and 
permeability associated with the subsequent acquisition of linear growth 
deficits in infants. The American journal of tropical medicine and hygiene 
2013, 88, (2), 390-6. 
 
87 
25. Yori, P. P.; Lee, G.; Olortegui, M. P.; Chavez, C. B.; Flores, J. T.; 
Vasquez, A. O.; Burga, R.; Pinedo, S. R.; Asayag, C. R.; Black, R. E.; 
Caulfield, L. E.; Kosek, M., Santa Clara de Nanay: the MAL-ED cohort in 
Peru. Clin Infect Dis 2014, 59 Suppl 4, S310-6. 
26. WHO/UNICEF Progress on Sanitation and Drinking Water: 2015 
Update and MDG Assessment; Geneva and New York: WHO/UNICEF Joint 
Monitoring Program for Water Supply and Sanitation, 2015. 
27. Heitzinger, K.; Rocha, C. A.; Quick, R. E.; Montano, S. M.; Tilley, D. 
H., Jr.; Mock, C. N.; Carrasco, A. J.; Cabrera, R. M.; Hawes, S. E., 
"Improved" But Not Necessarily Safe: An Assessment of Fecal 
Contamination of Household Drinking Water in Rural Peru. The American 
journal of tropical medicine and hygiene 2015, 93, (3), 501-8. 
28. Kosek, M.; Yori, P. P.; Pan, W. K.; Olortegui, M. P.; Gilman, R. H.; 
Perez, J.; Chavez, C. B.; Sanchez, G. M.; Burga, R.; Hall, E., Epidemiology 
of highly endemic multiply antibiotic-resistant shigellosis in children in the 
Peruvian Amazon. Pediatrics 2008, 122, (3), e541-9. 
29. Agtini, M. D.; Soeharno, R.; Lesmana, M.; Punjabi, N. H.; 
Simanjuntak, C.; Wangsasaputra, F.; Nurdin, D.; Pulungsih, S. P.; Rofiq, A.; 
Santoso, H.; Pujarwoto, H.; Sjahrurachman, A.; Sudarmono, P.; von 
Seidlein, L.; Deen, J. L.; Ali, M.; Lee, H.; Kim, D. R.; Han, O.; Park, J. K.; 
Suwandono, A.; Ingerani; Oyofo, B. A.; Campbell, J. R.; Beecham, H. J.; 
Corwin, A. L.; Clemens, J. D., The burden of diarrhoea, shigellosis, and 
cholera in North Jakarta, Indonesia: findings from 24 months surveillance. 
BMC infectious diseases 2005, 5, 89. 
30. Platts-Mills, J. A.; Babji, S.; Bodhidatta, L.; Gratz, J.; Haque, R.; 
Havt, A.; McCormick, B. J.; McGrath, M.; Olortegui, M. P.; Samie, A.; 
Shakoor, S.; Mondal, D.; Lima, I. F.; Hariraju, D.; Rayamajhi, B. B.; 
Qureshi, S.; Kabir, F.; Yori, P. P.; Mufamadi, B.; Amour, C.; Carreon, J. D.; 
Richard, S. A.; Lang, D.; Bessong, P.; Mduma, E.; Ahmed, T.; Lima, A. A.; 
Mason, C. J.; Zaidi, A. K.; Bhutta, Z. A.; Kosek, M.; Guerrant, R. L.; 
Gottlieb, M.; Miller, M.; Kang, G.; Houpt, E. R.; Investigators, M.-E. N., 
Pathogen-specific burdens of community diarrhoea in developing countries: 
a multisite birth cohort study (MAL-ED). Lancet Glob Health 2015, 3, (9), 
e564-75. 
 
88 
31. Investigators, M.-E. N., The MAL-ED study: a multinational and 
multidisciplinary approach to understand the relationship between enteric 
pathogens, malnutrition, gut physiology, physical growth, cognitive 
development, and immune responses in infants and children up to 2 years of 
age in resource-poor environments. Clin Infect Dis 2014, 59 Suppl 4, S193-
206. 
32. Lee, G. O.; Kosek, P.; Lima, A. A.; Singh, R.; Yori, P. P.; Olortegui, 
M. P.; Lamsam, J. L.; Oliveira, D. B.; Guerrant, R. L.; Kosek, M., Lactulose: 
mannitol diagnostic test by HPLC and LC-MSMS platforms: considerations 
for field studies of intestinal barrier function and environmental enteropathy. 
Journal of pediatric gastroenterology and nutrition 2014, 59, (4), 544-50. 
33. Denno, D. M.; VanBuskirk, K.; Nelson, Z. C.; Musser, C. A.; Hay 
Burgess, D. C.; Tarr, P. I., Use of the Lactulose to Mannitol Ratio to 
Evaluate Childhood Environmental Enteric Dysfunction: A Systematic 
Review. Clinical Infectious Diseases 2014, 59, (suppl_4), S213-S219. 
34. Lee, S. E.; West, K. P., Jr.; Cole, R. N.; Schulze, K. J.; Christian, P.; 
Wu, L. S.; Yager, J. D.; Groopman, J.; Ruczinski, I., Plasma Proteome 
Biomarkers of Inflammation in School Aged Children in Nepal. PloS one 
2015, 10, (12), e0144279. 
35. Raiten, D. J.; Sakr Ashour, F. A.; Ross, A. C.; Meydani, S. N.; 
Dawson, H. D.; Stephensen, C. B.; Brabin, B. J.; Suchdev, P. S.; van 
Ommen, B.; Group, I. C., Inflammation and Nutritional Science for 
Programs/Policies and Interpretation of Research Evidence (INSPIRE). The 
Journal of nutrition 2015, 145, (5), 1039S-1108S. 
36. Rosales, F. J.; Topping, J. D.; Smith, J. E.; Shankar, A. H.; Ross, A. 
C., Relation of serum retinol to acute phase proteins and malarial morbidity 
in Papua New Guinea children. Am J Clin Nutr 2000, 71, (6), 1582-8. 
37. Crenn, P.; Messing, B.; Cynober, L., Citrulline as a biomarker of 
intestinal failure due to enterocyte mass reduction. Clin Nutr 2008, 27, (3), 
328-39. 
38. Keusch, G. T.; Denno, D. M.; Black, R. E.; Duggan, C.; Guerrant, R. 
L.; Lavery, J. V.; Nataro, J. P.; Rosenberg, I. H.; Ryan, E. T.; Tarr, P. I.; 
Ward, H.; Bhutta, Z. A.; Coovadia, H.; Lima, A.; Ramakrishna, B.; Zaidi, A. 
K.; Hay Burgess, D. C.; Brewer, T., Environmental enteric dysfunction: 
 
89 
pathogenesis, diagnosis, and clinical consequences. Clin Infect Dis 2014, 59 
Suppl 4, S207-12. 
39. UNICEF, W., WHO Joint Monitoring Programme for Water Supply 
and Sanitation. Progress on drinking water and sanitation 2012. 
40. Jenkins, M. W.; Cumming, O.; Cairncross, S., Pit latrine emptying 
behavior and demand for sanitation services in Dar Es Salaam, Tanzania. 
International journal of environmental research and public health 2015, 12, 
(3), 2588-611. 
41. Blackett, I. H., P.; Heymans, C. The missing link in sanitation service 
delivery : a review of fecal sludge management in 12 cities; World Bank 
Group: Washington DC, 2014. 
42. Shaheed, A.; Orgill, J.; Montgomery, M. A.; Jeuland, M. A.; Brown, 
J., Why "improved" water sources are not always safe. Bulletin of the World 
Health Organization 2014, 92, (4), 283-9. 
43. Hunter, P. R.; Zmirou-Navier, D.; Hartemann, P., Estimating the 
impact on health of poor reliability of drinking water interventions in 
developing countries. Sci Total Environ 2009, 407, (8), 2621-4. 
44. Organization, W. H., Guidelines for drinking-water quality World 
Health Organization. Geneva, Switzerland 2011. 
45. Pickering, A. J.; Julian, T. R.; Marks, S. J.; Mattioli, M. C.; Boehm, 
A. B.; Schwab, K. J.; Davis, J., Fecal Contamination and Diarrheal 
Pathogens on Surfaces and in Soils among Tanzanian Households with and 
without Improved Sanitation. Environ Sci Technol 2012, 46, (11), 5736-
5743. 
 
90 
Chapter 3 
Floors and toilets: Association of floors and sanitation 
practices with fecal contamination in Peruvian Amazon 
peri-urban households   
 
Natalie G. Exuma, Maribel Paredes Olórteguib,c, Pablo Peñataro Yorib,c, 
Meghan F. Davisa, Christopher D. Heaneya,d, Margaret Kosekb,c, Kellogg J. 
Schwaba* 
 
a Department of Environmental Health Sciences, Bloomberg School of Public Health, 
Johns Hopkins University, Baltimore, MD 21205-2179, USA 
b Department of International Health, Johns Hopkins Bloomberg School of Public Health, 
Baltimore, Maryland 
c Asociación Benéfica Proyectos de Informática, Salud, Medicina, y Agricultura (A.B. 
PRISMA), Iquitos, Peru 
d Department of Epidemiology, Bloomberg School of Public Health, Johns Hopkins 
University, Baltimore, MD 21205-2179, USA 
*Corresponding author: Kellogg J Schwab, Department of Environmental Health 
Sciences Room E6620, Bloomberg School of Public Health, Johns Hopkins University, 
Baltimore, 615 North Wolfe St, MD 21205-2179, USA, E-mail: kschwab1@jhu.edu 
 
Abstract 
Over two billion people worldwide lack access to an improved sanitation 
facility that adequately retains or treats feces. This results in the potential for 
fecal material containing enteric pathogens to contaminate the environment, 
including household floors. This study aimed to assess how floor type and 
sanitation practices impacted the concentration of fecal contamination on 
household floors. We sampled 189 floor surfaces within 63 households in a 
peri-urban community in Iquitos, Peru. All samples were analyzed for 
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colony forming units (CFUs) of E. coli and households were evaluated for 
their water, sanitation and hygiene characteristics. Results of multivariate 
linear regression indicated that households with improved sanitation and 
cement floors in the kitchen area had reduced fecal contamination to those 
with unimproved sanitation and dirt floors (Beta: -1.18 log10 E. coli 
CFU/900 cm2; 95% confidence interval [CI]: -1.77, -0.60). Households that 
did not versus did share their sanitation facility also had less contaminated 
kitchen floors (Beta: -0.65 log10 E. coli CFU/900 cm2; 95% CI: -1.15, -0.16). 
These findings suggest that the sanitation facilities of a home may impact 
the microbial load found on floors, contributing to the potential for 
household floors to serve as an indirect route of fecal pathogen transmission 
to children. 
 
Introduction 
Diarrheal diseases are a leading cause of malnutrition and death in children 
under five years old, accounting for 10 percent of all deaths (approximately 
760,000 children annually).1 Children living in low-income countries 
disproportionately suffer from malnutrition, which has been shown to 
increase mortality risk, affect cognitive development, increase infection risk, 
limit physical capacity and childbearing, and reduce adult economic 
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productivity.2 Fecal contamination in the environment due to a lack of 
sanitation leads to high rates of diarrhea and is hypothesized to impact 
malnutrition through environmental enteropathy (EE), a condition in the gut 
caused by exposure to enteric pathogens that lead to alterations in intestinal 
structure, function, and local and systemic immune activation.3 EE is also 
considered to negatively impact growth. A growing body of evidence 
supports the contribution of environmental factors related to poor water, 
sanitation and hygiene conditions to stunting in children.4-6 
 
There are many fecal-oral transmission pathways, which account for 
important routes of exposure for the pathogens that cause enteric infection. 
These pathways can broadly be categorized by the F-diagram, which depicts 
the concept that human-derived enteric pathogens are transmitted through 
food, flies, floors, fingers, and fluids.7 A lack of access to clean water is 
often implicated as the primary fecal-oral transmission route; however, a 
number of randomized, controlled trials investigating the effect of drinking 
water on gastrointestinal health have shown no additional benefit from 
point-of-use interventions.8-11 This lack of benefit from clean water is 
hypothesized to stem from the additive contributions of poor sanitation and 
hygiene, which allow for exposures through alternative fecal-oral 
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transmission pathways and negate any potential benefit observed from 
improved water quality alone. In addition, a recent review of 
epidemiological studies on the effect of water and sanitation interventions on 
self-reported diarrhea episodes revealed no difference in point-of-use water 
interventions when blinding was taken into account.12 These studies 
emphasize the importance of investigating other transmission routes to 
understand which fecal-oral pathways pose the greatest risk for ingestion of 
pathogens.  
 
One of the pathways that has not been well characterized in communities 
with significant fecal contamination are household floors. This transmission 
pathway is especially important for infants (7-12 months) who are more 
likely to remain indoors and spend more time playing on the floor than older 
children.13 Younger children are also more likely to engage in pica (i.e. soil 
consumption), object-to-mouth, and hand-to-mouth activity than older 
children.14, 15 These behaviors, combined with immature immune responses, 
render the youngest children most vulnerable to enteric infections. Despite 
its importance, limited research has focused on floors as a critical pathway 
for pathogen transmission. The few studies conducted have highlighted the 
importance of quantifying fecal indicator bacteria on household floors and 
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surfaces to understand the distribution of fecal matter.16-18 One limitation of 
these studies is that no duplicate samples were processed at the sample 
collection level to understand if the fecal contamination is significantly 
associated with location within a household. Repeat samples are also 
necessary to characterize between sample variability and understand if the 
fecal contamination within a household is consistent or varies over time and 
displays a “patchiness” as has been demonstrated in quantifying bacteria in 
beach sands.19 
 
Our study reports on the Escherichia coli bacteria levels of the main floor 
surfaces in the homes of children near Iquitos, Peru enrolled in the Etiology, 
Risk Factors and Interactions of Enteric Infections and Malnutrition and the 
Consequences for Child Health and Development (MAL-ED) cohort study. 
The use of E. coli concentration as a fecal indicator bacteria within the 
household has been shown to be effective in a number of studies16-18, 20 as 
well as at this study site in Iquitos Peru.21 The aim of this study was to 
compare concentrations of E. coli recovered from household floors 
according to characteristics of household sanitation. A secondary aim was to 
characterize the variability of recovery of E. coli within households. 
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Methods 
 
Study Setting and Population 
This study was nested within the MAL-ED cohort in three peri-urban 
communities of Iquitos, Peru: Santa Clara de Nanay, Santo Tomas, and La 
Union (3°47’S, 73°20’W). In order to be eligible for the floor sampling 
study, a household had to have a child less than 48 months of age who was 
still enrolled in the MAL-ED study at the time of sampling. 
 
Prior work has shown that these communities lag behind the rest of the Peru 
in terms of development indicators.22 Only 20.2 percent of the population 
had access to an improved sanitation facility while 58.4 percent of the 
overall Peru population had access. Similarly, 46.7 percent of households in 
the study communities had access to clean water versus 77.1 percent in all of 
Peru. Child growth also lagged behind with 46.3 percent of children under 5 
years old being stunted versus 19.5 percent in Peru. Children under 5 years 
old who were reported to have diarrhea in the past week was 35.4 percent 
versus 13.9 percent in Peru.22 The households were low-income with the 
mean monthly per-capita income at $28 US dollars.23 The temperature 
ranges between 21.9 and 32.4 degrees Celsius with an average of 25.8 
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degrees Celsius.22 Rainfall is frequent and occurs throughout the year on 
about half of all days with the heaviest rainfall in January.22 
 
The communities are located proximal to the Nanay River, which is a major 
branch of the Amazon river system. The river levels rise until March and, at 
the time of initiation of the study, the Nanay River was receding and no 
flooding was apparent within any of the households visited. There is no 
centralized sewerage infrastructure in the community and hence open ditches 
are used to drain storm and gray water away from the home. The frequent 
flooding in this riverine community also leads to fecal matter from latrines 
being released into the environment.  
 
Classification of Floors and Sanitation Practices 
During each household visit, a household questionnaire was administered in 
Spanish prior to floor sampling. The questionnaire was based on the 
Demographic and Health Surveys3 and was a shortened version of the 
standardized questionnaire. In addition, study staff conducted a standardized 
visual inspection of floor type by room within households and noted the 
materials used as either dirt, wood, cement or tile.   
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The questionnaire assessed the primary exposure variable of the type of 
sanitation facility used by household members and whether or not this 
facility was shared. The options for type of sanitation facility were: i) no 
facility/open field; ii) pit latrine; iii) pour flush toilet to a septic; iv) flush to 
somewhere else; or v) ventilated improved pit latrine. Responses to water 
and hygiene questions provided covariate data on the household’s primary 
water source, mode of water treatment, time it takes to fetch water, hygiene 
behavior and crowding. Information was also collected on socio-economic 
factors such as housing construction materials, length of tenancy, electricity 
access, maternal education, and monthly income. Given the propensity for 
households to keep free-ranging or corralled chickens in this community, 
participants also were interviewed regarding the presence of chickens in the 
home to evaluate the influence of chicken feces on the bacterial 
contamination of household floors. 
 
Floor Sampling 
From August to September 2015 household floors were sampled for E. coli 
bacteria using a modified dry electrostatic cloth method based on one 
designed for household settings.24 Samples were collected from highly 
trafficked areas, namely the household entrance and the kitchen, which has 
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been shown to have higher levels of fecal bacteria than the bathroom 
areas.17, 25 These areas were also selected for high likelihood of fecal 
pathogen exposure for children under five years of age who spend large 
amounts of time in play near the entrance and near the primary caregiver 
engaged in cooking activities. The first area sampled was the entryway floor, 
typically located at the front of the house and closest to the open drains that 
conveyed untreated wastewater and had a tendency to overflow during 
periods of rainfall. The second area sampled was the kitchen floor area, 
typically located at the back of the house (Figure 1). If there was a latrine or 
toilet, it was most commonly in the back of the house, closest to the kitchen 
area. The kitchen area was also observed to be the area of the house where 
most water use and storage activities took place, creating a potentially 
favorable environment for bacterial growth. Duplicate samples were taken 
side by side at the entryway location to investigate the heterogeneity of fecal 
contamination across floors.  To assess the potential influence of different 
floor material types (e.g. dirt, wood, cement) on fecal contamination, we 
recorded information about the floor material types at the household 
entrance and in the kitchen area at the time of sampling.  
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Prior to field collection, sterile packets of dry electrostatic cloths (Swiffer™; 
Proctor & Gamble, Cincinnati, OH) were separated, quartered, and 
individually wrapped in autoclave paper (Fisher Scientific™, Pittsburgh, 
PA). Wrapped packets were then sterilized by autoclaving. For each 
collection an adapted protocol from Davis et al. (2012) was used where a 
prepared cloth was passed over a 30 cm by 30 cm floor surface with medium 
pressure to maximize the amount of pick-up from the surface 24. The cloth 
was then placed into a sterile 700 mL Whirlpak bag (Nasco, Fork Atkinson, 
WI) and 5 mL of sterilized Milli-Q ultra-pure water to guard against 
microbial desiccation during transport. Collected material on the cloth 
buffered the water on contact to prevent bacterial osmotic shock (data not 
shown). Samples were stored in a cooler on ice at 4°C during field collection 
and transported to the laboratory. Samples were processed within six hours 
of collection. 
 
Microbiological evaluation 
For elution, 100 ml of sterile 0.1% Peptone buffer was added into the 
Whirlpak bag containing the cloth and vigorously shaken for one minute. 
The cloth was aseptically removed and E. coli in the buffer were enumerated 
following USEPA Method 160426 using m-coliblue24 commercial media 
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(HACH, Loveland, U.S.A.). Positive E. coli were identified as blue colonies. 
Pre, intermittent and post blanks were run to confirm the absence of cross 
contamination of samples. To obtain a countable number of colonies (i.e. 20-
200), undilute, 10-fold, 100-fold and 1000-fold dilutions of eluate for 
samples collected on dirt floors and undilute, 10-fold and 100-fold for 
samples collected on wood and cement floors were processed, enabling a 
detection range of 0 to 200,000 colony forming units (CFU) per 900 cm2of 
floor area to be enumerated. 
 
Data Analysis 
The data were processed and visualized using R software version 3.0.3 (R-
FSC, Vienna, Austria) and subsequent statistical analysis was conducted 
using Stata version 12.1 (College Station, TX). The primary independent 
variable of sanitation facility was categorized into “improved” and 
“unimproved” sanitation facilities as defined by the Joint Monitoring 
Program (JMP) for Water Supply and Sanitation.27 The JMP classifies 
improved facilities as those that ensure hygienic separation of human excreta 
from human contact and include facilities that flush or pour flush to a piped 
sewer system, septic tank or pit latrine. Unimproved facilities on the other 
hand, do not ensure hygienic separation of human excreta from human 
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contact and include pit latrines without a slab. For the purposes of this study, 
those households that did not have a toilet facility were also categorized as 
“unimproved”.  
 
Water source, water treatment and floor type covariates were analyzed as 
categorical variables. A hygiene index variable score was calculated as a 
cumulative score from the following four questions: i) Do you wash your 
hands after helping your child defecate? ii) Do you wash your hands before 
preparing food? iii) Do you wash your hands after going to the bathroom? 
and iv) Do you use toilet paper? The hygiene index score had three levels 
with good indicating the interviewee answered all questions as always 
practicing the hygienic behaviors; average indicated that for one of the four 
questions the interviewee only sometimes practiced the hygienic behavior; 
and poor indicated that for two or more questions the interviewee only 
sometimes practiced the hygienic behavior. E. coli concentrations were 
log10-transformed and reported as log10 E. coli CFU/900 cm2. 
 
Two-sample t-tests with equal variances and Pearson Chi-squared analysis 
were used to compare household characteristics across improved and 
unimproved sanitation facility types. Unadjusted linear regression analyses 
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were conducted to evaluate associations between water, sanitation, hygiene 
(WASH) and household characteristics with log10 E. coli CFU/900 cm2 in 
the entrance and kitchen areas. Using generalized linear models we 
conducted a stratified analysis by sanitation type (improved versus 
unimproved). For this analysis of the relation between floor types and the 
levels of log10 E. coli CFU in strata of household sanitation type 
(unimproved and improved), observations in the entrance and kitchen of 
each house were combined. We adjusted for potential confounding 
covariates in linear regression models using a backward elimination 
approach. A final parsimonious covariate adjustment set was selected based 
on considerations of sample size and the minimization of the Akaike 
Information Criterion (AIC).28 Interaction terms between sanitation type and 
floor type were included to determine if the association between sanitation 
and log10 E. coli CFU/900 cm2 was modified by floor type. Beta coefficients 
and 95% confidence intervals were estimated and represent the log10-unit 
change in E. coli CFU/900 cm2 per unit of each of the independent variables 
(household sanitation type, floor type, etc). Pearson correlation coefficients 
and 95% confidence intervals were calculated to estimate the variability 
between duplicate floor samples within the same household. 
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Ethics 
The study protocol and questionnaires were approved by the institutional 
review boards from Johns Hopkins Bloomberg School of Public Health 
(Baltimore, MD) and Asociación Benéfica Proyectos de Informática, Salud, 
Medicina, y Agricultura (A.B. PRISMA), Iquitos, Peru. All participants gave 
written consent prior to household sampling. 
 
Results 
Table 1 illustrates that, among 63 household visits during the study period, 
189 samples were collected, representing 63 entrance floor samples, 63 
additional samples (duplicates) from adjoining areas to the primary entrance 
floor samples, and 63 samples from the kitchen floor. There were a total of 
31 households that were classified as having unimproved sanitation and 32 
households with improved sanitation facilities. In the entrance area there 
were 36 homes with dirt floors, 3 with wood floors and 24 with cement 
floors. In the kitchen area there were 46 homes with dirt floors, 4 with wood 
floors and 13 with cement floors. One household in each category for 
sanitation type had ceramic tile in either the entrance and kitchen area.  
These households were categorized as having a cement floor for analysis due 
to the common composition and construction characteristics between the 
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local tile and cement. There were no missing data for the log10 E. coli 
CFU/900 cm2outcome variable and less than ten percent of data were 
missing when all variables were considered in the full model. 
 
Figure 2 depicts the log10 E. coli CFU/900 cm2 in both the entrance and 
kitchen areas of the home by floor type. The entrance area of homes had an 
average of 3.40 log10 E. coli CFU (standard deviation=1.00) per 30 by 30 cm 
sample and the kitchen areas had significantly higher levels of log10 E. coli 
with 3.91 log10 E. coli CFU (sd=1.00) (p-value = 0.005).  Within the 
entrance areas, dirt floors had statistically significantly higher levels of log10 
E. coli CFU than cement floors (3.75 vs 2.86, p-value<0.001) and within the 
kitchen areas, dirt floors also had statistically significantly higher levels of 
log10 E. coli CFU than cement floors (4.27 vs 2.96, p-value=0.002) and 
wood floors (4.27 vs 2.89, p-value=0.023). Lastly, when comparing dirt 
floors between the entrance and kitchen areas within a household, the levels 
of log10 E. coli CFU in the kitchen area were statistically significantly higher 
than in the entrance (4.27 vs 3.75, p-value=0.013).  
 
Household characteristic differences by sanitation type 
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For households with unimproved versus improved sanitation facilities, there 
were significant differences in household characteristics (Table 1). 
Households with unimproved versus improved sanitation had a higher 
percentage of dirt floors in both the entrance (77.4 vs 37.5, p<0.01) and 
kitchen (87.1 vs 59.4, p<0.05 level) and a more frequent reporting of 
chickens in the home (45.2 vs 12.5, p<0.01).  Households with improved 
versus unimproved sanitation had a higher percentage of cement floors in 
both the entrance (56.3 vs 19.4, p<0.01) and kitchen (31.3 vs 9.7, p<0.05). 
There were no significant differences across sanitation type for other 
household WASH characteristics such as sharing sanitation facilities, type 
water connection, time to fetch water, household chlorine use to treat 
drinking water, crowding, income, education, electricity connection, wall 
and roof type and tenancy in the house. 
 
Unadjusted analysis of household WASH characteristics and E. coli 
levels on floors 
Linear regression models comparing individual household WASH 
characteristics and the levels of log10 E. coli CFU demonstrated significant 
associations in both the entrance and kitchen areas (Table 2). Households 
with improved sanitation had lower levels of log10 E. coli CFU/900 cm2 on 
floors when compared to homes with unimproved sanitation in both the 
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entrance and kitchen (Beta: -0.63 (95% CI: -1.12, -0.15); and Beta: -0.80 
(95% CI: -1.27, -0.33) respectively). For shared sanitation, households that 
reported not sharing their sanitation facility versus those did share had lower 
levels of log10 E. coli CFU/900 cm2 (Beta: -0.70; 95% CI: -1.27, -0.13) in 
the kitchen area. Household entrance and kitchen areas with cement floors 
also had lower levels of log10 E. coli CFU/900 cm2 when compared to 
household entrance and kitchen areas with dirt floors (Beta: -0.89 (95% CI: -
1.38, -0.40); and Beta: -1.31 (95% CI: -1.83, -0.79) respectively). For every 
additional minute that interviewees reported needing to fetch water, 
corresponding increases in the concentrations of log10 E. coli CFU/900 cm2 
on entrance floors (Beta: 0.06; 95% CI: 0.02, 0.10) and kitchen floors (Beta: 
0.05; 95% CI: 0.01, 0.09) were observed. Table 2 illustrates that wall type, 
crowding, electricity access, maternal education and housing tenancy were 
independently associated with increases in log10 E. coli CFU/900 cm2.  
 
To further understand the relationship between floor type and sanitation 
type, the stratified data by sanitation type (improved versus unimproved) are 
shown in Figure 4. The lowest log10 E. coli CFU/900 cm2 were found in the 
homes with both improved sanitation and improved floor types (defined by 
their ability to be disinfected such that wood and cement floors are 
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combined into the improved category and dirt as unimproved). The 
reduction in log10 E. coli CFU/900 cm2 among households with unimproved 
sanitation was -0.60 (95% CI: -1.03, -0.17) when comparing wood or cement 
(improved) floors to dirt floors (unimproved). An even greater reduction of -
1.17 log10 E. coli CFU/900 cm2 (95% CI: -1.68, -0.66) was observed among 
households with improved sanitation when comparing wood or cement 
floors to dirt floors (Table 3). 
 
Adjusted analysis of household WASH characteristics and E. coli levels 
on floors 
Two multivariate linear regression models were run for the entrance and 
kitchen floor areas with predictor variables that included both the sanitation 
type (improved or unimproved) as an interaction term with floor type and 
the variable for whether the sanitation facility was shared (Table 4). The 
models adjusted for time to fetch water, presence of chickens in the 
household, crowding, maternal education and wall type. For the entrance 
floor area, households with improved sanitation and cement floors had lower 
log10 E. coli CFU/900 cm2 on their floors when compared to households 
with unimproved sanitation and dirt floors (Beta: -0.43; 95% CI: -1.08, 
0.21). For the kitchen floor area, households with unimproved sanitation and 
wood floors and households with improved sanitation and cement floors 
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both had statistically significantly lower log10 E. coli CFU/900 cm2 on their 
floors when compared to households with unimproved sanitation and dirt 
floors (Beta: -2.36 (95% CI: -3.86, -0.86) and (Beta: -1.18 (95% CI: -1.77, -
0.60) respectively). Households that did not share their sanitation facility 
also had significantly reduced log10 E. coli CFU/900 cm2 on their kitchen 
floors (Beta: -0.65; 95% CI: -1.15, -0.16) when compared to kitchen floors 
in households that did share their sanitation facility. The significant 
covariates in the adjusted model for the kitchen area included lack of 
chickens in the household (Beta: -0.63; 95% CI: -1.12, -0.15; indicating 
lower log10 E. coli CFU/900 cm2 for those without versus with a presence of 
chickens) and maternal education (Beta: -0.08; 95% CI: (-0.15, -0.004; 
indicating lower log10 E. coli CFU/900 cm2 in homes for every year increase 
in of education). The significant covariates in the adjusted model for the 
entrance area, were time to fetch water (Beta: 0.05; 95% CI: 0.003, 0.09; 
indicating higher log10 E. coli CFU/900 cm2 for every minute increase in 
time to fetch water) and maternal education (Beta: -0.10; 95% CI: -0.19, 
0.00; indicating lower log10 E. coli CFU/900 cm2 for every year increase in 
of education).  
 
Variability of recovery of E. coli within households 
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For the entrance area where side-by-side samples were collected to 
understand the distribution of E. coli bacteria across floor surfaces, the 
Pearson correlation coefficient between the initial and duplicate samples was 
0.83 with a p-value < 0.001 (n=63) (Figure 3). The 95% confidence interval 
for the Pearson correlation coefficient ranged from 0.73 to 0.89 indicating a 
homogenous spread of bacteria across the sampling area.  
 
Discussion 
This study found evidence that household floors carried differential loads of 
fecal contamination depending on the type of sanitation facility and whether 
or not that sanitation facility was shared. The kitchen area had a higher level 
of E. coli than the entryway, which is consistent with previous studies that 
reported that the kitchen area is the location of greatest contamination.17, 25 
Additionally, the kitchen areas of these households were most commonly in 
the back, in closest proximity to the sanitation facility (if sanitation facilities 
were onsite) (Figure 1). This makes the kitchen area the most likely first 
point of contact for a household member after defecation and may therefore 
increase the bacterial loads within this area of the house. Homes with dirt 
floors were also found to have higher levels of bacteria than homes with 
cement floors. This supports the findings from previous interventions that 
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replacing dirt floors with cement floors may significantly improve child gut 
health.29 
 
The sanitation facility was the household characteristic found to have the 
most significant and consistent relationship with the levels of bacteria on 
kitchen floors. These findings support the potential for sanitation 
interventions targeting hygienic containment of human waste to reduce 
exposures to fecal pathogens in the home. In the study communities, a flush 
toilet to a septic was a more hygienic sanitation option than the pit latrine, 
which was simply a hole in the ground (either covered or uncovered). Those 
who shared sanitation facilities were also more likely to have floors 
contaminated with E. coli in the kitchen area. This provides evidence in 
support of the definition for “shared” sanitation facilities being characterized 
as “unimproved” by JMP. The underlying assumption by the JMP that there 
is little commitment or incentive for users to keep a shared facility clean 
may in fact hold true in this community despite contrary evidence in other 
settings.16 
 
Among homes with the same sanitation type, there was a reduction in fecal 
contamination when comparing unimproved (dirt) to improved (either wood 
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or cement) floors however, the magnitude of reduction was greater among 
homes with improved sanitation. Interestingly, the reduction of fecal 
contamination was not as large with only one of the two fecal-oral 
transmission pathways was interrupted (improved sanitation or an improved 
floor). This highlights the importance of interrupting additional fecal-oral 
transmission pathways, such as floors, during a sanitation intervention to 
most effectively reduce exposures to fecal pathogens in the home 
 
This study also found that the presence of chickens in homes significantly 
increased the E. coli contamination on floors. Similar to people, either 
pathogenic or commensal E. coli can be identified in the chicken 
gastrointestinal tract, and chickens can be either asymptomatic carriers or 
exhibit disease.30 Study staff frequently observed the presence of chicken 
droppings on surfaces in the home when chickens were present, suggesting 
the potential for direct fecal contamination from the birds.  
 
This was the first study to use a dry electrostatic cloth as the sampling 
method for E. coli on floor surfaces in low-resourced settings. Other studies 
that sampled for E. coli either collected soil or used a cotton swab. One 
study in Tanzania examined household floors across different locations in 
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the home by quantifying the number of E. coli from a layer of soil 10 cm by 
10 cm by 1 cm thick.17 Another study in Cambodia sampled the floor surface 
around the base of household latrine and a floor surface near the kitchen sink 
using a swab method over the sample surface of 4 cm2.18 In comparison to 
these studies, the concentrations of E. coli contamination found of the dirt 
floors of these Peruvian homes were approximately 518 to 8017 times more 
contaminated. This may be due to the efficiency of the sampling method 
used or may additionally or alternately reflect a higher typical bacterial load 
among homes in this community. The climate in the Peruvian Amazon 
provided an ideal environment for Gram-negative bacterial growth with 
consistently hot and humid weather year round and regular precipitation 
with dark and shady spaces inside the houses. Dirt floors in homes further 
promote bacterial growth and are difficult to disinfect due to the organic 
material and complex matrix. Therefore, fecal pathogens that reach 
household floors have a high chance for survival in the environment with 
increased potential for transmission to children.     
 
This study also found evidence for the consistency in the contamination of 
floors across the entrance floor area as evidenced by the side-by-side 
sampling. This finding enhances confidence that the concentrations of E. 
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coli measured on floors represents a spatially-typical exposure for children. 
It also highlights the utility of the use of a dry electrostatic cloth sampling 
method as reproducible. Previous research on beach sand contamination 
found that on a micro-spatial scale, fecal indicator bacteria can vary greatly 
over short distances.19 The strong correlations between the side-by-side 
measurements taken on the entrance floors suggest that the E. coli are more 
evenly distributed across households.  
 
The main limitation of this study was that E. coli is an indicator organism for 
fecal contamination and may have limited accuracy for determining the 
presence of pathogens.31 E. coli represents a large group of fecal bacteria 
from both human and animal sources and may come from relatively low-risk 
sources of fecal pollution.32 Many E. coli are commensal, while other more 
pathogenic species, such as enteroviruses, norovirus, Cryptosporidium spp. 
and Giardia spp., have different survival rates in the environment than E. 
coli.33, 34 Therefore, the presence virulent strains or other pathogenic 
microbes may or may not be accurately indicated by the detection of E. coli. 
The strengths of the study were that it used a novel sampling technique of 
the dry electrostatic cloth with high recovery efficiencies during the elution 
process. As the evidence base increases for the importance of the floors 
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pathway, this study highlights the need for rigorous methodological 
evaluation of household bacterial sampling strategies and methods in the 
context of environmental enteropathy. Another strength of the study was the 
analysis of within sample variability. This analysis showed the high 
correlations between samples taken side-by-side and therefore increased the 
confidence that the fecal contamination measured in this study is an accurate 
reflection of the levels of microbial pressure within the home. 
 
This study demonstrated that household floors are a potential pathway for 
transmission of fecal pathogens and demonstrated that households with 
unimproved sanitation facilities and shared facilities had higher loads of E. 
coli bacteria. The high loads of E. coli bacteria suggest that this route of 
exposure is especially important for children less than 12 months of age who 
spend most of their time on the floor and partake in hand-to-mouth activity. 
These results suggest that interventions, such as covering dirt floors with 
cement and excluding chickens from contact with surfaces in the home, hold 
promise to reduce chronic exposure to fecal pathogens that may be 
implicated in diseases such as environmental enteropathy. This study also 
highlights the importance of a multidisciplinary approach to the reduction of 
fecal contamination that extends current drinking water interventions to 
 
115 
interrupt the transmission of pathogens in the environment by other 
pathways.  
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Figure 1. Floor plan of typical household in the study communities 
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Figure 2. Concentrations of E.coli in Entrance and Kitchen by Floor 
Type (Mean log10-transformed colony forming units (CFU/900cm2), 
error bars represent 95% confidence intervals) 
	
*Error bars represent 95% confidence intervals 
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Figure 3. Pearson correlation coefficient of log-10 transformed E.coli 
colony forming units per 900 cm2 from entrance floor duplicate samples 
taken side by side 
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Figure 4. Log10 E.coli CFU per 900 cm2 by Sanitation and Floor Type 
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Table 1. Household characteristics by sanitation type (Pearson Chi-
squared tests and two-sample t-tests with equal variances performed) 
 
Unimproved 
Sanitation 
Facility (N=31) 
Improved 
Sanitation 
Facility (N=32) 
Sanitation facility is shared (n=58) 38.5% 21.9% 
Entrance floor type**: 
Dirt (n=36)
Wood (n=3)
Cement (n=24)
 
77.4% 
3.2% 
19.4% 
 
37.5% 
6.3% 
56.3% 
Kitchen floor type*: 
Dirt (n=46)
Wood (n=4)
Cement (n=13)
 
87.1% 
3.2% 
9.7% 
 
59.4% 
9.4% 
31.3% 
Drinking water source: 
Faucet in house (n=2)
Public tap (n=8)
Community hand pump (n=44)
Open well (without top) (n=1)
Surface water (n=2)
Other (n=6)
 
3.3% 
9.7% 
71.0% 
3.2% 
0.0% 
12.9% 
 
3.1% 
15.6% 
68.8% 
0.0% 
6.3% 
6.3% 
Time to fetch water in minutes (n=62) 8.6 (6.2, 11.1) 5.9 (4.0, 7.7) 
Household uses chlorine to treat water 
(n=63) 
25.8% 25.0% 
Presence of chickens in HH** (n=63) 45.2% 12.5% 
Crowding (Number of people sleeping in 
HH/ Number of rooms) (n=62) 
1.9 (1.5, 2.4) 1.7 (1.2, 2.2) 
Hygiene Score: 
Good (n=41)
Average (n=11)
Poor (n=11)
 
64.5% 
12.9% 
22.6% 
 
65.6% 
21.9% 
12.5% 
Monthly income per capita (in USD) 
(n=61) 
26.1 (19.8, 32.3) 27.7 (20.2, 35.3) 
Maternal Education (years) (n=62) 6.6 (5.5, 7.6) 8.1 (7.0, 9.2) 
Electricity connection (n=62) 77.4% 93.5% 
Wall type: 
Wood (n=48)
Concrete (n=14)
Other (n=1)
 
83.9% 
12.9% 
3.2% 
 
68.8% 
31.3% 
0.0% 
Roof type: 
Tin (n=60)
Palm (n=2)
Other (n=1)
 
93.6% 
3.3% 
3.3% 
 
96.9% 
3.1% 
0.0% 
Tenancy in household: 
Less than a year (n=13)
 
32.3% 
 
9.4% 
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Between one and five years (n=19)
Between five and ten years (n=14)
Between ten and twenty years (n=9)
More than twenty years (n=8)
22.6% 
25.8% 
12.9% 
6.5% 
37.5% 
18.8% 
15.6% 
18.8% 
* Significant difference at the p<0.05 level, Pearson Chi-squared 
** Significant difference at the p<0.01 level, Pearson Chi-squared 
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Table 2. Relation of household characteristics with log10-transformed 
E.coli colony forming units (CFU) per 900 cm2 in entrance and kitchen 
areas. 
 
Entrance 
Log10 E. coli 
CFU/900cm2  
Beta1 (95% CI) 
Kitchen 
Log10 E. coli 
CFU/900cm2 
Beta (95% CI) 
Sanitation Type: 
Unimproved (n=31)
Improved (n=32)
 
REF 
-0.63 (-1.12, -0.15)** 
 
REF 
-0.80 (-1.27, -0.33)† 
Shared Sanitation Facility: 
Shared (n=17)
Unshared (n=41)
 
REF 
-0.53 (-1.09, 0.03) 
 
REF 
-0.70 (-1.27, -0.13)* 
Floor Type (Entrance, Kitchen): 
Dirt (n=36, n=46)
Wood (n=3, n=4)
Cement (n=24, n=13)
 
REF 
-0.31 (-1.42, 0.81) 
-0.89 (-1.38, -0.40)† 
 
REF 
-1.38 (-2.27, -0.51)** 
-1.31 (-1.83, -0.79)†† 
Drinking water source: 
Community hand pump (n=44)
Faucet in house (n=2)
Public tap (n=3)
Open well (without top) (n=1)
Surface water (n=2)
Other (n=6)
 
REF 
-0.04 (-1.54, 1.46) 
0.33 (-0.47, 1.13) 
-0.43 (-2.53, 1.67) 
0.38 (-1.12, 1.89) 
0.22 (-0.68, 1.13) 
 
REF 
1.10 (-0.36, 2.56) 
0.003 (-0.77, 0.78) 
-1.05 (-3.09, 1.00) 
-0.46 (-1.92, 1.00) 
0.48 (-0.40, 1.36) 
Time to fetch water in minutes (n=62) 0.06 (0.02, 0.10)** 0.05 (0.01, 0.09)* 
Household uses chlorine to treat 
water: 
No (n=47)
Yes (n=16)
 
REF 
0.08 (-0.51, 0.66) 
 
REF 
-0.004 (-0.59, 0.59) 
Presence of chickens in HH: 
Yes (n=18)
No (n=45)
 
REF 
-0.38 (-0.93, 0.18) 
 
REF 
-0.53 (-1.08, 0.02) 
Crowding (Number of people 
sleeping in HH/ Number of rooms) 
(n=62) 
 
0.22 (0.02, 0.42)* 
 
0.16 (-0.04, 0.36) 
Hygiene Score: 
Good (n=41) 
Average (n=11)
Poor (n=11)
 
REF 
0.26 (-0.43,0.95) 
0.18 (-0.51, 0.87) 
 
REF 
0.10 (-0.59, 0.79) 
0.39 (-0.30, 1.08) 
Monthly income per capita (in USD) 
(n=61) 
0.002 (-0.01, 0.02) -0.0004 (-0.01, 0.01) 
Maternal Education (years) (n=62) -0.09 (-0.17, -0.01)* -0.04 (-0.13, 0.04) 
Electricity connection: 
Yes (n=53)
No (n=9)
 
REF 
0.78 (0.07, 1.49)* 
 
REF 
0.67 (-0.05, 1.39) 
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Wall type: 
Wood (n=48)
Concrete (n=14)
 
REF 
-0.88 (-1.45, -0.31)** 
 
REF 
-1.05 (-1.61, -0.52)†† 
Roof type: 
Tin (n=60)
Palm  (n=2)
 
REF 
1.16 (-0.26, 2.58) 
 
REF 
0.41 (-1.04, 1.85) 
Tenancy in household: 
Less than a year  (n=13)
Between one and five years (n=19)
Between five and ten years (n=14)
Between ten and twenty years (n=9)
More than twenty years (n=8)
 
REF 
-0.72 (-1.44, -0.01)* 
-0.78 (-1.54, -0.02)* 
-0.49 (-1.35, 0.37) 
-0.86 (-1.74, 0.03) 
 
REF 
-0.40 (-1.13, 0.32) 
-0.76 (-1.53, 0.02) 
-0.33 (-1.21, 0.54) 
-0.61 (-1.52, 0.30) 
* Significance at the p<0.05 level 
** Significance at the p<0.01 level 
†Significant difference at the p<0.001 level 
††Significant difference at the p<0.0001 level 
 
1 The beta coefficient represents the log10-unit change in E. coli CFU/900 cm2 between the exposed and 
unexposed (REF) categories. For the continuous independent variables the beta coefficient represents the 
log10-unit change in E. coli per increase in a unit change of the variable. 
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Table 3. Relation between floor type and Log10 E.coli CFU per 900 cm2 
by sanitation type  
 
 
Improved Sanitation Type2 
(n=64) 
Unimproved Sanitation Type3 
(n=62) 
Floor Type1:  
Unimproved  
Improved 
 
REF (n=31) 
-1.17 (-1.68, -0.66)†† (n=32) 
 
REF (n=51) 
-0.60 (-1.03, -0.17)** (n=11) 
1 Improved floor type is classified as either cement or wood and unimproved as dirt. 
2 Among homes with improved sanitation, Beta 0 for dirt floors = 3.90 log10-transformed CFU versus 2.74 
log10-transformed CFU for cement or wood floors 
3 Among homes with unimproved sanitation, Beta 0 for dirt floors = 4.12 log10-transformed CFU versus 
3.52 log10-transformed CFU for cement or wood floors 
 
** Significance at the p<0.01 level 
††Significant difference at the p<0.0001 level 
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Table 4. Adjusted regression model of household characteristics with log10-transformed E.coli colony 
forming units (CFU) per 900 cm2 in entrance and kitchen areas (models adjust for time to fetch water, 
presence of chickens in the household, crowding, maternal education and wall type). 
 
Entrance 
Log10 E. coli CFU 
Kitchen 
Log10 E. coli CFU 
N 56 56 
R-Squared (Adjusted R-squared) 0.392 (0.241) 0.651 (0.564) 
 β (SE) 95% CI p-value β (SE) 95% CI p-value 
Primary independent variables:       
Sanitation Type with Floor Type: 
Unimproved with Dirt
Unimproved with Wood
Unimproved with Cement
Improved with Dirt
Improved with Wood
Improved with Cement
 
REF 
-1.13 (0.92) 
-0.51 (0.57) 
0.45 (0.36) 
0.25 (0.69) 
-0.43 (0.32) 
 
REF 
(-2.99, 0.74) 
(-1.66, 0.64) 
(-0.28, 1.18) 
(-1.14, 1.64) 
(-1.08, 0.21) 
 
REF 
0.230 
0.372 
0.271 
0.721 
0.183 
 
REF 
-2.36 (0.75) 
0.40 (0.52) 
0.32 (0.26) 
-0.74 (0.47) 
-1.18 (0.29) 
 
REF 
(-3.86, -0.86) 
(-0.65, 1.45) 
(-0.20, 0.83) 
(-1.68, 0.20) 
(-1.77, -0.60) 
 
REF 
0.003 
0.444 
0.222 
0.119 
<0.001
Shared Sanitation Facility: 
Shared
Unshared
 
REF 
-0.40 (0.31) 
 
REF 
(-1.02, 0.22) 
 
REF 
0.203 
 
REF 
-0.65 (0.25) 
 
REF 
(-1.15, -0.16) 
 
REF 
0.011 
Adjustment covariates:       
Time to fetch water in minutes 0.05 (0.02) (.003, 0.09) 0.038 0.03 (0.02) (-0.002, 0.07) 0.063 
Presence of chickens in HH:
Yes
No
 
REF 
-0.63 (0.24) 
 
REF 
(-1.12, -0.15) 
 
REF 
0.185 
 
REF 
-0.63 (0.24) 
 
-- 
(-1.12, -0.15) 
 
-- 
0.012 
Crowding -0.06 (0.13) (-0.32, 0.19) 0.622 -0.17 (0.10) (-0.37, 0.02) 0.084 
Maternal education (years) -0.10 (0.05) (-0.19, 0.00) 0.048 -0.08 (0.04) (-0.15,-0.004) 0.040
Wall type:  
Wood
Concrete
 
REF 
-0.11 (0.35) 
 
REF 
(-0.81, 0.60) 
 
REF 
0.766 
 
REF 
-0.33 (0.25) 
 
REF 
(-0.84, 0.18) 
 
REF 
0.198 
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This review discusses the utility of pathogen-specific antibody biomarkers 
for improving estimates of the population burden of waterborne infections, 
assessing the fraction of infections that can be prevented by specific water 
treatments, and understanding transmission routes and the natural history 
and ecology of disease in different populations (including asymptomatic 
infection rates). The application of pathogen-specific antibody response data 
to estimate incidence and prevalence of acute infections and their utility in 
assessing the contributions of waterborne transmission pathways are 
discussed. Advantages and technical challenges associated with the use of 
serum versus minimally-invasive salivary antibody biomarkers in cross-
sectional and prospective surveys are discussed. We also highlight 
challenges and outline future directions for research and development of 
antibody-based and other immunological biomarkers of waterborne 
infections. 
 
Introduction 
Waterborne infections cause an estimated two million deaths and four billion 
episodes of diarrheal illness per year worldwide 1. Waterborne diseases will 
continue to be of broad public health importance as peri-urban populations 
rapidly expand at a pace that exceeds developing countries’ abilities to 
 
132 
invest in infrastructure 2. While most of these illnesses occur in developing 
countries, industrialized countries also bear a substantial burden of 
waterborne diseases 3. For high-income countries, if investments in water 
supply and sewer systems do not enable proper maintenance and timely 
replacement of aging infrastructure, the risk of waterborne infections is 
likely to increase 4.  
 
Waterborne disease outbreaks are defined as two or more persons 
experiencing a similar illness after exposure to water where epidemiologic 
evidence implicates water as the probable source of the outbreak 5. 
Waterborne pathogens that result in human infections include bacteria (e.g., 
Campylobacter spp., Shigella spp.), viruses (e.g., norovirus, rotavirus) and 
protozoa (e.g., Cryptosporidium spp., Giardia spp.) and these pathogens 
may be conveyed to humans via drinking and/or recreational water 
transmission routes 6. The health outcome most commonly associated with 
exposure to waterborne pathogens is acute gastrointestinal illness (AGI). 
AGI is defined in various ways and definitions used in epidemiological 
research range widely 7, 8. One commonly used definition is: diarrhea (3 or 
more loose stools in a 24-hour period), vomiting, nausea, stomach ache, 
fever, and/or interference with regular activities (missed time from work or 
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school or missed regular activities as a result of illness) 8-10. Other illnesses 
caused by waterborne pathogens include viral hepatitis (hepatitis A and E 
viruses 11), skin and soft tissue infections and sepsis (Vibrio spp, 
Staphylococcus aureus12), primary amoebic meningoencephalitis (Naegleria 
fowleri 13) and pneumonia (Legionella pneumophila14).  
 
In this review we summarize the latest evidence on use of pathogen-specific 
antibodies as biomarkers (defined as “any substance, structure, or process 
that can be measured in the body or its products and can influence or predict 
the incidence of outcome or disease” 15) of infection for the waterborne 
pathogens that cause the greatest population burden of AGI in the United 
States (norovirus, Shiga toxin-producing E. coli, and Cryptosporidium 
spp.)16 and in developing countries globally (rotavirus, Cryptosporidium 
spp., Shigella, Giardia spp., Vibrio cholerae, and Campylobacter spp.)17, 18. 
We also include hepatitis A and E viruses because these pathogens are the 
most common causes of feces-transmitted acute viral hepatitis worldwide 
(Table 1)19, 20. Such pathogen-specific antibody biomarkers represent 
promising tools to identify causative agents in population-based studies of 
AGI, including waterborne disease outbreak investigations, surveillance 
studies, and observational and randomized intervention studies to test 
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hypotheses related to transmission routes, water treatments, and disease 
ecology. Because not all individuals who become infected with waterborne 
pathogens will experience symptoms of AGI – i.e., a waterborne infection 
may be asymptomatic (without clinical disease) or symptomatic (clinical 
disease observable) 21 – immunological biomarkers of host response can be 
used to identify a causative pathogenic agent and estimate symptomatic 
and/or asymptomatic waterborne disease burden. Knowledge of the 
waterborne pathogens responsible for asymptomatic infections can improve 
estimates of waterborne infections in source populations and advance 
understanding of upstream risk factors and transmission routes. Not knowing 
these can hinder the development of effective prevention strategies to reduce 
waterborne outbreaks and/or contamination events (e.g., via infrastructure 
improvements prior to onset of symptoms).  
 
We review the challenges in measuring population burdens of infection that 
can be attributed to waterborne versus other transmission routes 
(contaminated food, hygiene, sanitation, person-to-person and animal-to-
person contact). Antibodies as biomarkers of waterborne infections are then 
discussed to highlight their current and future utility in population-based 
settings. Antibody responses to specific pathogens are described as they 
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relate to measuring immunoconversions (defined as a change from antibody 
negative to antibody positive in serial samples or a four-fold increase in 
antibody titer in serial samples), rates, and time-intervals of infection. The 
use of antibody biomarkers in serum are presented, followed by the 
discussion of novel salivary antibody biomarkers and their potential to 
improve upon estimates of waterborne infections. The utility of antibody 
biomarkers for detection of acute and chronic infections in population-based 
settings is discussed, including how estimates of the incidence of acute 
short-term infections can be obtained within the context of both cross-
sectional and prospective study designs. Finally, the technical challenges 
involved with using minimally-invasive saliva samples as a matrix for the 
detection of pathogen-specific antibodies are presented along with future 
directions for salivary immunoassay work. 
 
Challenges with epidemiologic estimates of waterborne AGI in 
population-based settings 
The outcome most commonly employed in epidemiologic studies of 
waterborne disease is self-reported AGI symptoms. Because most AGI 
symptoms are self-limited, only a small proportion of the individuals who 
experience AGI actually seek medical care and have a stool sample 
submitted for testing. Furthermore, clinical diagnostic laboratories are not 
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always able to identify a pathogenic agent responsible for AGI symptoms 22. 
Thus only a small proportion of AGI disease will be captured by studies of, 
or reporting systems involving, patient populations seeking a clinical 
diagnosis (Figure 1). AGI symptoms are also non-specific, with numerous 
pathogens and transmission routes that must be investigated in order to 
determine the etiologic agent. These features of AGI symptoms mean that 
epidemiologic studies that rely upon AGI as a primary outcome may not 
provide an accurate estimate of the population burden of disease. The ability 
to determine a host’s immunologic response to specific pathogens that are 
responsible for waterborne infections could improve the specificity and 
decrease the misclassification of AGI in epidemiologic studies. Biomarkers 
of pathogen-specific host immunologic response could improve studies of 
the effects of improved water treatment and/or source water protection as 
well as advance understanding of pathogen exposure (e.g., spatial and 
temporal distribution) and modifiable factors that are associated with 
progression from asymptomatic to symptomatic states of infection (e.g., 
natural history and ecology of disease) in populations. For example, 
objective biomarkers of asymptomatic waterborne infections have helped 
identify low water pressure at the faucet as an important risk factor for self-
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reported diarrhea in the control group of a case-control study of sporadic 
cryptosporidiosis 23. 
 
Most evidence of waterborne transmission in developed countries comes 
from outbreaks of infectious diseases. In the United States, the Centers for 
Disease Control and Prevention (CDC) as well as state and local authorities 
investigate outbreaks and attempt to identify the source. CDC publishes the 
biannual Morbidity and Mortality Weekly Report on outbreaks associated 
with drinking and recreational water sources. For example, in 2011-2012 for 
drinking water a total of 32 outbreaks were reported and associated with 431 
illnesses, 102 hospitalizations and 14 deaths 16. For recreational water in 
2011-2012, there were 90 outbreaks that resulted in at least 1,788 cases, 95 
hospitalizations, and one death 24.  
 
Knowledge of the pathogen-specific etiology of waterborne infections would 
help identify different risk factors and transmission routes, which can 
improve the evidence base for decision-making about management and 
prevention strategies. A classic example of this is the massive waterborne 
outbreak of cryptosporidiosis in Milwaukee in 1993 when the chlorine-based 
disinfectant used had little effect on C. parvum oocysts and the drinking 
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water treatment plants consequently had to investigate alternative 
disinfectants such as UV light 25. Another example is a study of the presence 
of enteric viruses in non-disinfected drinking water from municipal wells 
and their relation with community incidence of AGI 26. In this study the 
authors noted a positive association between norovirus genogroup I (GI) and 
AGI. But the associations between the presence of other enteric viruses – 
adenovirus and echovirus serotypes – and AGI were not statistically 
significant. This lack of association could be due to misclassification and/or 
the non-specificity of AGI as an outcome in epidemiologic studies (e.g., 
potential influence of measurement error due to participant self-reporting of 
AGI symptoms).  
 
Waterborne outbreaks usually occur from causative factors such as weather 
events, wastes from animals, agriculture, or humans and failures in water 
treatment 27. Drinking water associated outbreaks are often caused by 
contaminated source waters, inadequacies in treatment, or contamination 
occurring within the distribution system 28. Whereas, recreational water 
associated outbreaks have been attributed to swimming in waters impacted 
by inadequate chlorination or other disinfection (swimming pools), fecal 
contamination shed by swimmers (swimming pools and natural waters), 
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runoff from publicly-owned treatment works (POTW) wastewater effluents, 
sanitary and combined sewer overflows of untreated sewage, private on-site 
septic systems, agricultural production, and wildlife 29.  
 
Most cases of waterborne infections are sporadic or diffuse, low-level 
outbreaks. Ingestion of waterborne pathogens can also result in a completely 
asymptomatic infection depending on the interplay of pathogen-specific and 
host-specific factors, such as a pathogen’s virulence and a host’s immune 
response 30. They may be caused by deficiencies  in drinking water 
treatment, resulting in contamination with waterborne pathogens, and 
transmission to consumers 31. Waterborne pathogens that are resistant to 
chlorination (especially Cryptosporidium spp.)32 or physical removal 
(especially viruses) can pass through the water treatment barrier and 
contaminate tap water even when water quality indicators based on surrogate 
bacteria (total and/or fecal coliforms, E. coli) are within the regulatory limits 
33. Viruses, such as noroviruses, can filter through the soil, contaminate 
shallow ground water sources and present a health risk in drinking water 
systems that are ground water supplied and do not use chemical disinfection 
26. Individual sporadic cases of AGI usually cannot be linked to a specific 
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source in the framework of routine surveillance, contributing to the 
underestimation of waterborne infections in the population. 
 
Antibody biomarkers of waterborne infection 
Specific antibody responses can be used as biomarkers of infection in 
epidemiological studies to estimate the prevalence and incidence of 
infections and to assess the contribution of waterborne transmission. 
Different pathogens result in different temporal distributions of antibody 
response and infection. Both symptomatic and asymptomatic infections 
typically cause an antibody response in the host 31. A pre-existing antibody 
response can be a factor affecting host’s susceptibility to re-infection or the 
probability of developing symptoms if infection occurs 34. The presence of 
antibodies specific to the pathogen of interest in biological samples (e.g. 
serum, saliva, stool, breastmilk) is an indication of current or prior infection 
31. The different immunoglobulin isotypes (IgG, IgA, IgM) have different 
utility as estimates of population disease frequency and burden. Single time 
point measurements of pathogen-specific IgG have utility as an estimate of 
historical/prior exposure or prevalent infection whereas IgA and/or IgM 
have utility as an estimate of acute-phase or incident infection 35, 36. 
Immunoconversion is used to detect incident infections in prospective 
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survey settings. This change from an antibody-negative sample to an 
antibody-positive sample in a time series of two or more samples, also 
defined as a four-fold increase in antibody titer in a time series of two or 
more antibody-positive samples, is used to measure new, acute cases in a 
defined population over a defined time period 37-39. 
 
Serologic antibody response 
Serum is the most accurate and widely used matrix to monitor population 
immune responses to pathogens. Sera can be collected by sampling the 
population or residual blood banks can be used. However, there are 
significant drawbacks to both since blood collection requires trained 
individuals to visit participants 40 and may be cost prohibitive along with 
low response rates that have been shown in Europe due to the invasive 
nature of blood collection 41, 42. Its application in prospective studies and 
especially in studies involving children is problematic due to high attrition 
and low compliance 43. Relying on previously collected samples from sera 
banks overcomes these issues however they are usually anonymous with 
limited data available on the patient and importantly, their background as it 
pertains to water, sanitation, and hygiene-related behaviors and activities 44. 
However, a number of studies have successfully used sero-epidemiological 
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methods in the context of waterborne disease 45, 46. Frost et al. found that 
people who live in cities using surface-derived drinking waters had an 
increased risk of Cryptosporidium infection compared to those using 
drinking water from municipal groundwater sources 45. And in the context 
where sanitation conditions are poor and clean water supplies are limited, 
Priest et al. found IgG antibody responses during Cryptosporidium 
infections with C. parvum, C. felis, and C. meleagridis and with four 
different subtypes of C. hominis 46. 
 
Salivary antibody response 
The utility of novel salivary antibody biomarkers as a measure of host 
immune response to specific pathogens has the potential to improve upon 
estimates of waterborne infections that rely on invasive collection of serum. 
Saliva collection is minimally invasive and can be self-collected and 
returned by mail47, allowing for a larger sampling of the population than is 
possible with serum. Saliva is a mixture of secretions from salivary glands. 
Oral fluid contains saliva (enriched with secretory IgA), crevicular fluid 
(flows from between the gum margins and teeth), and is enriched with serum 
antibodies 48. Some oral fluid sampling techniques are specifically designed 
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to collect samples enriched with crevicular fluid for measurements of 
systemic antibody responses 49-51.   
 
Salivary assays have been used to identify various viral, bacterial and 
parasitic infections 52 (see Table 2). Measuring antibodies in saliva is 
appropriate for both children and adults, and is suitable for population-based 
surveillance settings 38. Salivary immunoassays have been developed for 
pathogens such as Helicobacter pylori, T. gondii, Cryptosporidium, and 
noroviruses 50. Griffin et al. (2011) applied the Luminex xMAP 
microsphere-based technology (Luminex Corp., Austin, TX) assay to 
measure antibodies to multiple pathogens within a single saliva sample 
volume 50. The Norwalk virus assay developed in Griffin et al. (2011) was 
subsequently validated using samples from a  human volunteer challenge 
study 51. A similar salivary immunoassay is being applied to measure the 
incidence of norovirus infections following recreational water exposures at 
beaches in Puerto Rico, Iowa, and Wisconsin where saliva has been 
collected as part of the Environmental Protection Agency’s National 
Epidemiologic and Environmental Assessment of Recreational Water 
Study53. 
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An important challenge in using saliva to measure immunologic responses is 
the greater inter- and intra-individual variability in saliva composition and 
immunoglobulin levels. While saliva contains a high level of secretory IgA 
(SIgA) antibodies, there can be significant diurnal, age, and oral health-
related variability54, making these factors important to consider in 
community-based field studies. The salivary concentrations of IgG and IgM 
isotypes are lower than in serum. Thus, a salivary antibody assay targeting 
IgG has to be sensitive enough to quantify low intensity antibody responses. 
Typically it is necessary to assay saliva at relatively low dilutions, where 
matrix effects (e.g. inhibition, high background signal) can be pronounced in 
some pathogen-specific antibody assays 55. For each pathogen-specific 
antibody target it is critical to optimize the conditions that may influence 
assay performance and sensitivity and specificity 51. 
 
There is scant evidence on the temporal patterns of salivary antibody 
responses to infection with a specific pathogen (peak levels and rates of 
decline for different antibody isotypes). Our current understanding of 
generalized trajectories (Figure 2) comes from prospective studies using 
serum or saliva from individuals with confirmed infections, such as 
volunteer challenge studies for norovirus38, 56, 57, Cryptosporidium58, Giardia 
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lamblia59, 60, and Shigella61. The pattern of antibody isotypes may be used in 
diagnostic and research settings to provide information on the infection state 
(acute versus convalescent) and to assess the timing of infection 31.  
Typically, the IgA and/or IgM response to a waterborne pathogen ramps up 
before the IgG response 34, 56, 57. The generalized trajectories of different 
antibody isotype levels during a transient acute infection from a waterborne 
pathogen are depicted in Figure 2. After the convalescent stage, IgG 
pathogen-specific antibodies may remain detectable for weeks to years, 
depending on the causative agent, and may remain elevated above pre-
infection levels 34, 62. There can be vast differences in these temporal patterns 
of antibody responses depending on the pathogen causing the infection. 
Thus, an area of future work is to develop population-based antibody 
infection curves for specific waterborne pathogens. 
 
Platforms and assay types 
Various immunoassay platforms have different costs, quantitation levels, 
dynamic ranges and multiplexing potentials 63. The most basic of these 
platforms is the indirect enzyme immunoassay, however the low through-put 
and high sample volume requirements make it less desirable for population 
based analyses where multiple pathogens are being analyzed and sample 
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volume is limited. Multiplex immunoassays, such as those based on the 
Luminex (Luminex Corp., Austin, TX) microbead suspension fluorescence 
immunoassay platform, require a low sample volume to analyze multiple 
pathogen-specific antibody analytes simultaneously. They are also less labor 
intensive because more data are generated per test/analyte, and thus are more 
cost-effective 50, 51, 64-67. Another immunoassay platform that is used and 
allows multiplexing is the Meso Scale Discovery (MSD; Rockville, MD) 
electrochemiluminescence (ECL) platform. Platforms that facilitate 
multiplexing can be used to expand the range of available options for testing 
the signal of pathogen-specific antibody responses as well as background 
signals. The adjustment of the pathogen-specific antibody signal for 
background signals, such as those produced by total IgA or total IgG or by 
antigen tags such as glutathione-S-transferase (used during antigen 
purification), can improve the performance of antibody assays 50, 51. 
Multiplexing of these target signals can also reduce excess use of 
biospeciment sample volume because all signals can be measured in the one 
sample volume in a single reaction well. Thus multiplexing testing platforms 
can facilitate a broader application of antibody testing in community-based 
epidemiologic investigations of diverse waterborne pathogens. 
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Applications of pathogen-specific antibody biomarkers in population-
based studies of waterborne infections 
To improve current epidemiologic estimates of AGI from waterborne 
pathogens in population-based settings, pathogen-specific antibody 
biomarkers can be used. For chronic infections, antibody responses can be 
positive or negative, and can be validated against diagnostic tests. The 
proportion of IgG positive results in serum or saliva can serve as a direct 
measure of infection prevalence in the population 68, 69. In contrast, for acute 
short-term infections, such as noroviruses and Cryptosporidium, the 
presence of pathogen-specific antibodies in serum or saliva may indicate an 
ongoing infection or more commonly a past infection with or without 
symptoms. Thus, the concept of “positive” antibody response to an acute 
short-term infection or seroprevalence of positive responses, often reflect the 
proportion of results above an arbitrary threshold, such as a detection limit 
of the method or by standardizing response intensities to the response of a 
reference sample of positive control sera 70-73 or saliva.  
 
One approach to estimating incidence of acute infections using antibody data 
is to use immunoconversion in prospective study settings as a marker of new 
infections. The sensitivity and specificity of an immunoconversion test is 
related to its ability to detect infections that occurred during the interval 
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between two sampling dates. In prospective studies, biological sampling 
(serum or saliva) can be combined with symptoms diaries to produce 
information on the association of certain infections with specific types of 
symptoms and/or the association of exposures with infections or 
interventions (designed to reduce exposure) with a lack of symptoms 74. 
 
Prior studies have used pathogen-specific antibody markers and 
demonstrated their ability to identify waterborne infections that were more 
widespread than previously appreciated. In the massive Cryptosporidium 
outbreak in Milwaukee in April 1993, a retrospective analysis was 
conducted with banked serum specimens from children that had routine lead 
level surveillance in blood from March to May of that year and showed a 
seroprevalence increase from 15-17% to 82-87% for levels of IgG antibody 
against the immunodominant Triton-17 and 27-kDa C. parvum antigens 75. 
This demonstrated that the outbreak had affected a greater proportion of the 
population with infection when accounting for both symptomatic and 
asymptomatic infections than the previous estimate of 26% that only 
surveyed the population using the cryptosporidiosis case definition (watery 
diarrhea) 76. Teunis et al. applied these approaches in the European Union to 
estimate seroconversion rates for Campylobacter infections and found that 
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they were several orders of magnitude higher than the notification rates, 
reflecting both detection deficits in the surveillance and the reality that these 
enteric infections often remain asymptomatic77. Frost et al. used serum 
antibodies to Cryptosporidium from a population in Hungary to determine 
that those using groundwater had significantly lower serological responses 
than those using conventionally filtered and disinfected surface water and 
found that riverbank filtration may be an effective alternative treatment to 
reduce Cryptosporidium exposures and infections for individuals using 
surface water sources 78. Tollestrup et al. focused on non-outbreak settings 
where a low probability of outbreak detection should be expected and found 
a significant association for residents in the River Valley of New Mexico 
using onsite wastewater systems combined with private wells to have a 
strong response to the 27-kDa Cryptosporidium antigen 73. And lastly, in the 
first postal population-based survey that used saliva, Morris-Cunnington et 
al. used approximately 5,500 self-collected oral fluid samples along with a 
questionnaire of demographic and social information to successfully 
demonstrate that antibody prevalence data along with risk factor data can be 
used assess the population-based immunity to common viral infections in 
England and Wales 47. 
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Such application of immunological biomarkers in epidemiologic studies also 
can improve knowledge of the temporal patterns of antibody responses, 
which can be used to extrapolate incidence estimates based on cross-
sectional data on pathogen-specific antibody responses in the population 77, 
79, 80. Others have expanded this approach using parametric statistical models 
65, 81-83 to determine incidence of infection based on pathogen-specific 
antibody results from a single cross-sectional sampling time. The person-to-
person variability in antibody responses to a specific pathogen and limited 
data on temporal patterns of antibody responses in various populations 
affects the precision of such estimates. A pattern of antibody responses may 
also be affected by the number of prior infections and the time interval from 
the previous infection. This may further limit the applicability of the 
available antibody pattern data to populations with comparable 
epidemiological characteristics or to research questions focused on intra-
individual variability in antibody responses over time.   
 
In low-income communities where there is less developed drinking water 
and wastewater infrastructure and individuals may experience repeated 
exposures to multiple waterborne pathogens, the application of 
immunological biomarkers can be used as a monitoring and evaluation tool 
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for infrastructure and point-of-use interventions. The multiplex 
immunoassay methodology targeting salivary IgG and IgA responses to 
potentially waterborne pathogens50 can be applied as a minimally invasive 
and objective exposure and outcome screening tool to assess the efficacy of 
interventions designed to reduce pathogen exposure and/or AGI illness 
within a specified population. Such multiplex pathogen antibody screening 
tools could improve the objectivity of water, sanitation, hygiene, and health 
programs and interventions. Integration of these biomarkers into monitoring 
activities for the Sustainable Development Goals recently adopted at the 
2015 UN Summit (https://sustainabledevelopment.un.org/topics), could 
improve the evidence base for Goal 6 which is to “by 2030, achieve access 
to adequate and equitable sanitation and hygiene for all and end open 
defecation” (Target 6.2)5.  
 
Challenges and perspectives for future work 
Pathogen-specific antibody assays represent a promising tool for 
understanding the relative contribution of waterborne versus other pathways 
to infectious disease burden in population-based settings. However, assays 
based on invasive serum specimens may fail to capture a majority of cases in 
                                                 
5 https://sustainabledevelopment.un.org/topics/waterandsanitation 
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population-based field studies. Because they can be self-administered and 
returned by mail, salivary antibody assays may increase participation in 
surveys of potentially waterborne infections in populations that are difficult 
to reach, including children, pregnant women, and individuals living in 
remote, resource-limited settings. Saliva collection can also be self-
administered and returned by mail to reach a larger proportion of the general 
population. This may facilitate a more fine-scale, spatio-temporal study of 
the ecology and natural history of waterborne disease, including elucidation 
of optimal points of intervention to prevent waterborne pathogen 
transmission.  
 
While such minimally invasive pathogen-specific salivary antibody 
biomarkers are promising, challenges remain in their broad application to 
diverse pathogen exposures and infections. Not all pathogens elicit a robust 
systemic or salivary antibody response. Additionally, a majority of 
waterborne infections may be asymptomatic and not result in adverse health 
effects. Therefore, the incidence of infections estimated from cross-sectional 
antibody data may not be representative of disease burden but only reflect 
recent or historical exposure to a pathogen 84. Nevertheless, cross-sectional 
antibody response data can provide an improved estimate of human 
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exposure to certain pathogens and can be used as an epidemiological tool to 
estimate the contribution of waterborne versus other pathways to the total 
infection pressure. However, the underlying infection and immune response 
to the pathogen must be considered in the interpretation of cross-sectional 
seroprevalence estimates and depends on whether the infection results in 
lifetime immunity following one exposure or the infection is acute and 
immunity wanes following exposure. 
 
The detection of cytokines in serum and saliva also presents an opportunity 
to measure the onset of waterborne infections. However, cytokines are not 
capable of identifying a specific causative agent, rather they are more 
generic biomarkers of infection. The hallmark for a viral infection begins 
with a wave of cytokine production 85 and their presence can be employed as 
a marker of infection (Table 2). Cytokine levels in serum of individuals 
infected with norovirus that were shown to be significantly increased 
included IFN-gamma, IL-6, IL-8, IL-12p70, MCP-1 and TNF-alpha two 
days following exposure 86. Evidence has shown that the elevation of 
cytokines in a newborn’s salivary gland epithelium promotes secretory 
immunity 87. Proinflammatory cytokines can upregulate the polymeric Ig 
receptor (pIgR), including IL-17, which is particularly abundant at mucosal 
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sites 88. The extracellular part of pIgR is essential for resistance against 
proteolytic degradation of the secretory component of secretory IgA found 
in saliva and gut mucosa 89. A challenge in using cytokines in saliva is to 
determine if there is a serum-saliva association, for which there is currently 
limited evidence 90. Although elevated levels of IL-6, which has a major role 
in the regulation of inflammatory bowel diseases, was found to be elevated 
in both the saliva and serum of patients when compared to reference persons 
91. There could also be specific hyper-inflammatory physiological states 
(systemic infection/sepsis, burns, etc.) when more of the variance in salivary 
levels of cytokines could be due to systemic circulating cytokine levels 90. 
An area for future study is identifying if a specific waterborne pathogen 
generates a unique or predictive cytokine profile that is observable in both 
saliva and serum.  
 
Conclusion 
The ability to estimate waterborne infections via measurements of host 
immunological response at the population-level is improving as 
technological and analytical advancements are made. Diagnostic 
advancements are enabling a paradigm shift in how waterborne infections 
can be measured, not just in clinical settings or outbreak settings but also 
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more widely as tools for population-based screening of incidence and 
prevalence. The measurement of salivary antibody responses to specific 
pathogens as biomarkers of waterborne infection hold great potential to 
expand surveillance to reach larger numbers of people in diverse population-
based settings. Future work lies in the development of sensitive and specific 
multiplexed serum and salivary immunoassays to measure exposures to, and 
infections with, specific waterborne pathogens. 
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Figure 1. The Iceberg Concept of Waterborne Infection Surveillance 
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Figure 2. Trajectories of antibody titers during infection from a 
waterborne pathogen  
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Table 1. Data sources that provide estimates of the most common 
waterborne pathogens attributable to the burden of waterborne 
infections. 
 
Region Date source 
Top waterborne pathogens 
identified 
United States 
CDC Morbidity Mortality Weekly 
Report (MMWR) Surveillance for 
Waterborne Disease Outbreaks 
Associated with Drinking Water, 
2011-2012 16  
 
CDC MMWR for Outbreaks of Illness 
Associated with Recreational Water, 
2011–2012 24 
Norovirus, and Shiga 
toxin-producing E. coli 
 
 
 
 
Cryptosporidium spp. 
Developing 
countries 
The Global Enteric Multicenter Study 
(GEMS) 17 
 
 
 
 
The Etiology, Risk Factors, and 
Interactions of Enteric Infections and 
Malnutrition and the Consequences for 
Child Health and Development Project 
(MAL-ED) 18 
 
Ishii et al (2015)19 and Hoofnagle et al 
(2012) 20 
Rotavirus, 
Cryptosporidium spp., 
Shigella, Giardia spp.,6 
Vibrio cholerae,7 
Campylobacter spp2 
 
Giardia spp.8  
 
 
 
 
 
Hepatitis A and E virus9 
 
 
 
 
 
 
                                                 
6 In univariate analyses Giardia was identified significantly more frequently in controls than in patients 
with moderate-to-severe diarrhoea aged 12–59 months in ten of the 14 age-site strata {Kotloff, 2013 #193}. 
7 Important in selected sites in GEMS study17. 
8 Giardia spp. was in the top five pathogens for highest prevalence in diarrheal and non-diarrheal stools for 
both 0-11 month and 12-24 month age groups18. 
9 Hepatitis A and E viruses are the most common causes of feces-transmitted acute viral hepatitis 
worldwide. 
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Table 2. Immunologic biomarkers for waterborne pathogens with highest attributable global acute 
gastrointestinal disease burden 
 
PATHOGEN 
OF INTEREST 
SPECIMEN IMMUNOLOGIC BIOMARKER RESPONSE REFERENCE 
Cryptosporidium 
spp. 
Serum 
 
 
 
 
Saliva 
IgG antibody  
 
 
 
 
IgG and IgA antibody  
Priest, J. W., et al. (2001) 92; 58; Crump, J. A., 
et al. (2007) 93; Sarkar, R., et al. (2012) 94; 
Becker, D. J., et al. (2015) 95; Checkley, W., et 
al. (2015) 96 
 
Cozon, G., et al. (1994) 97; Moss, D. M., et al. 
(2004) 67; Egorov, A. I., et al. (2010) 98; 
Griffin, S. M., et al. (2011) 50; 
Campylobacter  Serum 
 
 
 
Stool 
 
 
 
Saliva 
IgG, IgM and IgA antibodies 
 
 
 
Cytokines (IL-1β, IL-6, IL-8, TNF-α, and IFN-
), IgA antibodies 
 
 
IgG and IgA antibodies (responses to acid-
glycine extracts of C. jejuni strain 81116 and 
an aflagellate mutant, and a whole-cell R2 
sonicate) 
Ang, C. W., et al. (2011); 84; Teunis, P. F., et 
al. (2012) 79; Rokosz-Chudziak, N. and W. 
Rastawicki (2014) 99. 
 
Tribble, D. R., et al. (2010) 100; Islam, D., et al. 
(2014) 101; 
 
 
Cawthraw, S. A., et al. (2002) 102 
Giardia 
intestinalis 
Serum 
 
 
 
Saliva 
IgG and IgA antibodies 
 
 
 
sIgA, IgA and IgG antibody (responses against 
G. duodenalis) 
Crump, J. A., et al. (2007) 93; Jiménez, J. C., et 
al. (2009) 103; Priest, J. W., et al. (2010) 64; 
Moss, D. M., et al. (2014) 66 
 
Rodriguez, O. L., et al. (2004) 104; El-Gebaly, 
N. S., et al. (2012) 105 
Hepatitis A 
virus 
Serum 
 
 
Saliva 
IgM and IgG antibodies 
 
 
IgM and IgG antibodies 
Vitral, C. L., et al. (2014) 11; Hundekar, S., et 
al. (2015) 106 
 
Laufer, D. S., et al. (1995) 107; Ochnio, J. J., et 
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al. (1997)108; Morris-Cunnington, M. C., et al. 
(2004) 47; Tourinho, R. S., et al. (2015) 109 
Hepatitis E virus Serum 
 
 
 
 
IgG and IgM antibody, cytokines (IL-5, IL-6, 
IL-8, IL-10, IL-2, IFN-γ, TNF-α, TGF-β1, IL-
1β) 
 
Adjei, A. A., et al. (2009) 110; Pas, S. D., et al. 
(2013) 111; Wu, W. C., et al. (2014) 36; Kumar, 
A., et al. (2014) 112; Gu, G., et al. (2015) 113; 
Cong, W., et al. (2015) 35; Heaney, C. D., et al. 
(2015) 114, 115 
Norovirus Serum 
 
 
 
 
Stool 
 
 
Saliva 
IgG and IgA antibodies, cytokines (IL-1, IL-2, 
IL-4, IL-5, IL-6, IL-8, IL-10, and IL-12, IFN-γ, 
TNF-α) 
 
 
IgA antibody 
 
 
IgA and IgG antibodies  
Erdman, D. D., et al. (1989) 62; Monroe, S. S., 
et al. (1993) 37; Moe, C. L., et al. (2004) 38; 
Lindesmith, L., et al. (2005) 56; Crump, J. A., et 
al. (2007) 93; Newman, K. L., et al. (2015) 86 
 
Iritani, N., et al. (2007) 116; Ramani, S., et al. 
(2015) 117 
 
Moe, C. L., et al. (2004) 38; Lindesmith, L., et 
al. (2003) 57; Lindesmith, L., et al. (2005) 56; 
Griffin, S. M., et al. (2011) 50; Griffin, S. M., et 
al. (2015)51 
Rotavirus Serum 
 
 
 
 
Stool 
 
 
Saliva 
IgM, IgA and IgG antibodies, cytokines (IFN-
γ, TNF-α, IL-8, and IL-10) 
 
 
 
IgM, IgA and IgG antibodies 
 
 
IgM, IgA and IgG antibodies 
Grimwood, K., et al. (1988) 118; Azim, T., et al. 
(2003) 119; Xu, J., et al. (2005) 120; Premkumar, 
P., et al. (2014) 121; Sindhu, K. N., et al. (2014) 
122; Moon, S. S., et al. (2015) 123 
 
Stals, F., et al. (1984) 124; Grimwood, K., et al. 
(1988) 118; Azim, T., et al. (2003) 119 
 
Stals, F., et al. (1984) 124; Grimwood, K., et al. 
(1988) 118; 125; Friedman, M. G., et al. (1996) 
126;  
Shiga toxin-
producing 
Escherichia coli 
Serum 
 
 
 
Saliva 
IgG antibodies against  51 O serogroup strains, 
B subunit of Stx2 and Stx1 
 
 
IgM and IgA antibodies 
Ludwig, K., et al. (2001) 127; Kulkarni, H., et 
al. (2002) 128; Fernández-Brando, R. J., et al. 
(2011) 129; Guirro, M., et al. (2014) 130 
 
Ludwig, K., et al. (2002) 131; Chart, H., et al. 
(2003) 132 
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Shigella Serum 
 
 
 
 
 
 
Stool 
 
Saliva 
IgA, IgM and IgG subtypes to S. sonnei O-
antigen, IgA and IgG antibodies to S. flexneri 
2a lipopolysaccharide, total IgA antibody-
secreting cells (ASC) and anti-LPS IgA ASC, 
cytokines (IFN-γ, TNF-α, TNF-β, IL-4, IL-6, 
TGF-β) 
 
Cytokines (TNF-α, IL-6) 
 
IgA antibody 
Van De Verg, L. L., et al. (1996) 133; Raqib, R., 
et al. (1997) 134; Rasolofo-Razanamparany, V., 
et al. (2001) 135; Levine, M. M., et al. (2007) 
136; Muhsen, K., et al. (2014)137; Thompson, C. 
N., et al. (2014) 138 
 
 
Azim, T., et al. (1995) 139 
 
Schultsz, C., et al. (1992) 140; 
Vibrio cholerae Serum 
 
 
 
Stool 
 
Saliva 
IgA and IgG antibodies, IgG, IgM, and IgA 
ASC 
 
 
IgA antibody 
 
IgA antibody 
Chowdhury, F., et al. (2008) 141; Johnson, R. 
A., et al. (2012) 142; Fujii, Y., et al. (2014) 143; 
Khan, A. I., et al. (2015) 144 
 
Qadri, F., et al. (2003) 145 
 
Jertborn, M., et al. (1986) 146 
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Abstract 
We assessed the relationship between fecal contamination of the household 
environment and secretory immunoglobulin-A (SIgA) in the saliva of 
children between three and four years old. We compared the SIgA marker 
between 69 children in a peri-urban community of Iquitos Peru with a 
history of numerous enteric infections and limited access to water and 
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sanitation infrastructure. Fecal contamination was assessed both by 
questionnaire for the household water, sanitation and hygiene characteristics 
along with quantification of E.coli on floors, tables and drinking water. 
Adjusted for potential confounders, children in households with pit latrines 
versus those with flush toilets to a septic had reduced SIgA (-0.17 log10 
SIgA ug/mL (95% CI: -0.24, -0.10) and -0.11 log10 SIgA/TP (95% CI: -0.21, 
-0.008) and children from homes with greater E.coli contamination in their 
drinking water had higher levels of SIgA (comparing the third highest 
quartile to the lowest quartile with +0.11 log10 SIgA ug/mL [95% CI: 0.03, 
0.19]). These results demonstrate the ability for salivary SIgA to 
differentiate between households using different sanitation options within a 
community. They also validate the proof-of-concept for using salivary SIgA 
as an objective outcome in field-based studies and justify further 
investigation in studies with larger sample sizes to detect differences in pre 
and post intervention settings. 
 
Introduction 
Children who grow up in extreme poverty without safe water and and 
adequate sanitation often suffer from repeated enteric infections and diarrhea 
due to high fecal contamination in their household environments. When 
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these pathogens are introduced early in life, during the critical period of gut 
development under 24 months of age, they may damage the absorptive 
capacity of the intestine contributing to malnutrition and result in long-term 
growth deficits.1 Enteric infections can also compromise the intestinal 
barrier and increase intestinal inflammation leading to the condition of 
environmental enteropathy (EE),2 though the mechanisms involved with 
immune response are poorly understood.3 Therefore, there is a need to 
understand how fecal contamination in the environment impacts the mucosal 
immune system as it contributes to EE in children.  
Research that associates water, sanitation and hygiene conditions of 
children’s living environments to their growth outcomes has increased 
substantially in recent years4-8 and necessitates investigation into how fecal 
contamination can impact the underlying biological mechanisms.9 Limited 
studies have examined the impact of unsanitary environmental conditions on 
gut barrier function, absorptive capacity of the small intestine and intestinal 
inflammation.7, 10, 11. There has been even less work done to understand the 
mucosal immune system response of children in environments without safe 
water and adequate sanitation. Research has shown that recurrent enteric 
infections during infancy and other factors indicating increased microbial 
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pressure were associated with high levels of secretory immunoglobulin A 
(SIgA) in saliva.12 And results from a study of children in a slum of São 
Paulo speculated to have EE suggested that environmental factors influenced 
the early development of the SIgA system.13 
 
Salivary SIgA has potential to be a robust marker for microbial exposure in 
an EE cohort where children are undernourished. The SIgA response in 
salvia has been shown to illustrate the response in the gut to antigenic 
exposure.14 In a study that measured SIgA abundance and affinity in well-
nourished and malnourished groups of children from São Paulo, no 
differences were observed suggesting that in this respect their immune 
system was not impaired.15 On the other hand, differences in SIgA in saliva 
have been observed in Pakistani infants who were heavily exposed to 
Escherichia coli from birth where their antibody levels increased 
significantly by 2 and 3 weeks of age16 compared to less exposed Swedish 
infants where such levels for both for total SIgA and SIgA antibodies to E. 
coli O antigens were not reached until 1 year of age17 and the differences 
between the two groups is possibly explained by the differences in the 
antigenic exposure.18 Interestingly, the same salivary SIgA response was not 
observed in the serum IgA antibody response which remained low in both 
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groups. This illustrates that antigen exposure on the mucosal system may 
result first in production of mucosal antibodies.16 
 
The aim of this study was to investigate the associations of salivary SIgA in 
children enrolled in an EE cohort to the fecal contamination in their 
household environments. We hypothesized that children living in households 
with conditions more likely to foster enteric pathogens would have higher 
concentrations of SIgA in their saliva. Children enrolled in the MAL-ED10 
cohort study in Iquitos, Peru between the ages of 3 and 4 years old were 
sampled for saliva. The varying water, sanitation and hygiene conditions in 
their home were characterized at the same time their floors, tables and 
drinking water in each home were sampled to quantify the number of E. coli 
bacteria.  
 
Methods 
 
Study community 
This study took place in three peri-urban communities of Iquitos, Peru 
(3°47’S, 73°20’W) located next to the Nanay River, Santa Clara de Nanay, 
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Santo Tomas, and La Union. The tropical conditions of the Amazon river 
system are highly favorable to pathogens to persist in the environment. 
There is an average temperature of 25.8 degrees Celsius19 and rainfall is 
frequent and occurs throughout the year.19 Diarrheal incidence is high in 
children 12-23 months of age when compared to the literature in the last 
decade20 with 4.38 episodes per child-year.21 Stunting prevalence in the 
study community is also remarkably high with 46.3 percent of children 
under 5 years old classified as stunted (height for age z-score < -2)19 when 
compared to the rates in Africa and Asia where 35.6 percent and 26.8 
percent of children under 5 years old are stunted, respectively.22 In a prior 
cohort study in Santa Clara frequent causes of bacterial diarrhea were 
Shigella, Campylobacter, and enterotoxigenic E. coli.21 Norovirus is also 
thought to be a significant cause of diarrhea and has been found in 21.3 
percent of diarrheal stool samples and 3 percent of non-diarrheal samples.23 
Giardia lamblia had a higher presence in asymptomatic stool samples with 
21.3 percent compared to symptomatic diarrheal samples with 18.9 percent. 
The communities lack centralized sewerage infrastructure and are prone to 
frequent fecal contamination from onsite storage of human feces in either pit 
latrines or septic systems21 that can overflow during flooding from the 
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Nanay River or when fecal matter is not hygienically emptied, transported 
and/or treated. 
 
Water, sanitation and hygiene household characterization 
Households were characterized for their household water, sanitation and 
hygiene (WASH) conditions at the beginning of the study in May and June 
of 2015 and at the end during August and September of 2015. During each 
household visit, a household questionnaire was administered in Spanish 
based on the Demographic and Health Surveys24 and was a shortened 
version of the standardized questionnaire used during the MAL-ED study. 
The questionnaire assessed the type of sanitation facility used by household 
members and whether or not this facility was shared, the household’s 
primary water source, mode of water treatment, time it takes to fetch water, 
hygiene behavior and crowding. Information was also collected on socio-
economic factors such as housing construction materials, length of tenancy, 
electricity access, maternal education, and monthly income. Given the 
propensity for households to keep free-ranging or corralled chickens in this 
community, participants also were interviewed in a separate survey 
regarding the presence of chickens in the home to evaluate the influence of 
chicken feces on bacterial contamination in the household. 
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Household E. coli sampling and evaluation 
Household floors, tables and drinking water were sampled at the beginning 
and end of the study in May to June and August to September of 2015. The 
floors and tables were sample for E. coli bacteria using a modified dry 
electrostatic cloth method based on one designed for household settings.25 
The highly trafficked floor areas were sampled near the entrance and in the 
kitchen area where cooking activities were performed to represent the likely 
encounters that children have with fecal contamination on floors. Different 
floor material types (e.g. dirt, wood, cement) were recorded at both locations 
at the time of sampling to determine if the varying surface types influenced 
the presence of E. coli bacteria. A sample of drinking water was collected 
during the sampling at the end of the study by requesting a glass of water 
from the main interviewee in the same manner they would fetch one for 
themselves. Prior to field collection, sterile packets of dry electrostatic cloths 
(Swiffer™; Proctor & Gamble, Cincinnati, OH) were prepared and 
autoclaved as previously described (Chapter 3, Methods Section). For each 
collection on floors and tables an adapted protocol from Davis et al. (2012) 
was used where a prepared cloth was passed over a 30 cm by 30 cm surface 
with medium pressure to maximize the amount of pick-up from the surface 
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25. The cloth was then placed into a sterile 700 mL Whirlpak bag (Nasco, 
Fork Atkinson, WI) and 5 mL of sterilized Milli-Q ultra-pure water to guard 
against microbial desiccation during transport. All surface and water 
samples were stored in a cooler on ice at 4°C during field collection and 
transported to the laboratory. Samples were processed within six hours of 
collection and enumerated following USEPA Method 160426 using m-
coliblue24 commercial media (HACH, Loveland, U.S.A.). Results were 
reported in colony forming units (CFU) per 900 cm2 sampled for floors and 
tables and CFU per 100 mL of water.  
 
Saliva collection and analysis 
Children under 48 months of age who were enrolled in the MAL-ED cohort 
were eligible for the study. The children were visited weekly for saliva 
collection over a three month period from June through August 2015. 
During the final two weeks of the study repeat samples were collected from 
children 2 to 3 days following the protocol sample for that week and used 
for validation. Along with each saliva sample, a form was completed by the 
field worker that recorded information about the sample including potential 
confounding factors (time since last waking, time of day, eating 20 minutes 
prior to the sample, if a mouthwash was performed, oral health of the child 
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and if the child was experiencing an episode of diarrhea). Saliva collection 
was performed with the Oracol device manufactured by Malvern Medical 
Developments (Worcester, UK), which has been shown to yield the highest 
quality oral fluid in terms of total and specific antibody concentrations.27 
Saliva samples were taken by field workers at the child’s home in the 
presence of a caretaker by wiping the sponge swab around the gum margin 
for about a minute28 until the sponge was visibly saturated with oral fluid. 
After collection of oral fluid, devices were brought on ice to a field 
laboratory and assigned a unique sample identifier before transportation to 
the laboratory. The oral fluid was extracted and stored in labelled screw cap 
tubes and immediately frozen at -80 degrees C until analyzed. It has been 
shown that long-term storage does not have an affect on antibody affinity17 
nor does long-term storage and multiple freeze-thaw cycles alter the 
molecular weight of IgA.29. For the detection of SIgA commercial enzyme 
immunoassay kits (Salimetrics LLC, State College, PA) were used that 
capture the full range of salivary SIgA levels and use 25 uL of saliva per test 
with minimal incubation times. The kits were kept stable at the 
recommended temperature of 2-8 degrees C. Final concentrations of SIgA 
are reported in μg/mL. 
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Stool collection and analysis 
Under the MAL-ED protocol stool samples were collected on a monthly 
basis and children were followed twice weekly for active surveillance for 
diarrheal disease and illness. Prior to stool testing all samples were stored at 
−70°C. Stool samples collected from May to August 2015 of the children 
with saliva samples were analyzed for the presence or absence of both 
Campylobacter and norovirus infections. Enzyme immunoassay was used 
for detection of Campylobacter spp (ProSpecT, Remel, Lenexa, KS, USA) 
and PCR was used to test stool samples for norovirus of both genotypes I 
(GI) and II (GII). 
 
Statistical analysis 
The relationships between the concentration of salivary SIgA and each 
WASH variable or household fecal contamination sample were analyzed 
using generalized estimating equations and used to fit a linear regression 
model for each child and account for non-independence of saliva testing 
within each participant. The outcome variables were log-10 transformed to 
meet the normality assumptions of linear regression. In all analyses, SIgA 
was adjusted for time since waking, saliva volume and time in weeks of 
study adjusted while SIgA divided by TP was adjusted for time since waking 
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and time in weeks of study. Independent variables were analyzed as 
categorical or ordinal if they were continuous in nature. A hygiene index 
variable score was calculated from four questions as a cumulative score and 
categorized into three levels indicating how often they practiced the hygienic 
behaviors: i) always, ii) most of the time, and iii) sometimes. For the 
multivariate WASH analysis we selected a final parsimonious set of 
independent variables based on considerations of sample size and the 
minimization of the Akaike Information Criterion (AIC).30 Beta coefficients 
and 95% confidence intervals were estimated and represent the log10-unit 
difference in SIgA or SIgA/TP when comparing a category of each 
independent variable (i.e. type of toilet facility used, floor type, etc) to its 
reference category. R-squared and Adjusted R-squared (in the case of low 
intraclass correlation) are presented to determine model fit. Data were 
visualized using R software version 3.0.3 (R-FSC, Vienna, Austria) and all 
statistical analyses were conducted using Stata version 12.1 (College Station, 
TX).  
 
Ethics 
The study protocol and questionnaires were approved by the institutional 
review boards from Johns Hopkins Bloomberg School of Public Health 
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(Baltimore, MD) and Asociación Benéfica Proyectos de Informática, Salud, 
Medicina, y Agricultura (A.B. PRISMA), Iquitos, Peru. All participants gave 
written consent prior to saliva collection and household sampling. 
 
Results 
A total of 69 children were enrolled upon 1 June 2015 who were less than 48 
months of age. They ranged in age from 39 months to 48 months old with 11 
of these children aging out of the cohort before the end of August. During 
saliva collection, 3.2 percent of the samples collected were from children 
reported to be undergoing a diarrheal episode. Given enrollment, there were 
972 expected saliva samples with 907 samples collected for analysis, 
resulting in 6.7 percent of missing data. The coefficient of variation (CV) 
between the samples taken during the last two weeks of the study, 2 to 3 
days from the protocol sample was 13.8 percent compared to the CV of 
samples taken weeks apart, which was 22.6 percent. 
 
WASH variables associated with SIgA 
The study population had various type of sanitation access, including 42.3% 
had access to a pit latrine with no flush, 37.2% had access to a pour flush 
toilet to a septic tank, and 9.7% did not have access to a toilet facility or 
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used the field or a bucket for a toilet. For water source, 68.6% used 
community hand pumps and 11.5% used the public taps with 48.6% doing 
nothing to treat their water, 22.0% using chlorine to treat their water, and 
14.1% allowing their water to stand and settle before drinking it. For the 
hygiene index score 64.2% of the study population always practiced all of 
the hygienic behaviors, 21.9% practiced them most of the time, and 14.0% 
sometimes practiced the hygiene behaviors. The household floors of the 
study population were composed of 61.4% with dirt floors, 32.6% with 
cement floors and 6.0% with woods floors.  
 
The unadjusted analyses (Table 1) found that for those using pit latrines 
compared to those with access to a pour flush toilet to a septic tank, there 
was -0.12 log10 SIgA ug/mL (95% CI: -0.19, -0.04) and -0.09 log10 SIgA/TP 
(95% CI: -0.18, 0.001). For those that used the public tap as their drinking 
water source compared to those that used the community hand pump, there 
was was +0.11 log10 SIgA ug/mL (95% CI: -0.03, 0.24) and +0.18 log10 
SIgA/TP (95% CI: 0.10, 0.26). There was no significant statistical difference 
found for the comparisons between categories in either the hygiene index 
score variable or the floor types.  
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In the multivariate risk factor analysis (Table 2) the comparison between 
those using pit latrines to those with access to a pour flush toilet to a septic 
tank became highly significant and increased in effect size compared to the 
unadjusted analysis where there was -0.17 log10 SIgA ug/mL (95% CI: -
0.24, -0.10) and -0.11 log10 SIgA/TP (95% CI: -0.21, -0.008). The 
concentration of SIgA/TP for those using the public tap as their drinking 
water source was no longer significant compared to those using the 
community hand pump. When comparing the SIgA of children in 
households in the highest quartile of the number of household members to 
those in the lowest quartile, there was +0.12 log10 SIgA ug/mL (95% CI: 
0.04, 0.20). For children in households with longer tenancy, there were 
reduced levels of SIgA for all categories when comparing them to the lowest 
category of having lived in the house for less than a year (e.g. a household 
with more than twenty years tenancy in the same home had -0.13 log10 SIgA 
ug/mL (95% CI: -0.25, -0.02).  
 
E. coli contamination associated with SIgA 
There was a total of 117 household visits to sample the floors, tables, and 
drinking water in the homes of 69 children for whom saliva was also 
sampled. Of these homes, 48 were visited in the beginning and end of the 
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study period, and 21 were visited at either the beginning or end. For the 
homes that had one visit to sample household contamination, the data for 
those households during the period that were not sampled were considered 
missing resulting in 15.2% missing data for the household contamination 
sample.  
 
Of the floor areas sampled, the levels of log10 E. coli CFU/900 cm2 on 
kitchen floors were found to have the greatest association with the levels of 
SIgA in the children’s saliva in these homes though not statistically 
significant (Table 3). The highest quartile of log10 E. coli CFU compared to 
the lowest quartile had -0.08 log10 SIgA ug/mL (95% CI: -0.18, 0.01) and -
0.12 log10 SIgA/TP (95% CI: -0.25, 0.007) (Table 3). For the glass of 
drinking water, the log10 E. coli CFU per 100mL of water was found to be 
statistically significant when comparing the third highest quartile to the 
lowest quartile with +0.11 log10 SIgA ug/mL (95% CI: 0.03, 0.19) (Table 3).  
 
SIgA associated with stool pathogen presence  
A total of 317 stool samples were collected from the 69 children enrolled 
and analyzed for the presence or absence of Campylobacter spp and 
norovirus GI and GII for the period of May to August 2015. There were 27 
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stools that tested positive for norovirus GI, 29 stools positive for norovirus 
GII and 2 stools that were positive for both norovirus GI and GII. There 
were 134 stools that tested positive for Campylobacter spp with 32 children 
testing positive for Campylobacter spp two or more times during the study 
period.  
 
As displayed in Figure 1, there was a negative association between the 
concentrations of salivary SIgA and the number of pathogens detected in a 
stool sample four weeks later with -0.27 pathogens detected in stool (95% 
CI: -0.53, -0.02) for every unit increase in log10 SIgA (Table 4a). There was 
also a decreased risk for a norovirus GII positive stool detection with 
increased concentrations of salivary SIgA three and four weeks prior (Table 
4a).  
 
Discussion 
This study found evidence for an association between household 
contamination and the concentrations of salivary SIgA in children between 
the ages of three and four years old. The type of household toilet facility, 
number of people living in the home, and number of years tenancy of the 
household were all significantly associated with salivary SIgA in the 
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multivariate analysis. The elevated concentrations of salivary SIgA in this 
peri-urban community in Iquitos Peru is confirmed by comparison to other 
populations that are hypothesized to have less household contamination. For 
example, the mean log10 SIgA in Iquitos was 1.79 ug/mL (95% CI: 
1.71,1.88) versus 1.60 ug/mL (95% CI: 1.51, 1.70) in an age-matched 
reference group of the children from rural North Carolina (data not 
published).   
 
The finding of significantly lower salivary SIgA in children from homes 
with pit latrines compared to those with a flush toilet to a septic supports 
may indicate impaired mucosal immunity in the mucosal surfaces that 
occurs when there is enhanced susceptibility to enteric infections and are 
often more frequent and severe in protein-calorie malnutrition.31 The 
increased enteric infections and therefore, impaired mucosal immunity as 
indicated by lower SIgA in the saliva may be attributable to the increased 
contamination of households by pit latrines. This finding is in line with the 
finding from Chapter 3 of this dissertation that found increased 
contamination on household floors from an unimproved sanitation facility, 
such as a pit latrine.  
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The utility of salivary SIgA to measure the overall exposure to fecal 
contamination in the household is further supported by the increased SIgA 
detected in the saliva of children living in homes with the greatest number of 
household members compared to the lowest quartile. This finding is 
confirmed by a study in Swedish children that found that infants with older 
siblings were associated with higher SIgA levels.12 This study also found 
that having a history of more than three infections in infancy (another 
environmental factor associated with a high microbial load stimulating the 
immune system) was associated with higher SIgA levels, thereby having a 
protective effect on late-onset wheezing. These findings are also similar to 
this study, in that those with higher SIgA had a lower likelihood of detection 
of a pathogen in their stool sample four weeks later.  
 
This study had several important limitations. Most notable was the lack of 
heterogeneity across the different WASH characteristics. This is best 
demonstrated by the drinking water source variable where the majority of 
the population used the community hand pumps. The sample sizes were 
small for the other less protected water sources thereby preventing decisive 
statistical results. At the same time, there was a significant increase in 
salivary SIgA for the children in homes with higher levels of E.coli in 
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drinking water which suggests that drinking water may be an important 
modulator of SIgA in saliva. We also did not control for the number of 
respiratory infections that may potentially confounding the relationships 
observed.  
 
The strengths of this study include an intensive longitudinal follow-up study 
design that collected weekly SIgA measurements in a field-based setting. 
The age requirements for enrollment into the study had a tight window to 
ensure that the age-dependence of salivary SIgA did not bias results. 
Additionally, a baseline and end line community questionnaire was 
administered to ensure that any changes in the WASH characteristics were 
accurately represented thereby reflecting any changes observed in salivary 
SIgA.  
 
Conclusion 
Our study provides new evidence for the use of salivary SIgA as a potential 
marker for fecal contamination in the household environment. Household 
use of a pit latrine resulted in significantly lower levels of salivary SIgA 
compared to those using a pour flush toilet to a septic tank, potentially 
indicating impaired mucosal immunity from repeated enteric infections. The 
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ability to differentiate salivary SIgA levels within a community validates 
this proof-of-concept for using salivary SIgA as an objective outcome in 
field-based studies and these findings justify its use within in a larger sample 
size where differences are detected in pre and post intervention settings. 
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Table 1. WASH Household Risk-Factor Analysis for Salivary IgA marker using generalized 
estimating equations with robust variance estimation to account for correlations due clustering at the 
child level. 
	
 Log10 sIgA11 R2 Log10 sIgA/TP12 R2 
SANITATION 
Type of toilet facility that households usually use 
(N=67, n=736): 
Flush toilet to septic tank (n=272) 
No facility/bush/field or bucket toilet (n=71) 
Pit latrine without flush (n=317)  
Flush toilet to piped sewer system (n=37) 
Ventilated improved pit latrine (n=17) 
Flush toilet to somewhere else (n=22)
 
 
REF 
0.02 (-0.12, 0.17) 
-0.12 (-0.19, -0.04)** 
-0.14 (-0.24, -0.05)** 
-0.11 (-0.38, 0.17) 
-0.10 (-0.24, 0.05) 
0.215 
 
 
REF 
-0.004 (-0.14, 0.13) 
-0.09 (-0.18, 0.001)* 
-0.16 (-0.29, -0.02)* 
-0.14 (-0.21, -0.07)✝ 
0.02 (-0.26, 0.29)
0.102 
Shared Sanitation Facility (N=64, n=681): 
Unshared (n=504)
Shared (n=177)
 
REF 
0.05 (-0.04, 0.14) 
0.190 
 
REF 
0.03 (-0.09, 0.15) 
0.089 
WATER 
Drinking water source (N=67, n=736): 
Community hand pump (n=507) 
Household piped connection (n=7) 
Public tap (n=83) 
Protected well (n=7) 
Unprotected well (n=7) 
Surface water (n=21) 
Other (n=104)
 
REF 
-0.04 (-0.09, 0.02) 
0.11 (-0.03, 0.24) 
0.26 (0.20, 0.31)✝✝ 
0.16 (0.11, 0.21)✝✝ 
-0.11 (-0.21, -0.01)* 
0.01 (-0.06, 0.09) 
0.207 
 
REF 
0.01 (-0.05, 0.08) 
0.18 (0.10, 0.26)✝✝ 
0.10 (0.04, 0.16)** 
0.31 (0.24, 0.36)✝✝ 
-0.23 (-0.35, -
0.11)✝✝ 
-0.02 (-0.14, 0.10) 
0.117 
Time to fetch water in minutes (N=66, n=713): 
Q1 (n=354) 
Q2 (n=0) 
Q3 (n=242) 
Q4 (n=117)
 
REF 
-- 
-0.04 (-0.12, 0.04) 
-0.02 (-0.10, 0.06) 
0.199 
 
REF 
-- 
-0.03 (-0.12, 0.06) 
0.01 (-0.10, 0.13) 
0.098 
                                                 
11 Adjusted for time since waking, saliva volume and time in weeks of study 
12 Adjusted for time since waking and time in weeks of study 
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Methods to treat water (N=67, n=729): 
Do nothing (n=354) 
Let is stand and settle (n=106) 
Chlorine (n=161) 
Boiling (n=50) 
Other (n=58)
 
REF 
-0.06 (-0.14, 0.03) 
-0.008 (-0.10, 0.08) 
0.13 (-0.05, 0.32) 
0.01 (-0.08, 0.10) 
0.202 
 
REF 
-0.12 (-0.24, -0.01)* 
0.03 (-0.09, 0.15) 
0.14 (0.003, 0.27)* 
-0.03 (-0.15, 0.08) 
0.106 
CHICKENS 
Presence of chickens in HH (N=69, n=842): 
No (n=628) 
Yes (n=214)
 
REF 
0.02 (-0.05, 0.09) 
0.179 
 
REF 
0.02 (-0.07, 0.12) 
0.079 
Chickens are corralled (N=38, n=211): 
No (n=171) 
Yes (n=40)
 
REF 
-0.01 (-0.17, 0.14) 
0.305 
 
REF 
0.01 (-0.18, 0.21) 
0.138 
Number of chickens in household (N=64, n=501): 
Q1 (n=190) 
Q2 (n=153) 
Q3 (n=45) 
Q4 (n=113)
 
REF 
-0.05 (-0.16, 0.05) 
0.04 (-0.06, 0.15) 
-0.02 (-0.12, 0.08) 
0.171 
 
REF 
-0.01 (-0.13, 0.10) 
0.13 (0.03, 0.23)** 
0.04 (-0.10 0.19) 
0.079 
HYGIENE 
Hygiene Score (N=67, n=729): 
Always (n=470) 
Most of the time (n=158) 
Sometimes (n=101)
 
REF 
0.02 (-0.06, 0.10) 
-0.01 (-0.12, 0.10) 
0.195 
 
REF 
-0.03 (-0.11, 0.05) 
0.006 (-0.15, 0.16) 
0.092 
SOCIO-ECONOMIC STATUS 
Monthly income per capita (in USD) (N=67, n=716): 
Q1 (n=222) 
Q2 (n=135) 
Q3 (n=256) 
Q4 (n=103)
 
 
REF 
0.08 (0.007, 0.16)* 
0.01 (-0.08, 0.10) 
0.04 (-0.07, 0.14) 
0.203 
 
 
REF 
0.05 (-0.05, 0.15) 
0.01 (-0.09, 0.12) 
0.05 (-0.06, 0.17) 
0.096 
Maternal Education (years) (N=66, n=724): 
Q1 (n=184) 
Q2 (n=231) 
Q3 (n=171) 
Q4 (n=138)
 
REF 
-0.06 (-0.18, 0.05) 
-0.01 (-0.13, 0.10) 
0.02 (-0.09, 0.14) 
0.201 
 
REF 
-0.08 (-0.21, 0.05) 
0.006 (-0.13, 0.14) 
0.07 (-0.06, 0.21) 
0.109 
HOUSEHOLD CHARACTERISTICS 
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Floor type (N=66, n=728): 
Cement (n=237) 
Wood (n=42) 
Dirt (n=449)
 
REF 
-0.08 (-0.18, 0.02) 
-0.06 (-0.12, 0.006) 
0.204 
 
REF 
-0.06 (-0.23, 0.11) 
0.01 (-0.07, 0.10) 
0.204 
Crowding (# of rooms in HH/# people sleeping in HH 
(N=67, n=723): 
Q1 (n=195) 
Q2 (n=214) 
Q3 (n=139) 
Q4 (n=175)
 
 
REF 
-0.06 (-0.15, 0.03) 
-0.01 (-0.13, 0.11) 
0.05 (-0.03, 0.12) 
0.204 
 
 
REF 
-0.05 (-0.15, 0.05) 
-0.008 (-0.15, 0.13) 
0.02 (-0.10, 0.14) 
0.095 
Number of household members (N=67, n=723): 
Q1 (n=253) 
Q2 (n=160) 
Q3 (n=195) 
Q4 (n=115)
 
REF 
-0.01 (-0.11, 0.08) 
-0.06 (-0.16, 0.04) 
-0.001 (-0.08, 0.07) 
0.199 
 
REF 
-0.10 (-0.23, 0.03) 
-0.09 (-0.20, 0.02) 
-0.03 (-0.13, 0.07) 
0.100 
Electricity connection (N=66, n=735): 
Yes (n=668) 
No (n=67)
 
REF 
0.03 (-0.06, 0.13) 
0.196 
 
REF 
-0.06 (-0.21, 0.08) 
0.093 
Wall type (N=67, n=728): 
Concrete (n=194) 
Wood (n=536)
 
REF 
-0.06 (-0.12, 0.004) 
0.200 
 
REF 
-0.002 (-0.09, 0.08) 
0.091 
Roof type (N=66, n=728): 
Metal (n=699) 
Palm/thatch (n=29)
 
REF 
0.22 (0.17, 0.27)✝✝ 
0.204 
 
REF 
0.28 (0.12, 0.44)✝ 
0.104 
Tenancy in household (N=67, n=736): 
Less than a year (n=106) 
Between one and five years (n=252) 
Between five and ten years (n=188) 
Between ten and twenty years (n=105) 
More than twenty years (n=85)
 
REF 
-0.11 (-0.20, -0.02)* 
-0.15 (-0.25, -0.05)** 
-0.12 (-0.23, -0.02)* 
-0.14 (-0.23, -0.06)** 
0.207 
 
REF 
-0.03 (-0.18, 0.12) 
-0.10 (-0.25, 0.05) 
-0.07 (-0.21, 0.07) 
-0.19 (-0.34, -0.04)* 
0.104 
* Significance at the p<0.05 level 
** Significance at the p<0.01 level 
✝Significant difference at the p<0.001 level 
✝✝Significant difference at the p<0.0001 level 
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Table 2. Multivariate WASH Household Risk-Factor Analysis for Salivary IgA marker using 
generalized estimating equations with robust variance estimation to account for correlations due 
clustering at the child level. 
	
 
Log10 sIgA13 
(N=66, n=715) 
Log10 sIgA/TP14 
(N=66, n=715) 
R2 (Adjusted R2) 0.262 (0.219) 0.171 (0.123) 
Type of toilet facility that households usually use 
Flush toilet to septic tank (n=271) 
No facility/bush/field or bucket toilet (n=58) 
Pit latrine without flush (n=310)  
Flush toilet to piped sewer system (n=37) 
Ventilated improved pit latrine (n=17) 
Flush toilet to somewhere else (n=22)
 
REF 
-0.007 (-0.11, 0.09) 
-0.17 (-0.24, -0.10)✝✝ 
-0.10 (-0.23, 0.04) 
-0.18 (-0.42, 0.05) 
-0.22 (-0.35, -0.09)** 
 
REF 
0.02 (-0.08, 0.11) 
-0.11 (-0.21, -0.008)* 
-0.04 (-0.23, 0.15) 
-0.15 (-0.28, -0.02)* 
-0.08 (-0.31, 0.15)
Drinking water source 
Community hand pump (n=492) 
Household piped connection (n=7) 
Public tap (n=77) 
Protected well (n=7) 
Unprotected well (n=7) 
Surface water (n=21) 
Other (n=104)
 
REF 
-0.12 (-0.27, 0.03) 
0.03 (-0.06, 0.13) 
0.26 (0.16, 0.36)✝✝ 
0.10 (-0.03, 0.24) 
-0.16 (-0.29, -0.03)* 
0.01 (-0.06, 0.09) 
 
REF 
-0.04 (-0.28, 0.20) 
0.09 (-0.03, 0.21) 
0.13 (0.01, 0.25)* 
0.32 (0.16, 0.47)✝✝ 
-0.14 (-0.35, 0.08) 
-0.01 (-0.13, 0.11) 
Floor type 
Cement (n=224) 
Wood (n=42) 
Dirt (n=449)
 
REF 
0.06 (-0.05, 0.17) 
0.01 (-0.06, 0.08) 
 
REF 
-0.009 (-0.13, 0.11) 
0.02 (-0.07, 0.11) 
Number of household members 
Q1 (n=252) 
Q2 (n=160) 
 
REF 
0.0007 (-0.08, 0.08) 
 
REF 
-0.10 (-0.21, 0.008) 
                                                 
13 Adjusted for time since waking, saliva volume and time in weeks of study 
14 Adjusted for time since waking and time in weeks of study 
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Q3 (n=188) 
Q4 (n=115)
0.007 (-0.06, 0.08) 
0.12 (0.04, 0.20)** 
-0.07 (-0.17, 0.04) 
0.07 (-0.06, 0.20) 
Wall type 
Concrete (n=192) 
Wood (n=515)
 
REF 
-0.09 (-0.18, 0.002)* 
 
REF 
-0.08 (-0.16, 0.002) 
Roof type 
Metal (n=678) 
Palm/thatch (n=29)
 
REF 
0.37 (0.30, 0.43)✝✝ 
 
REF 
0.43 (0.28, 0.57)✝✝ 
Tenancy in household 
Less than a year (n=100) 
Between one and five years (n=251) 
Between five and ten years (n=174) 
Between ten and twenty years (n=105) 
More than twenty years (n=85)
 
REF 
-0.12 (-0.22, -0.02)* 
-0.19 (-0.30, -0.08)** 
-0.18 (-0.29, -0.07)* 
-0.13 (-0.25, -0.02)* 
 
REF 
-0.003 (-0.15, 0.14) 
-0.07 (-0.24, 0.09) 
-0.03 (-0.19, 0.12) 
-0.16 (-0.34, 0.01) 
* Significance at the p<0.05 level 
** Significance at the p<0.01 level 
✝Significant difference at the p<0.001 level 
✝✝Significant difference at the p<0.0001 level 
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Table 3. Associations of household contamination on floors, tables and drinking water with Salivary 
IgA as measured in the saliva of 4-year olds living in the households using generalized estimating 
equations with robust variance estimation to account for correlations due clustering at the child level. 
 
Log10 sIgA15  
(ug/mL) 
R2 
Log10 sIgA/TP16 
 (ug/mL) 
R2 
Log10 E. coli on entrance floor (CFU 
per 900 cm2) (N=67, n=736): 
Q1 (n=200) 
Q2 (n=188) 
Q3 (n=164) 
Q4 (n=184)
 
 
REF 
-0.05 (-0.13, 0.03) 
-0.02 (-0.11, 0.06) 
0.002 (-0.08, 0.09) 
0.198 
 
 
REF 
-0.03 (-0.11, 0.06) 
0.02 (-0.09, 0.12) 
-0.004 (-0.12, 0.11)
0.092 
Log10 E. coli on kitchen floor (CFU 
per 900 cm2) (N=67, n=736): 
Q1 (n=190) 
Q2 (n=190) 
Q3 (n=188) 
Q4 (n=168)
 
 
REF 
-0.04 (-0.12, 0.04) 
-0.03 (-0.13, 0.06) 
-0.08 (-0.18, 0.01) 
0.200 
 
 
REF 
-0.03 (-0.13, 0.07) 
-0.06 (-0.16, 0.05) 
-0.12 (-0.25, 0.007)
0.099 
Log10 E. coli on main table (CFU per 
900 cm2) (N=67, n=730): 
Q1 (n=219) 
Q2 (n=166) 
Q3 (n=173) 
Q4 (n=172)
 
 
REF 
-0.06 (-0.14, 0.03) 
-0.05 (-0.15, 0.05) 
-0.03 (-0.12, 0.06) 
0.198 
 
 
REF 
-0.09 (-0.20, 0.02) 
-0.06 (-0.16, 0.04) 
0.02 (-0.09, 0.13)
0.098 
Log10 E. coli in glass of drinking water 
(CFU per 100 mL) (N=55, n=372): 
Q1 (n=257) 
Q2 (n=0) 
Q3 (n=26) 
Q4 (n=89)
 
 
 
REF 
-- 
0.11 (0.03, 0.19)** 
0.180 
 
 
 
REF 
-- 
0.07 (-0.17, 0.31) 
0.098 
                                                 
15 Adjusted for time since waking, saliva volume and time in weeks of study 
16 Adjusted for time since waking and time in weeks of study 
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-0.01 (-0.14, 0.11) 0.01 (-0.12, 0.15) 
* Significance at the p<0.05 level 
** Significance at the p<0.01 level 
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Figure 1. Relationship between the number of pathogens found in stool 
(Campylobacter spp, norovirus GI and GII) with concentrations of 
log10 SIgA in saliva four weeks prior 
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Table 4. Associations of Salivary IgA with the number of pathogens detected in stool (Norovirus GI, 
Norovirus GII, and Campylobacter) using GEE models adjusting for time in weeks of study. 
 
 
Norovirus GI + Norovirus GII + Campylobacter 
Number of pathogens per stool (0, 1, 2 (or 3) 
Same week saliva (n=226): 
log10SIgA 
log10(SIgA/TP)
 
0.01 (-0.19, 0.22) 
-0.11 (-0.30, 0.08) 
1 week prior saliva (n=201): 
log10SIgA 
log10(SIgA/TP)
 
-0.12 (-0.33, 0.10) 
-0.11 (-0.30, 0.08) 
2 week prior saliva (n=178): 
log10SIgA 
log10(SIgA/TP)
 
0.02 (-0.29, 0.33) 
-0.11 (-0.34, 0.12) 
3 week prior saliva (n=152) 
log10SIgA 
log10(SIgA/TP)
 
-0.002 (-0.22, 0.22) 
-0.09 (-0.28, 0.10) 
4 week prior saliva (n=159): 
log10SIgA 
log10(SIgA/TP)
 
-0.27 (-0.53, -0.02) 
-0.18 (-0.39, 0.03) 
5 week prior saliva (139): 
log10SIgA 
log10(SIgA/TP)
 
0.005 (-0.34, 0.35) 
-0.08 (-0.39, 0.22) 
6 week prior saliva (114): 
log10SIgA 
log10(SIgA/TP)
 
-0.36 (-0.78, 0.06) 
0.03 (-0.41, 0.47) 
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Table 5. Associations of Salivary IgA with Norovirus GI, Norovirus GII, and Campylobacter detection 
in stool using GEE models adjusting for time in weeks of study. 
	
 
Norovirus GI 
Odds Ratio (95% CI) 
Norovirus GII 
Odds Ratio (95% CI) 
Campylobacter 
Odds Ratio (95% CI) 
Same week saliva (n=226): 
Cases (n) 
N 
log10SIgA 
log10(SIgA/TP)
 
19 
167 
0.74 (0.25, 2.25) 
0.85 (0.24, 2.93) 
 
17 
134 
0.82 (0.22, 3.05) 
0.55 (0.19, 1.56) 
 
99 
226 
1.14 (0.49, 2.65) 
0.73 (0.35, 1.52) 
1 week prior saliva (n=201): 
Cases (n) 
N 
log10SIgA 
log10(SIgA/TP)
 
16 
141 
1.10 (0.18, 6.71) 
2.69 (0.41, 17.7) 
 
11 
104 
0.44 (0.07, 2.87) 
0.38 (0.08, 1.92)
 
87 
201 
0.64 (0.30, 1.40) 
0.59 (0.30, 1.14) 
2 week prior saliva (n=178): 
Cases (n) 
N 
log10SIgA 
log10(SIgA/TP)
 
15 
135 
1.37 (0.18, 10.59) 
1.70 (0.26, 11.34) 
 
9 
62 
0.70 (0.02, 21.02) 
1.40 (0.16, 12.28)
 
78 
176 
0.96 (0.38, 2.45) 
0.50 (0.21, 1.14) 
3 week prior saliva (n=152) 
Cases (n) 
N 
log10SIgA 
log10(SIgA/TP)
 
15 
130 
2.85 (0.70, 11.56) 
2.48 (0.42, 14.49) 
 
9 
60 
0.30 (0.11, 0.83) 
0.35 (0.14, 0.88) 
 
67 
149 
1.06 (0.54, 2.09) 
0.71 (0.38, 1.35) 
4 week prior saliva (n=159): 
Cases (n) 
N 
log10SIgA 
log10(SIgA/TP)
 
17 
126 
0.51 (0.19, 1.39) 
0.75 (0.32, 1.76) 
 
10 
77 
0.32 (0.11, 0.94) 
0.55 (0.23, 1.28)
 
71 
159 
0.61 (0.27, 1.37) 
0.64 (0.31, 1.30) 
5 week prior saliva (140): 
Cases (n) 
N 
log10SIgA 
log10(SIgA/TP)
 
16 
100 
1.49 (0.36, 6.13) 
2.11 (0.57, 7.82) 
 
10 
79 
0.92 (0.15, 5.52) 
1.13 (0.29, 4.43)
 
59 
139 
0.95 (0.31, 2.88) 
0.51 (0.19, 1.38) 
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6 week prior saliva (116): 
Cases (n) 
N 
log10SIgA 
log10(SIgA/TP)
 
15 
107 
0.92 (0.14, 5.85) 
1.76 (0.39, 7.96) 
 
10 
77 
0.28 (0.03, 2.77) 
2.58 (0.26, 25.36)
 
46 
113 
0.25 (0.05, 1.20) 
0.56 (0.14, 2.35) 
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Table S1. Sample size distribution for number of pathogens per stool (0, 
1, 2 (or 3). 
	
 
Number of pathogens per stool 
(0, 1, 2 (or 3)	
Same week saliva (n=226): 
0 
1 
2 or 3
 
108 
102 
16 
1 week prior saliva (n=201): 
0 
1 
2 or 3
 
100 
89 
12 
2 week prior saliva (n=178): 
0 
1 
2 or 3
 
88 
79 
11 
3 week prior saliva (n=152) 
0 
1 
2 or 3
 
74 
66 
12 
4 week prior saliva (n=159): 
0 
1 
2 or 3
 
75 
71 
13 
5 week prior saliva (139): 
0 
1 
2 or 3
 
68 
58 
13 
6 week prior saliva (114): 
0 
1 
2 or 3
 
57 
45 
12 
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Chapter 6 
 
Conclusion 
This dissertation set out to go beyond the paradigm of diarrheal disease as 
the main outcome of interest in water, sanitation and hygiene (WASH) 
interventions in developing countries. The research that was conducted 
investigated the hypothesis that fecal contamination in the household 
environment due to a lack of adequate WASH conditions contributes to the 
development of environmental enteropathy in peri-urban, flood-prone 
communities in Iquitos, Peru. The dissertation study was designed around 
the conceptual model outlined in Figure 1 below.  
 
Figure 1. Expected impact of improved sanitation 
 
The importance of focusing on multiple transmission routes to understand 
health outcomes in response to improvements in sanitation was described by 
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John Briscoe in 1984 when he argued, that “the effect of improvements in 
water quality should not be evaluated by the reduction in disease due to 
water supply improvements in isolation, but rather by the degree to which 
the improvements in water quality affect the health effects of other 
(simultaneous or subsequent) essential changes in environmental conditions 
or personal health practices”.1 
 
The research conducted in Specific Aim 1 of this work was the first study, to 
our knowledge, to longitudinally analyze household water, sanitation and 
hygiene characteristics of children from birth to 24 months of age and relate 
these characteristics to the newly developed EE fecal markers of NEO, AAT 
and MPO as a way to more effectively measure the risk a child faces in 
developing EE and provide a mechanism to prioritize interventions to 
children in greatest need. This study found that children with less protected 
water sources, an interrupted water supply and decreasing volumes of water 
stored in their homes experienced more EE. In addition, children that lived 
in homes where fecal matter was stored near their homes had greater 
occurrence of EE compared to children from homes that had no toilet 
facility. This is an important study in the field of WASH intervention 
research because the most commonly used outcome that has been used to 
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understand the EE mechanism in cluster randomized control trials (RCTs) 
has been linear growth.2-4 While linear growth is an important, objective 
outcome for child health, it is also an irreversible outcome that often is 
measured after the critical period of 0 to 24 months of age for gut 
development. The significant findings in this study, considering that this 
study was conducted in a non-intervention based setting in a community that 
was relatively homogeneous in terms of its levels of WASH services, gives 
promise to the use of these fecal biomarkers in larger RCTs to detect 
differences in child gut health while there is still time to alter EE outcomes.  
 
The study conducted to address the Specific Aim 2 of this dissertation 
characterized the floors pathway, for which there is limited research, as a 
mechanism for pathogen transmission. Contamination of household floors 
with enteric pathogens is especially of concern for children less than 24 
months of age, as this age group is particularly vulnerable to developing EE 
for those with inadequate sanitation and pervasive fecal contamination. 
Therefore, we conducted an exposure assessment of the floors of children 
enrolled in the MAL-ED study site in Iquitos Peru and found that 
households with unimproved sanitation versus improved sanitation had 
higher levels of log10 E. coli bacteria CFU per 900 cm2 of surface area in 
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fully adjusted multivariate regressions models. In addition, households that 
had shared sanitation facilities (compared to those that did not share) and 
households that had a presence of chickens (versus those that did not) both 
had higher levels of log10 E. coli bacteria CFU per 900 cm2 of surface area in 
fully adjusted multivariate regressions models. The concentrations of E. coli 
contamination that we found on the dirt floors of these Peruvian homes were 
approximately 5 to 80 times more contaminated than other studies that had 
conducted similar studies.5, 6 This may reflect either or both possibilities that 
the dry electrostatic cloth sampling method used in our study had a higher 
efficiency for sampling bacteria from floor surfaces than other methods and 
that the dirt floors in these tropical households carried particularly high 
bacterial loads. It is evident that if an infant is to play on a dirt floor in a 
home with unimproved sanitation and engages in hand to mouth activity, 
there is a greater chance that they will ingest fecal pathogens than if they had 
improved sanitation in their living environment. This study also 
demonstrated that improved sanitation along with an improved floor type 
(either cement or wood) resulted in a greater reduction of log10 E. coli 
bacteria CFU per 900 cm2 of surface area than when there was only an 
improvement in the sanitation facility. This provides evidence that WASH 
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interventions may have a greater impact on child gut health and linear 
growth if they are paired with flooring improvements in households. 
 
The third aim of this dissertation investigated the utility of salivary 
immunoassays using secretory immunoglobulin A (SIgA) as a marker of 
microbial pressure to improve assessment of recent exposure to fecal 
pathogens in a community-based longitudinal study. A review was also 
conducted of the pathogen-specific antibody biomarkers for waterborne 
pathogens to assess the prevalence and incidence of infections from 
pathogens that are typically waterborne but can also be transmitted via other 
fecal-oral routes. This review discussed the use of antibody biomarkers that 
have been most widely used in serum but are now increasingly being 
analyzed in saliva to understand the incidence and prevalence of infections 
that are potentially waterborne. The utility of these single pathogen assay 
platforms have limited application in contexts of extreme poverty where 
population-based infections are from a wide range of enteric pathogens. 
However, the development of multiplex platforms for antibodies to multiple 
pathogens has potential for population-based applications in developing 
countries where there is background knowledge of the burden and etiology 
of enteric infection in children, such as in the Global Enteric Multicenter 
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Study.7 For the purposes of our study, since such a multiplex platform had 
not yet been developed for the peri-urban communities of Iquitos Peru, the 
marker of salivary SIgA was used as a global marker for microbial exposure 
in an EE cohort. The household characteristic that had the greatest 
association with the levels of SIgA in children’s saliva in the fully adjusted 
multivariate model was the type of toilet facility used by the household. 
Children from homes with greater E. coli contamination in their drinking 
water also had higher levels of SIgA in their saliva. These results provide 
evidence for using SIgA as a global marker for environmental microbial 
pressure and confirmed the ease of use and minimally invasive collection 
method of saliva in children such that it could plausibly be applied widely 
across a population in a longitudinal study design to improve exposure 
assessments to fecal contamination. 
 
A look toward 2030: Measuring and monitoring the Sustainable 
Development Goals 
The Sustainable Development Goals (SDGs) recently adopted at the 2015 
UN Summit have set ambitious targets to be reached by 2030 and Goal 6 
states, “ensure availability and sustainable management of water and 
sanitation for all" 
(https://sustainabledevelopment.un.org/topics/waterandsanitation). The 
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SDGs follow on the Millennium Development Goals (MDGs) which in 2000 
called for the world to halve, by 2015, the proportion of people without 
access to safe drinking water as well as the proportion of people who do not 
have access to basic sanitation. The goal for water has largely been met 
while the MDG for sanitation lagged behind the targeted 50% reduction. The 
new SDGs therefore mean that in the next decade there will be a large 
number of infrastructure investments and behavioral change programs that 
go into place to accomplish these goals. In order to monitor and measure the 
progress that these SDGs bring about it will be important to measure the 
impact on child health outcomes. To accomplish this, new and innovative 
tools and methodologies are needed that can be applied across populations 
both urban and rural.  
 
This dissertation has laid out some examples of new tools and 
methodologies to help monitor and measure progress toward SDG 6. Most 
importantly, this thesis argues that diarrheal incidence health outcomes have 
reporting bias and measurement errors that justify a reappraisal of its use as 
the primary outcome to evaluate sanitation interventions. Here we argue for 
a paradigm shift towards evaluating a reduction in EE in the population in 
association with water and sanitation interventions and development 
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institutions have already begun to embrace the shift.8 The fecal markers for 
EE could be used to measure improvements in gut health and salivary SIgA 
could be used as a tool to measure the overall reduction of exposure to fecal 
contamination. Meanwhile, to more directly measure reductions of fecal 
bacteria in the environment, the dry electrostatic cloth method developed 
during this research could be used to sample floors and surfaces in homes to 
detect the expected reductions in contamination that proper containment, 
disposal and treatment of fecal matter would bring to a community. 
 
We look forward to a future where all communities will be able to meet their 
basic needs and have access to safe and sustainable water and sanitation. 
This goal may seem optimistic but we join with the authors of the SDGs to 
state that it is well within reach. This thesis aimed to contribute toward 
developing the tools necessary to ensure that this goal is met. 
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